Influence of Connexin Expression/Co-Expression Levels on Electrical Impulse Propagation Investigated in the HL-1 Cell Model by Dias, Priyanthi & Dias, Priyanthi
 1 
 
 
 
 
Influence of Connexin Expression/Co-Expression Levels on 
Electrical Impulse Propagation Investigated in the HL-1 Cell 
Model  
 
 
 
A thesis submitted to Imperial College  
for the degree of Doctor of Philosophy 
 
 
by 
 
 
Priyanthi Dias 
 
April 2011 
 
 
Cardiac Medicine 
National Heart and Lung Institute 
Imperial College 
Dovehouse Street 
London SW3 6LY 
 
 
 
 
 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For my family 
 3 
Acknowledgements 
I would like to express my deepest gratitude to Dr Ken MacLeod for giving me the 
opportunity to join his laboratory and for supporting me throughout my PhD.  
 
I would like to express my gratitude to Dr Emmanuel Dupont for his excellent guidance 
and contributions. It was through his extensive knowledge and many discussions that 
led to a number of experiments included in this thesis.  
 
I would also like to thank Professor Nicholas Severs for allowing me to work freely in 
his lab and for his helpfulness during my PhD. 
 
I am greatly indebted to Dr Thomas Desplantez and Mr Stephen Rothery for their 
invaluable support and advice. Many thanks to Dr Michele Miragoli and Dr Nina 
Ullrich for their teaching and continued guidance in my studies. Additionally I would 
like to thank all my colleagues in the lab, Dr Giselle Rowlinson, Dr Kimberly Trim, Dr 
Alexandra Bruce and particularly Dr Katharina Grikscheit for her constant support and 
friendship and making my stay in and outside the lab an enjoyable experience. 
 
I am also very grateful to the National Heart & Lung Institute Foundation for funding 
my PhD studentship.  
 
I would like to give special thanks to mama and papa for their continued support, for 
always believing in me and without them this PhD would not have happened. On a 
personal level I would like to thank Abbey and Susan for their friendship and most of 
all to Gaurav for his constant encouragement, patience and being there when I needed 
him especially during the final stages of my write up. 
 4 
Abstract 
In the myocardium action potentials are transmitted from cell-to-cell through gap 
junctions. These specialised junctions play a pivotal role in regulating the speed and 
safety of impulse propagation by controlling the amount of depolarised current that is 
passed from excited to non-excited regions of the heart. In mammalian hearts gap 
junction proteins connexin43, connexin40 and connexin45 are co-expressed in 
distinctive combinations and relative quantities in functionally specialised subsets of 
cardiac myocyte. The functional consequences of these connexin expression/co-
expression patterns in modulating impulse propagation are poorly understood. To study 
the relative importance of membrane excitability and electrical coupling in relation to 
propagation velocities, clones of the HL-1 mouse atrial myocyte tumour line were used 
as an in vitro cell model. Five clones were characterised for expression of myocytic 
markers, calcium handling proteins and connexins, two of which (#2 and #6) displayed 
large differences in conduction velocities using microelectrode arrays. To ascertain 
which factor(s) were the main determinants of speed of conduction, the membrane 
excitability (voltage-gated channels) and electrical coupling (gap junctions) between the 
two clones were compared. Sodium, L- and T-type calcium channels were present in 
both clones but no significant differences were found in the current densities. However, 
large differences were seen in expression levels of connexin43, connexin40 and 
connexin45. RNA interference combined with microelectrode arrays was employed to 
establish the relative importance of each connexin in impulse propagation. The results 
indicate that electrical coupling by gap junctions is a major determinant of conduction 
velocities in HL-1 cell lines. Further experiments using RNA interference to suppress 
the expression of proteins thought to play a role in the action potential parameters 
should help in defining the part played by either the active or passive electrical 
properties in action potential propagation. 
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CHAPTER 1. 
Introduction 
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1.1. Intercellular communication 
Intercellular communication is of paramount importance in multicellular organisms and 
tissues permitting individual cells to interact with neighbouring cells and with cells at a 
distance in a coordinated manner through a variety of modes of transmembrane 
signalling (Yeager 2009; Herve et al. 2007). Direct cell-to-cell signalling requires 
intercellular junctions to be formed so mediating different types of interactions between 
cells (Severs 1995). Intercellular junctions consist of specialised microdomains in the 
apposing plasma membranes of neighbouring cells. The three main classes of junction 
are: occluding junctions (tight junctions), anchoring junctions (desmosomes and 
adherens junctions) and communicating junctions (gap junctions) (Severs 1995). 
 
The main focus of our study is on gap junctions which are clusters of transmembrane 
channels that directly link the cytoplasmic compartments of neighbouring cells allowing 
the passage of electrical impulses and exchange of various compounds such as 
regulatory molecules less than 1kDa including metabolites, ions and second messengers 
(Gros and Jongsma 1996; Sohl and Willecke 2004). Gap-junctional communication 
plays a key role in tissue homeostasis and regulation of growth, development and 
differentiation (Severs et al. 2008). In the heart gap junctions mediate the orderly spread 
of current flow from one cardiac myocyte to the next on which the sequential 
contraction of the cardiac chambers depends on (Severs et al. 2004a). Alterations in 
electrical coupling brought about by changes in connexin expression and gap junction 
organisation referred to as ‘gap junction remodelling’ are key contributors to rhythm 
disturbances (arrhythmias) and contractile dysfunction. Thus a detailed knowledge of 
the role of gap junctions is essential to our understanding of function in the healthy and 
diseased heart. 
 
1.2. Molecular and structural characteristics of gap junction channels 
1.2.1. Identification of gap junctions and connexins 
The first structural evidence of gap junctions emerged from thin-section electron 
microscopy between Mauthner cell synapses in goldfish brains described as a honey 
comb like hexagonal arrays of closely packed subunits (Robertson 1963). Further work 
by Benedetti and Emmelot (1968) revealed hexagonal arrays across membrane sheets in 
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negatively stained preparations of isolated liver membranes but mistook them as 
components of tight junctions (Figure 1.1 (A)). It was work by Revel and Karnovsky 
(1967) that distinguished gap junctions from tight junctions by using an extracellular 
tracer composed of oxidised lanthanum salts which identified extracellular spaces in 
electron microscope specimens. They were able to visualise cell junctions with a minute 
gap between the external membranes in both the liver and heart. It is this gap that gives 
gap junction its name. Figure 1.1 (B) shows a thin-section view of a gap junction. 
 
The development of freeze-fracture electron microscopy whereby the biological sample 
is frozen and physically broken apart (fractured) revealing the internal organisation of 
the exposed membrane (Severs 2007a) unequivocally recognized tight junctions and 
gap junctions as distinctive structures. A replica of the fractured membrane is made by 
vacuum-deposition of platinum carbon. Subsequent studies of these replicas 
demonstrated that gap junctions are organised in patches of closely-packed particles 
corresponding to earlier work by thin-section microscopy and negative staining studies 
as seen in Figure 1.1 (C) (Kreutziger 1968; Goodenough and Revel 1970). Freeze-
fracture combined with the complementary replica technique in which the matching 
replicas of each side of the fracture plane are viewed (Severs 1995) revealed two sets of 
membrane spanning structures, one in each of the two junctional membranes (Chalcroft 
and Bullivant 1970; Steere and Sommer 1972; De Mazière et al. 1987). Since the 
original identification of gap junctions, several procedures have been developed such as 
the use of detergents (e.g. sarkosyl deoxycholate) and biochemical analysis (e.g. sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE)) to isolate and purify 
gap junctions (Evans and Gurd 1972; Goodenough and Stoeckenius 1972; Fallon and 
Goodenough 1981). These developments led to the first identification of connexins- the 
protein components of gap junctions, in the liver (32 kiloDaltons (kDa)) and heart 
(43kDa) (Manjunath and Page 1985; Revel et al. 1985; Green et al. 1988). In the next 
section I will present the essential nomenclature applied to connexins and detail the 
genes that encode them. 
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Figure 1.1: Early views of gap junction channels by electron microscopy and freeze-fracture  
Frontal views of gap junctions from rat liver plasma membranes negatively stained with 
phosphotungstate at 37
o
 C. Gap junctions are seen as hexagonally packed subunits with a centre-to-
centre distance of ~9 nm. (Image enhanced by rotation; x 1,667,000). Image reproduced from 
Benedetti and Emmelot (1965). Image (B) is a high magnification view of a gap junction. The normal 
intercellular space (ics) is reduced to a gap (g) of ~2nm in the junctional area. Image reproduced from 
Revel and Karnovsky (1967). The aggregated particles in the circled area in (C) represent closely-
packed gap junction hemichannels from the rat heart. As freeze-fracture splits the membrane along its 
hydrophobic core, two types of views may be seen: clusters of particles attached to the protoplasmic 
(P) face and corresponding pits attached on the exoplasmic (E) face. Image reproduced from Severs et 
al. (1993). 
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1.2.2. Connexin nomenclature 
The family of connexin genes comprises of 20 members in the mouse and 21 in the 
human genome (Table 1.1) (Sohl and Willecke 2004; Laird 2006; Beyer and Berthoud 
2009). The connexin family members serve a common purpose of permitting the 
intercellular exchange of small molecules but the functional channel properties are 
attributed to the subset of connexins expressed in any one cell type (Laird 2006). For 
example in the myocardium, Cx43 plays a key role in action potential propagation 
(Severs et al. 2008) whereas in the lens, which is avascular, Cx43 shares the 
responsibility in maintaining homeostasis and transparency (White et al. 1994; 
Shakespeare et al. 2009). 
 
A new nomenclature system for connexin genes was decided at the International Gap 
Junction Conference 2007 that recognises the sub-divisions of the gene family based on 
DNA sequence comparisons (Kidder 2009). A key feature of this system is that 
orthologous genes in all mammalian species will have the same symbols whereas non- 
orthologous genes are assigned unique numbers. In brief, the new terminology retains 
the use of the connexin protein name written as the abbreviation Cx followed by a suffix 
indicating the molecular mass in kDa. Many of the connexin genes have identifiable 
orthologous pairs in both human and mouse (Table 1.1). There are exceptions with 
certain connexins expressed only in the mouse (e.g. Cx33) or the human genome (e.g. 
CX25). Furthermore, orthologous connexins in different species may not only differ in 
their molecular mass (e.g. mouse Cx30.2 is the ortholog of human CX31.9) but also in 
expression (e.g. human CX31.9 could not be detected in the atrioventricular node when 
its mouse counterpart Cx30.2 is expressed) (Sohl and Willecke 2004; Kreuzberg et al. 
2009). 
 
For identification of connexin genes a Greek letter classification is used. The genes 
begin with a three letter code starting with Gj (gap junction) and a sub-group derived 
from the Greek letter classification (, , ,  and ). This is then followed by a number 
according to the order of discovery (e.g. Cx43 the first identified connexin gene of the 
-group is encoded as Gja1). Although the connexin genes carry the same abbreviation 
irrelevant of the species in human and mouse, to distinguish human connexins from 
other species connexin genes and proteins are given capital letters such as GJA1 and 
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CX43 respectively. Throughout my thesis for clarity and convenience I will use the 
term Cx where the species is irrelevant.  
 
Table 1.1: Nomenclature of connexin proteins and genes in human and mouse  
 
Human Mouse 
Tissue expressing the connexins 
Protein Gene Protein Gene 
CX43 GJA1 Cx43 Gja1 Heart, Skin, Lung, Lens, Bone* 
CX46 GJA3 Cx46 Gja3 Lens 
CX37 GJA4 Cx37 Gja4 Blood vessels 
CX40 GJA5 Cx40 Gja5 Heart, Skin 
----- ----- Cx33 Gja6 Testes 
CX50 GJA8 Cx50 Gja8 Lens 
CX59 GJA9 (GJA10) ----- -----  
CX62 GJA10 Cx57 Gja10 Retina 
 
CX32 GJB1 Cx32 Gjb1 Liver, Nervous system 
CX26 GJB2 Cx26 Gjb2 Liver, Skin 
CX31 GJB3 Cx31 Gjb3 Skin 
CX30.3 GJB4 Cx30.3 Gjb4 Skin 
CX31.1 GJB5 Cx31.1 Gjb5 Skin 
CX30 GJB6 Cx30 Gjb6 Skin 
CX25 GJB7 ----- ----- Skin 
 
CX45 GJC1 (GJA7) Cx45 Gjc1 Heart, Skin 
CX47 GJC2 (GJA12) Cx47 Gjc2 Nervous system 
CX30.2/CX31.3 GJC3 (GJE1) Cx29 Gjc3 Brain 
 
CX36 GJD2 (GJA9) Cx36 Gjd2 Retina, Nervous system 
CX31.9 GJD3 (GJC1) Cx30.2 Gjd3 Heart 
CX40.1 GJD4 Cx39 Gjd4 Developing muscle 
 
CX23 GJE1 Cx23 Gje1 N/A 
 
The introduction of the new system led to same gene names having the same 
abbreviation. These were changed and their former names are in brackets. The table is 
adapted from (Laird 2006; Beyer and Berthoud 2009). *Cx43 is the most ubiquitously 
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expressed connexin in mammals present in more than 35 different cell types including 
astrocytes and smooth muscle cells. 
 
1.2.3. Structure of the connexin gene and protein 
Connexin gene structure 
The genomic structure of connexin genes is relatively simple. The gene consists of a 5’-
untranslated region (5’-UTR) designated as exon 1 (E1) that is separated from a second 
exon (exon 2) by an intron of variable size (Sohl and Willecke 2004; Oyamada et al. 
2005; Beyer and Berthoud 2009). Exon 2 contains the complete coding sequence and 
the 3’ untranslated region (3’-UTR) (Figure 1.2 (A)). Since the initial identification of 
connexin gene structure many exceptions have been identified. For examples Gjb1 the 
gene for Cx32, which contains multiple 5’-UTR exon 1 sequences that are alternatively 
spliced to exon 2 after transcription (Figure 1.2 (B)) (Neuhaus et al. 1995; Sohl et al. 
1996). Alternatively spliced variants of Gjb1 are driven by two tissue specific 
promoters: (1) in hepatocytes and acinar cells Cx32 mRNA is made from promoter 1 
upstream of exon 1 and (2) in Schwann cells transcription is initiated from promoter 2 
upstream of exon 1b (Oyamada et al. 2005). Another example is Gjc1 (encoding Cx45) 
as it contains three exons including two 5’-UTR exons with the complete reading frame 
located in exon 3 (Figure 1.2 (C)) (Baldridge et al. 2001; Jacob and Beyer 2001). Since 
Gjc1 contains multiple exons, transcripts can be differentially spliced containing the 5’-
UTR generated from either exon 1 or exon 2 or only exon 2. Studies on Gja1 (encoding 
Cx43) have identified six exons, five of which correspond to the 5’-UTR (exons IA to 
1E) and one containing the coding region (exon 2) and three alternative promoter 
regions (Figure 1.2 (D)) (Pfeifer et al. 2004). As a result nine different mouse Gja1 
mRNA have been generated through the use of different promoters and alternative 
splicing. The differing 5’-UTR could provide a major site for translational regulation by 
providing a site for interaction with other proteins that can increase or reduce the 
efficiency of translation initiation (Pickering and Willis 2005). For example 
approximately 10% of all mRNA contain a long 5’-UTR that increases the propensity 
for the formation of a stable secondary structure (e.g. hairpin structure). This structure 
could prevent the progress of the ribosome along the mRNA thereby inhibiting 
translation initiation. 
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Figure 1.2: Connexin gene structure  
(A) is the most common gene structure which contains only one 5’-UTR designated at exon 1 (E1) and 
an uninterrupted coding region in exon 2 (E2) using Gjb1 as an example. Some connexin genes contain 
two or more 5’-UTR exon 1 sequences that are alternatively spliced to exon 2 due to transcription from 
tissue-specific promoters (B). Gjc1 consists of two 5’-UTR exons (1 and 2) that may be present with 
the coding region (exon 3) in the mature mRNA (C). Nine different Gja1 mRNA can be generated by 
the presence of five 5’-UTR (exons 1A to E) and three alternative promoter regions (D). The connexin 
protein encoded by the gene is in brackets. Image modified from Beyer and Berthoud (2009) and 
Oyamada et al. (2005).  
 
In many connexin genes the promoter is located  300 base pairs upstream from the first 
exon containing the transcriptional initiation site (Beyer and Berthoud 2009). Within 
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this region binding sites for transcription factors are present. Examples of ubiquitous 
transcription factors include specificity protein family (Sp1/Sp3), TATA box binding 
protein and activator protein-1 (AP-1). Binding of these factors are important in the 
basal transcriptional process and may also be important for large changes in expression 
(Oyamada et al. 2005; Beyer and Berthoud 2009). For instance at the onset of labour a 
marked increase in the myometrial expression of Gja1 mRNA may occur through c-fos 
production which interacts with AP-1 (Piersanti and Lye 1995). 
 
Connexin gene promoters bind transcription factors specific to the tissue type. These 
include Nkx2.5, GATA4 and Tbx5 which regulate Gja5 (Cx40) expression in the heart. 
Nkx2.5 is also an important regulator of Gja1 and Gja7 (Dupays et al. 2005). 
Transcription factors can be specific for the cell type or more ubiquitous as 
demonstrated for the differential expression of Gjb1 (Cx32). For example the P1 
promoter contains binding sites for cell independent factors Sp1/Sp3 together with 
hepatocyte nuclear factor-1, a cell type specific promoter highlighting the different 
mechanisms of transcript regulation (Koffler et al. 2002). 
 
Transcription regulation is also governed by biological substances (e.g. cyclic adenosine 
monophosphate (cAMP) and retinoids) or through the manipulation of signal 
transduction pathways (e.g. Wnt/β-catenin/T-cell factor/lymphocyte enhancer binding 
factor and Ras-Raf-MAPK pathway). The majority of the work regarding gene 
regulation has been carried out using Gja1. For instance cAMP has been shown to affect 
Gja1 expression by not only enhancing the gene promoter activity but also the 
redistribution of Cx43 to the membrane (Oyamada et al. 2005). cAMP has been shown 
to work in parallel with the Wnt pathway in enhancing the activity of rat Gja1 promoter 
P1 thereby increasing mRNA expression (van der Heyden et al. 1998). Connexin 
transcription could also be suppressed through epigenetic mechanisms such as 
hypermethylation of DNA or histone acetylation of the DNA in promoter regions 
(Beyer and Berthoud 2009). 
 
Recently the role of microRNA (miRNA), which are non coding RNA (~22 nucleotides 
in length) that mediate post-transcriptional gene silencing by either reducing translation 
or mRNA stability through annealing to complementary sequences in the 3’-UTR of 
target mRNA, has been highlighted in regulating connexin expression (Bushati and 
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Cohen 2007). Anderson et al. (2006) demonstrated that during muscle differentiation 
miR-206 and miR-1 forms base pairs with Gja1 in the 3’-UTR thereby inhibiting the 
translation of Cx43 mRNA. In addition overexpression of miR-1 may function as a 
arrhythmogenic factor in humans with coronary heart disease and in rats with 
myocardial infarctions by post-transcriptionally suppressing Gja1 and KCNJ2 (which is 
a gene encoding the inward rectifying potassium (K
+
) channel Kir2.1) affecting cardiac 
conduction (Yang et al. 2007). 
 
To conclude, connexin expression is a complex process controlled by multiple 
regulatory mechanisms including transcription and post-translation processes depending 
on the tissue type and biological need of the cell. 
 
Connexin protein structure 
Connexins are classified as a family of proteins based on sequence similarity and 
inferred transmembrane topology (Beyer et al. 1990). Sequence analysis revealed a 
significant amount of similarity (35-65%) between connexins (Bruzzone et al. 1996). In 
certain cases (i.e. Cx43) a high degree of conservation across species is maintained. The 
organisation of connexins was first proposed by Zimmer et al. (1987) using a 
combination of proteolytic digestion and site-directed antibodies and this has remained 
largely unchanged since. 
 
Connexins are integral membrane proteins spanning the membrane four times to form 
four hydrophobic transmembrane domains (designated M1, M2, M3 and M4) separated 
by one cytoplasmic loop between M2 and M3 and two extracellular loops (E1 and E2) 
(Figure 1.3) (Goodenough et al. 1996; Sohl and Willecke 2004; Laird 2006). The 
carboxyl- and amino-termini of the protein are located in the cytoplasm (Harris 2001; 
Laird 2006). This topology has only been validated for Cx32 (Zimmer et al. 1987; 
Goodenough et al. 1988; Milks et al. 1988), Cx43 (Yancey et al. 1989) and Cx26 
(Zhang and Nicholson 1994) but no exceptions have been identified to date and so this 
model has been extrapolated to all the family members (Beyer and Berthoud 2009). 
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Figure 1.3: Membrane topology of connexin proteins  
A connexin is composed of four transmembrane domains (M1, M2, M3 and M4), two extracellular loops 
(EI and E2) with three characteristically spaced cysteine residues on each loop, a cytoplasmic loop (CL) 
an amino-terminus (NT) and carboxyl-terminus (CT). Each of the domains has specific functions in 
gating, phosphorylation and channel make-up, some of which are shown here. Image modified from 
Bruzzone et al. (1996). 
 
Amino acid sequence alignment of different connexins has revealed that the four 
transmembrane domains, two extracellular domains (only exception is rat Cx31) and the 
amino-terminus are conserved between connexin family members (Laird 2006). The 
sequences and the length of the cytoplasmic loop and carboxyl-terminus between 
connexins are not conserved and are responsible for the diversity and differences in 
molecular mass observed between connexins (Harris 2001; Laird 2006). 
 
There are different domains within the connexin structure that have specific roles: (1) 
each of the extracellular loops contain three cysteine residues that are involved in the 
docking of connexons in apposing membranes by disulphide bridge formation; (2) 
transmembrane domains form the channel and are critical determinants of the correct 
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membrane topology of connexins; (3) cytoplasmic loops influence pH and chemical 
gating properties; (4) amino-terminus influence the voltage gating and channel opening 
and closure (Maeda et al. 2009) and (5) carboxyl-terminus influence pH, voltage gating 
and unitary conductance and provides sites for post-translational modifications such as 
phosphorylation (Bruzzone et al. 1996; Harris 2001). 
 
Based on their sequence homologies connexins are divided into subgroups (e.g. ,  
and ) with respect to gene structure, degree of sequence identity and length of the 
cytoplasmic loop as shown in Figure 1.4 (Sohl and Willecke 2004; Koval 2006). For 
example: (1) the length of the cytoplasmic loop of the  connexins is approximately 
double that of the  connexins (Bruzzone et al. 1996) and (2)  connexins have a larger 
cytoplasmic loop and carboxyl-terminal tail (Yeager 1998). 
 
 
 
Figure 1.4: Connexin sequence homology 
Phylogram of 20 human connexins based on the sequence homology. Connexins are divided into two 
main subgroups  and  with an additional group with intermediate homology. Originally proposed as 
a scheme for terminology of connexin proteins, this type of classification remains useful in the context 
of compatibility of different connexin types to form gap junction channels. The mouse connexin 
names that differ from the human orthologs are in brackets. Image reproduced from Koval (2006). 
 
1.2.4. From connexins to connexons and gap junction channels 
Six connexin subunits oligomerise into a connexon or hemichannel. A single connexon 
is composed of 24 -helical bundles suggestive of the four transmembrane helices per 
connexin subunit with a central aqueous cavity (Figure 1.5 (A)) (Unger et al. 1997; 
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1999; Verselis 2009). Connexons from apposing plasma membranes interact across a 
narrow extracellular space (‘gap’) to form the complete gap junction channel. The 
individual gap junction channels are arranged in hexagonal arrays that are often referred 
to as ‘gap junction plaques’ (Goodenough et al. 1996). 
 
The structure of gap junction channels has been studied using nuclear magnetic 
resonance, atomic force microscopy and two- and three-dimensional image processing 
by electron cryomicroscopy (Yeager 2009). In brief, atomic force microscopy (Hoh et 
al. 1993; Lal and Lin 2001) and three dimensional crystallography (Perkins et al. 1997) 
revealed that the extracellular surface topology of a homomeric connexon consists of six 
alternating peaks and valleys due to structural asymmetry between the extracellular 
domains (Figure 1.5 (B)). From this is was proposed that the peak of one connexon will 
fit into the valley of the other which requires a 30º
 
rotational stagger to dock (Figure 1.5 
(C)) (Unger et al. 1997; Perkins et al. 1998). This interdigitation of the peaks and 
valleys significantly increases the potential number of bonds (i.e. hydrogen bonds, 
hydrophobic interactions and ionic interactions) creating a tight interlocking structure 
necessary for a functional channel and stability (Sosinsky and Perkins 2000).  
 
Maeda et al. (2009) determined the crystal structure of gap junction channels composed 
of Cx26 at a 3.5Å resolution, which further highlighted key structural determinants in 
channel regulation. The study identified the first transmembrane helix to be the major 
pore lining region in each connexin by forming a funnel at the channel entrance thereby 
restricting the charge and size of the molecules entering it. In addition the N-terminal 
region was shown to be crucial in regulating the gating of the channel (Oshima et al. 
2008; Maeda et al. 2009). For example Cx26 channels are known to close in response to 
a positive potential, which in turn results in the movement of the helical portion of the 
N-terminus forming a plug at the cytoplasmic entrance thereby closing the channel. 
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Figure 1.5: Connexin channel structure 
Image A, left panel is an en face view of a connexon showing only the transmembrane helical domains 
as viewed from outside the cell looking into the permeability pore (asterisk). The transmembrane 
domains correspond to M1 (blue), M2 (green), M3 (yellow) and M4 (red). Image reproduced from 
Koval (2006). Image A, right panel depicts a connexon structure within the plane of the plasma 
membrane. Approximate sizes of the extracellular loops, transmembrane domains and cytoplasmic 
regions are indicated. Image (B) is a reconstruction of split gap junction channels of Cx32 from 2D 
crystals. From left to right, cytoplasmic, cross section, and modelled docked structure of a channel. 
The peak and valley topology of connexons permits the formation of a channel sealed sufficiently to 
enable electrical communication. Image (C) is the alignment of two connexons to form junctional 
channels. Connexins in the apposed plasma membranes (red and blue) are represented as rectangles, 
and two -helices within each connexin as circles. The figure on the right illustrates the 30º rotational 
stagger between the two connexons, causing the -helices of each connexon to align. Images (B) and 
(C) are reproduced from Harris (2001).  
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As mentioned earlier the intermolecular interaction between two connexons occurs 
through disulphide bonds formed between the conserved three cysteine residues on the 
extracellular loops (CX6CX3C in extracellular loop 1; CX4CX5C in extracellular loop 2) 
(Dupont et al. 1989; Hoh et al. 1991; John and Revel 1991; Rahman and Evans 1991; 
Foote et al. 1998). Studies on isolated hepatocyte junctions showed that mutations in 
any of the six cysteine residues completely blocks gap-junctional conductances 
highlighting their importance in channel function (Dahl et al. 1991; 1992).   
 
Different connexins may be present within a given cell type. For example rodent 
hepatocyte gap junctions contain both Cx32 and Cx26. These observations raise the 
possibility that naturally occurring gap junction channels could be formed from more 
than one connexin subtype (Sosinsky 1995). Figure 1.6 illustrates the different 
connexon types that could be formed when two different connexin subtypes are co-
expressed: homomeric connexons composed of a single connexin; heteromeric 
connexons composed of at least two different connexins; homotypic channels when two 
identical connexons dock and heterotypic connexons formed by the docking of two non-
identical connexons (Cottrell and Burt 2005). In cells that express two connexin 
subtypes, fourteen different homomeric and heteromeric connexons may form (Brink et 
al. 1997). And if each of these fourteen connexons were to form channels with each 
other then this could yield as many as 196 (14
2
) different channels. These structural 
variants could provide a variety of channels with different permeabilities and gating 
sensitivities (Harris 2001). 
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Figure 1.6: Predicted configurations of connexons and gap junction channels formed from two 
different connexins 
When two different connexins are expressed, theoretically fourteen different connexons can be 
formed, two homomeric connexons consisting of one type of connexin and twelve heteromeric 
connexons consisting of two types of connexins (A). Image adapted from Brink et al. (1997). The 
docking of two homomeric connexons results in a homomeric/homotypic channels. Two homomeric 
connexons of different connexin composition produce a homomeric/heterotypic channel and two 
heteromeric connexons form a heteromeric/heterotypic channel. Image was kindly gifted by Stephen 
Rothery. 
 
Not all connexins are compatible and have the ability to form functional gap junction 
channels. To study compatibility a range of techniques has been used. The majority of 
evidence for heterotypic and heteromeric channels have been based on in vitro 
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electrophysiological experiments using the dual voltage clamp technique on paired 
Xenopus oocytes (Bruzzone et al. 1993; White et al. 1995) and transfected mammalian 
cell lines (Elfgang et al. 1995; Haubrich et al. 1996; Elenes et al. 2001; Desplantez et al. 
2004) expressing different connexin subtypes.  
 
Cells expressing a single connexin subtype are co-cultured together and the gap-
junctional conductance measured between the cell pairs. Fluorescence imaging using 
different fluorescent markers (e.g. green fluorescent protein (GFP) and cyan fluorescent 
protein (CFP)) has been used to distinguish cells expressing two different connexin 
subtypes and this has been followed by confocal microscopy to visualise gap junction 
formation (Hopperstad et al. 2000; Rackauskas et al. 2007a). Gap junction channel 
assembly and distribution from the different connexin types have also been studied in 
living cells using fluorescent tracers (Falk 2000). 
 
Evidence for heterotypic channels in vivo comes from scanning transmission electron 
microscopy of intact and split liver junctions between Cx26 and Cx32 (Sosinsky 1995). 
Other biological settings in which heterotypic channels have been identified include 
Cx45-Cx36 in the retina (Dedek et al. 2006) and Cx32-Cx26 in the central nervous 
system (Altevogt and Paul 2004). Studies on chimeric connexins whereby the different 
domains (e.g. extracellular loops 1 and 2 and cytoplasmic loop) between two different 
connexins are swapped indicated that compatibility between homomeric connexons 
likely depends on the specific motifs in the extracellular loops (White et al. 1995; 
Haubrich et al. 1996). 
 
Experimental data of multiple connexin co-expression and co-localisation at the cell and 
tissue level have come from double and triple labelling techniques. Examples include 
Cx40, Cx43 and Cx45 in the atria and Purkinje fibres (Vozzi et al. 1999; Severs et al. 
2001), Cx40, Cx43 and Cx37 in aortic endothelial cells (Yeh et al. 2000), Cx45 and 
Cx36 in the rodent retina (Li et al. 2004b) and Cx30, Cx26 and Cx31 in the rat cochlea 
(Nickel et al. 2009). It should be noted that multiple labelling by confocal microscopy is 
only indicative of a possible co-localisation within the same gap junction plaque. 
Electron microscopy is required for definitive evidence of co-localisation. 
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Co-immunoprecipitation and electrophysiological experiments using cell pairs provided 
evidence for heteromeric channels in endogenously co-expressing tissue such as Cx32-
Cx26 in the liver (Bevans et al. 1998), Cx46-Cx50 in the lens (Jiang and Goodenough 
1996) and Cx43-Cx46 in the lung (Das et al. 2001) and transfected cell models such as 
Cx40-Cx43 and Cx45-Cx43 (Brink et al. 1997; Valiunas et al. 2001; Martinez et al. 
2002a; Desplantez et al. 2004). Heteromeric compatibility between connexins loosely 
correspond to the  and  subgroups (Figure 1.4) although there are exceptions to the 
rule (Koval 2006). For instance Cx29 that does not belong to either subgroup can form 
heteromers with  connexin Cx32. Using site-directed mutagenesis it was found that 
motifs that determine heteromeric compatibility include amino acid residues at specific 
locations in the amino-terminus and the cytoplasmic end of the third transmembrane 
domain (Lagree et al. 2003). Although the formation of heterotypic and heteromeric 
channels give rise to gap junctions with unique biophysical properties their roles in vivo 
are still unknown (Cottrell and Burt 2005). 
 
1.3. Gap junction life cycle 
1.3.1. Connexin turnover 
Connexins are dynamic short-lived proteins with a half-life of only a few hours, 
exceedingly short compared to typical integral plasma membrane proteins (Laird 2010). 
The classical approach in studying connexin turnover involves pulse-chase studies 
whereby cells are exposed to labelled metabolic precursors (e.g. [
35
S] methionine) for 
short periods of time (pulse). This labelled compound is incorporated into the 
connexins. The introduction of this label is followed by unlabelled compound (chase). 
The label is tracked and the connexin formation and trafficking followed thereafter 
(Laird et al. 1991; Laing and Beyer 1995; Beardslee et al. 1998; Musil et al. 2000). 
From such studies in rat cardiac myocytes the half-lives of Cx43 and Cx45 are 1-2 
hours and 2-3 hours respectively (Laird et al. 1991; Darrow et al. 1995). However there 
are exceptions such as in cultured cells of the lens where two different kinetic pools of 
Cx56 were identified, with half-lives of 2-3 hours and of 2-3 days (Berthoud et al. 
1999). It is likely that the function of the longer half-life pool is to maintain connexin 
stability. The rapid turnover normally retained by connexins ensures cells are able to 
govern the level of intercellular communication by modulating their assembly and 
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degradation and rapidly respond to physiological stimuli that prolongs or enhances their 
function (Laird 2006; Musil 2009). 
 
1.3.2. Connexin synthesis, oligomerisation and transport to the plasma membrane 
Gap junction channels are oligomeric and the connexin subunits must assemble before 
delivery into the plasma membrane (Segretain and Falk 2004; Koval 2006). The early 
stages of connexin biogenesis examined using a cell-free coupled transcription-
translation in vitro approach showed that connexin polypeptides are co-translationally 
integrated into the endoplasmic reticulum (ER) (Falk et al. 1994; 1997; Ahmad et al. 
1999). The only identified exception to this rule is Cx26, which has been shown to be 
post-translationally imported to the ER membrane (Zhang et al 1996; Ahmad et al 1999) 
and directly imported into the plasma membrane bypassing the Golgi network (Diez et 
al. 1999; George et al. 1999; Ahmad and Evans 2002; Martin et al. 2001). In vitro 
studies using N-glycosylation site tagging of connexins combined with protease 
protection assays demonstrated that connexins integrated in vitro are in the correct 
topological orientation (Falk and Gilula 1998; Martin and Evans 2004). Although no 
clear mechanism in connexin membrane integration has been identified it is likely that a 
molecular chaperone facilitates the process as connexins reach their folded and stable 
state (Falk and Gilula 1998; Laird 2006). The formation of inter-disulphide bridges 
between the extracellular loops suggests that connexins are under the surveillance of 
disulphide-isomerases (Laird 2006). 
 
The precise location of connexin oligomerisation remains the subject of some debate. 
Studies from in vitro cell-free systems have reported that connexins assemble into 
connexons within the ER (Falk et al. 1994; 1997; Ahmad et al. 1999; Das et al. 2002; 
Maza et al. 2003; 2005). However treatments that block the ER-to-Golgi transport (e.g. 
brefeldin A disrupts the Golgi apparatus by vesiculating the membrane) did not interfere 
with oliogmeric assembly thereby identifying a novel site for multiunit assembly at the 
trans-Golgi network for Cx43 and Cx46 (Musil and Goodenough 1993; Koval et al. 
1997; Musil 2009). A schematic diagram of the life cycle of connexins is shown in 
Figure 1.7. Differences in the intracellular location of oligomerisation may differ 
between connexins and even cell types (Martin and Evans 2004; Musil 2009). There is 
also experimental evidence (Musil 2009) that the site of connexon assembly may be 
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driven by connexin protein concentration such that overexpression shifts the 
compartment in which assembly is initiated from the trans-Golgi network to the ER 
(Musil 2009; VanSlyke et al 2009). For instance in baby-hamster kidney cells in which 
Cx32 is overexpressed, electron microscopy revealed areas of unusual intercellular 
distribution with double-membrane gap junctions in the ER and the nuclear envelope 
(Kumar et al. 1995) which was later confirmed by VanSlyke et al. (2009). This could 
help explain inconsistent findings in different experimental settings such as exogenous 
overexpression in comparison to endogenous expression (Laird 2006; Musil 2009). It is 
also possible that connexon assembly is a progressive event where subunits begin to 
express in the ER and the ER-Golgi intermediate compartment with stable oligomers 
being established in the late-Golgi networks (Laird 2006; VanSlyke et al. 2009). 
 
 
Figure 1.7: Life cycle of gap junctions 
The gap junction life cycle is a multi-step pathway involving connexin synthesis, trafficking to the 
plasma membrane, channel formation, gap junction maintenance, gap junction internalisation and 
connexin degradation. Connexins furthermore interact with many protein partners, some of which are 
indicated in this overview. Image reproduced from Laird (2005). 
 
The plasma membrane is mainly composed of hexameric connexons confirming that 
oligomerisation is completed in the Golgi and is a key determinant for the trafficking of 
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connexons from the Golgi to the plasma membrane (Li et al. 1996; George et al. 1999). 
This suggests a precise intercellular mechanism that distinguishes between proteins for 
further trafficking and dispensable proteins must exist. The major component of ‘quality 
control’ of newly synthesised proteins occurs at the stage of the ER (Musil 2009). It is 
also likely there are quality control systems function in Golgi network that complements 
the ER quality control pathway since in some connexins, like Cx43, oligomerisation 
takes place after exiting the ER (Arvan et al. 2002). Proteins that are incorrectly 
synthesised or misfolded are degraded through an ER-associated degradation (ERAD) 
process (Figure 1.7) (Ellgaard and Helenius 2003; Meusser et al. 2005). Since ERAD is 
an important mechanism of connexin turnover either up- or down-regulation of this 
process would have a major effect on connexin protein levels and gap junction function 
(Musil 2009). 
 
Transport of connexons to the cell surface generally follows the conventional secretory 
pathways: passage from the ER to the ER-Golgi intermediate compartment and from 
there to the cis-, medial- and trans-Golgi cisternae, the trans-Golgi network and thence 
to the plasma membrane (VanSlyke and Musil 2000; Laird 2006; Musil 2009). 
Intracellular trafficking is usually monitored using newly synthesised connexins that are 
labelled with metabolic precursors or fluorescent markers such as chemiluminescent 
aequorin, GFP and its cyan and yellow (YFP) variants (George et al. 1999; Falk 2000; 
VanSlyke and Musil 2000; Martin et al. 2001; Lauf et al. 2002). Application of drugs 
that disrupt protein trafficking (e.g. brefeldin A) and the cytoskeleton (e.g. nocodazole 
that disrupts microtubules) have also been used. Connexins exit the Golgi 
predominantly in vesicular carriers heterogeneous in size and shape that traffic along 
microtubules to reach the plasma membrane (Lauf et al. 2002; Thomas et al. 2004; 
Thomas et al. 2005). Microtubules are not essential in facilitating connexin delivery but 
rather improve the efficiency of the delivery process (Thomas et al. 2001; Johnson et al. 
2002b; Laird 2006). Recently the role of ER-associated chaperone protein 29 (ERp29) 
has been highlighted in the trafficking process by binding to and stabilising Cx43 
oligomers facilitating its exit from the ER to the trans-Golgi network (Das et al. 2009). 
 
It is still discussed whether the fusion of vesicles occurs to all parts of the plasma 
membrane or whether the vesicles are specifically transported to the vicinity of existing 
gap junction plaques. Studies using fluorescent tagged vesicles showed that insertion of 
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connexons appears random with movement of connexons laterally in the plane of the 
plasma membranes and thus joining the periphery of pre-existing gap junction plaques 
(Lauf et al. 2002; Thomas et al. 2005). This is also supported by observations that 
connexons are distributed as single particles or small groups rather than large aggregates 
(Lauf et al. 2002). Pulse-chase labelling demonstrated that new gap junction channels 
accumulate preferentially at the outer margins of gap junction plaques, with older ones 
accumulating in the centre destined for internalisation and degradation (Gaietta et al. 
2002; Lauf et al. 2002). Support for direct insertion was described by Shaw et al. (2007) 
who noted that connexin-containing vesicles are transported directly along microtubules 
arriving closely at the edge of gap junction plaques. During ischemia and oxidative 
stress displacement of the end binding 1 protein from the microtubule plus ends not 
only limited the microtubule growth pattern but also reduced connexin delivery to the 
plasma membrane (Smyth et al. 2010). Most likely, the degree of specificity of targeting 
may depend on the cell type (e.g. polarised epithelial cells versus non-polarised cells), 
physiological conditions (e.g. ischemia) or connexin subtype (e.g. Cx26) (Martin and 
Evans 2004). 
 
In the life cycle, connexins interact with numerous proteins of the cell machinery 
(Figure 1.7) (Martin and Evans 2004; Giepmans 2006; Laird 2010). This is particularly 
apparent in the heart where connexin interacting proteins such as zonula occludens-1 
(ZO-1) has been associated with regulating the formation and size of Cx43 gap 
junctions (Hunter et al. 2005; Laing et al. 2007; Bruce et al. 2008). Other examples 
include the interaction of Cx43 with tubulin that links this connexin directly to the 
microtubule network (Giepmans et al. 2001) and interactions with calcium (Ca
2+
) 
dependent cell-adhesion molecules such as N- and E-cadherin to help facilitate 
connexon diffusion into the plasma membrane (Jongen et al. 1991; Meyer et al. 1992; 
Kostin et al. 1999; Wei et al. 2005). Wu et al. also demonstrated that Cx43 delivery to 
the plasma membrane requires an interaction between α-or -catenin with N-cadherin 
(Wu et al. 2003). It is likely that these adhesion molecules facilitate the docking of 
connexons by bringing the membranes close enough to initiate connexon interaction 
(Segretain and Falk 2004). 
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The structure of the carboxyl-terminus in particular, gives the opportunity for 
intracellular proteins to interact with connexins, creating a platform for connexin 
subtype or cell type specific regulation mechanisms (Severs 2007b). To date numerous 
connexin interacting proteins have been identified; for detailed reviews of this topic see 
Giepmans (2006) and Herve et al. (2007). The major categories of interaction are 
recognised as: (1) inter-connexin interactions that can lead to heteromeric or heterotypic 
channel formation; (2) post-transcriptional modifiers such as protein kinases and 
phosphatases that participate in regulation of channel gating events and connexin life 
cycle; (3) scaffolding and cytoskeletal proteins that bridge the connexins to 
microfilaments, microtubules and molecules such as cadherins and claudins to form a 
junctional nexus; (4) trafficking regulators that regulate or facilitate connexin delivery, 
assembly or internalisation such as caveolin 1 and 2 and ERp29, and (5) growth 
regulators and other molecules that facilitate growth, modulate channels structure and 
closure  (Laird 2010). 
 
1.3.3. Hemichannels and gap junctions 
Once connexons are in the plasma membrane they can either form gap junction 
channels by docking to another connexon or function as hemichannels (Li et al. 1996; 
Segretain and Falk 2004; Evans et al. 2006). After connexin oligomerisation is complete 
the resulting hemichannel is thought to be in a closed configuration after insertion into 
the plasma membrane (Evans et al. 2006; Laird 2006; Goodenough and Paul 2003). 
Studies on Cx46 expressed in Xenopus oocytes revealed that high concentrations of 
Ca
2+
 on the cytoplasmic side maintained hemichannels in their closed state but this 
effect could be reversed in solutions with a low extracellular Ca
2+
 (Ebihara et al. 1995; 
Evans et al. 2006). 
 
The use of connexin mimetic peptides (e.g. Gap 26 and Gap 27) which are peptides 
identical to a short amino acid sequence on the connexin subunit revealed that blocking 
hemichannels inhibited Ca
2+
 oscillations in smooth muscle cells (Dora et al. 1999) and 
electrical coupling (Isakson and Duling 2005). There is also evidence that hemichannels 
are utilised by cells in response to cell injury and metabolic inhibition (Evans et al. 
2006; Goodenough and Paul 2003). For example, in the heart during a stress response 
ATP crosses the hemichannels and vasodilates the blood vessels facilitating the increase 
 40 
in amount of oxygen being delivered (Headrick et al. 2003). Depending on the 
physiological condition of the cell, a connexon becomes docked into a gap junction 
channel or remains a hemichannel (Saez et al. 2005). 
  
Typically a single gap junction plaque is less than a 100nm to several micrometers in 
diameter and contains a varying number of channels (less than a dozen to many 
thousands) (Forge et al. 2003; Segretain and Falk 2004). The mechanisms that mediate 
gap junction channel aggregation are still unclear. It has been shown that connexons are 
inserted into the membrane randomly through lateral diffusion. Time-lapse microscopy 
of gap junctions assembly shows that as the connexons move closer together in the 
plane of the membrane plaque they suddenly fuse over their entire length indicating 
some intrinsic affinity for each other (Falk 2000).  
 
Structural studies have investigated the composition of gap junction channels and how 
channels composed of the different connexin subtypes are distributed within the plaque. 
Simultaneous visualisation of co-expressed connexins revealed that Cx32 and Cx26 
from the same  subgroup were homogenously expressed throughout the plaque while 
Cx43 of the  subgroup when paired with either Cx32 or Cx26 segregated into well-
separated domains. One of the mechanisms for segregation is that not all connexins are 
compatible and compatibility is dependent on the structural motifs encoded by the 
connexin polypeptide (Haubrich et al. 1996; Foote et al. 1998; Lagree et al. 2003; Koval 
2006). Another mechanism would be through the different affinities connexins have for 
surrounding lipids or connexin binding proteins (Segretain and Falk 2004; Cascio 2005; 
Koval 2006). For example connexins (e.g. Cx43) have shown to associate with lipid 
rafts, which are specialised domains, enriched in cholesterol, sphingolipids (Simons and 
Toomre 2000) and co-localisation with lipid raft marker protein caveolin-1 (Schubert et 
al. 2002; Mograbi et al. 2003) portioning into microdomains. It is also reported that 
depending on the connexin its preference for certain lipid environments may vary 
resulting in channel aggregation, mixing or segregation. 
 
1.3.4. Gap junction internalisation and connexin degradation  
Since connexins have short half-lives an efficient mechanism must be in place for their 
internalisation and degradation (Musil 2009). Electron micrographs identified double-
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membrane vesicular structures termed ‘annular junctions’ in the cytoplasm of cultured 
cells and in tissues which are proposed to contain fragments of gap junctions en route to 
degradation (Larsen and Hai 1978; Mazet et al. 1985; Severs et al. 1989). These 
findings were confirmed by immunogold labelling using specific connexin antibodies to 
establish that each vesicle contained substantial quantities of connexin protein (Figure 
1.7) (Naus et al. 1993; Murray et al. 1997). Further evidence from fluorescent-tagged 
connexins in live cells demonstrated the internalisation of Cx43 in only one of the two 
cells from the plasma membrane into the cytoplasm (Jordan et al. 1999; 2001; Gaietta et 
al. 2002; Falk et al. 2009). Similar studies of Cx43-GFP transfected HeLa cells showed 
that internalisation of gap junction vesicles also involves clathrin-coated endocytosis 
(Piehl et al. 2007; Gumpert et al. 2008). The intracellular vesicles of gap junction 
membrane are thought to form by the invagination and pinching off of both junctional 
membranes into the cytoplasm of one of the two cells without dissociating channels into 
their component connexons (Segretain and Falk 2004; Salameh 2006). Once inside the 
cells the junctions are subdivided into smaller vesicles that are targeted by 
endo/lysosomal pathways (Piehl et al. 2007). However there are indications that 
additional pathways exist for gap junction removal. For instance annular junctions do 
not facilitate the internalisation of small gap junctions from the plaque centre as 
observed by Lauf et al. (2002) and Gaietta et al. (2002) and are even absent in certain 
cell types (e.g. hepatocytes). It is also possible that annular junction formation is 
dependent on the physiological state of the cell rather than being a constitutive 
‘housekeeping’ process (Musil 2009). 
 
Proteins are also degraded by lysosomes and proteosomes (Laird 2005). Electron 
microscopy has shown that annular junctions may be in close proximity and possibly 
fuse to lysosomes for degradation by lysosomal enzymes (Qin et al. 2003). Inhibition of 
proteosomal degradation through N-acetyl-leucyl-leucyl-norleucinal treatment also 
leads to the accumulation of Cx43 (Laing and Beyer 1995; Laing et al. 1997; Musil et 
al. 2000) and in the perfused rat adult heart (Beardslee et al. 1998). Inhibiting 
proteosome activity also resulted in accumulation of connexins particular in the 
cytoplasm where majority of the proteosome-dependent degradation normally takes 
place (VanSlyke and Musil 2002). It is likely that the proteosome pathway is 
responsible for ER-associated degradation while the lysosomal pathway is primarily 
responsible form degradation of membrane connexins (Laird 2006). 
 42 
1.3.5. Connexin mutations in human disease  
Germline mutations of several different connexins are known to cause a number of 
human diseases. Disruptions in intercellular communication due to faulty connexin 
folding, oligomerisation, trafficking or docking have been identified as the underlying 
factors that lead to the manifestation of these diseases. I will briefly introduce a few 
selected samples here; more comprehensive information and detailed clinical features 
are available in recent reviews (e.g. Laird (2008)). 
 
Mutations can occur anywhere in the connexin gene. Mutations in the non-coding 
regions could affect elements that regulate transcription or interfere with the splicing to 
generate mature mRNA. An example of this is Chromosome X-linked Characot-Marie 
Tooth disease, an inherited neurological disorder characterised by a loss of sensation 
and progressive weakening and atrophy of the distal limbs. This is associated with 
mutations in GJB1 which encodes CX32 (Bergoffen et al. 1993; Bondurand et al. 2001; 
Martin et al. 2000). CX32 is expressed in Schwann cells and oligodendrocytes that 
provide the cell-to-cell communication in conjunction with other myelin-associated 
proteins essential for the functional and structural integrity of the myelin sheath and 
underpin nervous conduction (Martin et al. 2000). Site-directed mutagenesis of Cx32 
resulted in aberrant trafficking and disrupted oligomerisation (Martin et al. 2000; 
VanSlyke et al. 2009). This leads to the failure of transfer of ions and small molecules 
across the myelin sheaths and demyelination (Abrams and Rash 2009). The 
hemichannel open probability can also be affected by mutations. For instance a mutant 
that increases the probability of hemichannel opening may cause cell death similar to 
that suggested for CX32 (Abrams et al. 2002). 
 
The majority of known connexin mutations are located within the protein coding region 
(Beyer and Berthoud 2009). Non-sense mutations or frameshift mutations result in the 
loss of normal full-length protein because mRNA translation ends prematurely. An 
example in the 35delG mutation of GJB2 (encoding CX26) resulting in deafness 
(Carrasquillo et al. 1997). Over 90 mutations in the GJB2 gene are associated with 
inherited skin diseases and/or hearing loss (Laird 2006; Aasen and Kelsell 2009).  
Transfection of corresponding mutated forms of Cx26 all lead to reduced intercellular 
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coupling either due to faulty assembly (Martin et al. 2000; Forge et al. 2003) or failure 
to dock (Thomas et al. 2003). 
 
Gap junction channel properties including the permeability, selectivity and gating could 
be also be altered by mutations (Beyer and Berthoud 2009). Dominant-negative 
mutations may alter the specificity and compatibilities of the co-expressed connexin. In 
the skin Cx43 and Cx26 do not form heteromeric channels but several Cx26 mutants 
associated with skin disease can inhibit Cx43 function via heteromerisation (Rouan et 
al. 2001). More than 20 autosomal dominant mutations in the GJA1 gene are known to 
cause the rare disorder, oculodentodigital dysplasia, in which patients show craniofacial 
abnormalities and malformations in fingers and teeth (Paznekas et al. 2009). In patients 
with oculodentodigital dysplasia, gap junction communication is thought to be markedly 
reduced despite a functional CX43 wild-type allele (Roscoe et al. 2005). In addition to 
germline mutations, disease may be produced by the development of connexin 
mutations within somatic cells (Beyer and Berthoud 2009). Several mutant forms of 
GJA5 (encoding CX40) have been isolated from the hearts of patients with atrial 
fibrillation suggesting somatic mutations of GJA5 may be responsible for some cases of 
arrhythmia (Gollob et al. 2006). 
 
Taken together, these findings highlight that mutated connexins may cause disease 
through disrupting the connexin life cycle such that intercellular communication is 
markedly reduced. 
 
1.4. Regulation of gap junction function 
1.4.1. Electrical properties 
Gap junction channels are voltage sensitive. Macroscopic gap-junctional current (Ij) is 
sensitive to: (1) transjunctional voltage defined as the potential difference between the 
two cell interiors and (2) the transmembrane potential which is the voltage difference 
between the cell interior and the external medium, depending on the species (Bukauskas 
and Verselis 2004; Gonzalez et al. 2007). 
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Development of the dual whole-cell voltage clamp technique has allowed accurate 
resolution of the electrical properties of gap junction channels. This technique permits 
the cells to be clamped at a fixed membrane potential and the gap junction current to be 
recorded (Desplantez et al. 2004). To begin with the membrane potential of both cells is 
clamped to the same value. Thereafter the membrane potential of only one of the cells is 
depolarised or hyperpolarised in a stepwise fashion to establish a voltage gradient or 
gap-junctional potential. From the current recorded is possible to calculate the 
macroscopic junctional conductance. This value is influenced by: (1) the number of gap 
junction channels (N); (2) the open probability (P0) and (3) the channel specific unitary 
conductance (Van Veen et al. 2006; Moreno and Lau 2007). 
 
Dual voltage clamp analysis has shown that, in homotypic channels, steady-state 
junctional conductance is usually maximal when transjunctional voltage is zero. As one 
cell of a cell pair is depolarised or hyperpolarised, conductance relaxes from the main-
state to lower values. Junctional current is rarely abolished, even at high voltages a 
voltage-insensitive component of junctional conductance remains. This relationship of 
macroscopic voltage sensitivity is commonly visualised by plotting all normalised gap-
junctional current values measured at each depolarising and hyperpolarising voltage 
step, fit to a Boltzman equation. 
 
To establish the unitary conductance, the number of channels between cell pairs has to 
be reduced. To do so, treatments with gap-junctional communication inhibitors such as 
heptanol, octanol or halothane permitted the recordings of single channel behaviours. 
After removing the agent, the channels open gradually enabling single currents to be 
recorded at a given voltage over time. By analysis of these single channel recordings, 
unitary open conductances for individual channels can be determined. These values are 
connexin isotype and channel specific. The electrical properties of connexins (e.g. 
Cx40, Cx43 and Cx45) have been studied most commonly on Xenopus oocytes and 
cultured mammalian cells such as HeLa, N2a and RIN cells transfected with different 
connexin subtypes (Dahl et al. 1987; Elfgang et al. 1995; Valiunas et al. 2000; 2001; 
Elenes et al. 2001). From these experiments it was determined that homotypic channels 
composed of Cx45 exhibited the smallest unitary conductance at 30-40pS, whereas 
Cx43 and Cx40 homotypic channels have values of 60-120pS and 150- 200pS (Gros 
and Jongsma 1996; Moreno 2004). 
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The electrical properties of heteromeric and heterotypic channels have also been studied 
in co-transfected cells to identify the functional significance of connexin co-expression 
patterns in vivo. Heterotypic docking of Cx43-Cx45 channels produced conductances 
that were intermediate between that of the single unitary conductance for homotypic 
Cx43 or Cx45 indicating a good association between the two connexins (Elenes et al. 
2001; Desplantez et al. 2004; Moreno 2004). Similar results were obtained for Cx40-
Cx45 heterotypic channels (Moreno 2004) and Cx30.2-Cx45 (Kreuzberg et al. 2006; 
Rackauskas et al. 2007b). The formation of heterotypic channels between Cx40 and 
Cx43 remains controversial with conflicting results (Elfgang et al. 1995; Haubrich et al. 
1996; Rackauskas et al. 2007a). However work by Valiunas et al. (2000) and Cottrell et 
al. (2002) have reported the presence of heterotypic channels in cell pairs with 
considerably reduced coupling compared with the homotypic conductances for Cx43 or 
Cx40. 
 
It has also been shown that Cx45, Cx43 and Cx40 can form heteromeric connexons 
producing channels with intermediate conductances or lower that what was observed for 
their respective homotypic conductances. For example Cx40 and Cx43 form 
heteromeric channels in co-expressing HeLa cells with an average conductance that is 
lower than values for homotypic channels of either connexin (Valiunas et al. 2001). In 
the A7r5 smooth muscle cell line that naturally co-express Cx40 and Cx43, a range of 
unitary conductances distinct from homomeric-homotypic Cx40 or Cx43 channels were 
observed (He et al. 1999). Thus there is considerable scope for electrical properties to 
vary according to the precise connexin make-up of the channel. 
 
1.4.2. The role of phosphorylation  
Phosphorylation is a key regulatory element in the lifecycle of connexins and gating of 
hemichannels and gap junction channels (Warn-Cramer and Lau 2004; Laird 2005; 
Solan and Lampe 2005). The carboxyl-terminus of connexins contains consensus 
phosphorylation sites for multiple kinases such as protein kinase A, protein kinase C 
and mitogen activated protein kinase (Solan and Lampe 2005; Herve et al. 2007). 
Phosphorylation of connexins has been primarily identified through shifts in their 
electorphoretic mobility when analysed by SDS-PAGE and the direct incorporation of 
32
P (Musil and Goodenough 1991; Laird 1991; Laing et al 1994; Cooper et al 2000). 
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Cx43 phosphorylation has been the most extensively described to date. Cx43 is 
typically detected as three bands derived from different phosphorylation states; the 
fastest migrating band represents the newly synthesised connexin which is non-
phosphorylated (NP) and two slower migrating bands (P1 and P2) which represent the 
phosphorylated forms (Musil and Goodenough 1991). Treatment with alkaline 
phosphatase confirmed that differences in molecular weight were due exclusively 
phosphorylation. Pulse-chase experiments showed that the NP form is trafficked to the 
membrane where it is then phosphorylated and integrated into functional gap junction 
plaques. It should be noted that phosphorylation does not exclusively take place at the 
membrane as some studies have shown (Puranam et al. 1993; Solan et al. 2003). Using 
phosphospecific and epitope-specific antibodies it has been established that differences 
in the P1 and P2 mobility forms are derived from phosphorylation at different sites of the 
protein (Musil et al. 1990; Solan et al. 2003; Solan et al. 2007; Solan and Lampe 2009). 
 
Regulators of phosphorylation such as cAMP can mediate gap junctional 
communication via an increase in synthesis, trafficking and assembly at the plaque 
(Atkinson et al. 1995; Darrow et al. 1996; Paulson et al. 2000). cAMP has been shown 
to mediate its effects by adenylyl cyclase and protein kinase A leading to enhanced 
assembly of gap junction plaques (Paulson et al. 2000). Activation of kinases is cell 
type and cell stage specific and is highly sensitive to altered physiological conditions 
such as the presence of growth factors such as platelet derived growth factor and 
vascular endothelial growth factor (Warn-Cramer and Lau 2004).  
 
Phosphorylation also plays a very important role in disease particularly in ischemia. 
During ischemia changes in phosphorylation include a rapid shift (5 minutes) from the 
P1/2 isoforms to the faster migrating NP isoform in Cx43 (Solan and Lampe 2009). This 
loss in phosphorylation has been shown to occur at various sites (e.g. S325, 328 and 
330) and is typically observed in the gap junction plaques. In contrast to the decrease in 
phosphorylation at sites S325, 328 and 330, an increase in phosphorylation at S368 has 
also been reported at the cell membrane and this is likely to contribute to a change in 
channel permeability (Solan and Lampe 2009). Due to the increasing evidence that 
Cx43 plays an important role in ischemia, its function in cardioprotection has been 
illustrated in ischemic preconditioning (Li et al. 2004a; Srisakuldee et al. 2009). In these 
studies, ischemic preconditioning  preserved the phosphorylation of Cx43 
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phosphorylation by activating protein kinase  whereas hearts from Cx43 deficient mice 
could not be preconditioned (Li et al. 2004a; Rodriguez-Sinovas et al. 2009). The 
emergence of Cx43 as a therapeutic target will be discussed further in section 5.5 of this 
chapter. 
   
Phosphorylation has been correlated with an increase or decrease in hemichannels and 
gap junction channels (Moreno 2005). For instance the opening of a variety of 
hemichannels (e.g. Cx43, Cx46) can be blocked by the activation of protein kinases 
(e.g. protein kinase C) (Saez et al. 2003). Phosphorylation of rat Cx43 by protein kinase 
C causes a shift in the channel unitary conductance favouring a lower conductance and 
lower permeability to Lucifer yellow (Moreno et al. 1992; 1994; Kwak et al. 1995; 
Lampe et al. 2000).  
 
1.4.3. Molecular and ionic permeability  
Gap junctions are permeable to many biologically relevant molecules. Using a 
technique called transport specific fractionation Bevans et al. (1998) demonstrated the 
different permeabilites of connexins to biological molecules. Cyclic nucleotides such as 
cGMP and cAMP readily pass from one cell to the next through gap junction channels. 
However depending on the connexin type certain molecules are more efficiently 
transferred than others. For instance cGMP passes more efficiently through heteromeric 
channels composed of Cx32 and Cx26 than channels composed of Cx32 only (Bevans 
et al. 1998). 
 
Components of cellular signalling pathways are also spread through gap junctions. The 
second messenger inositol 1,4,5-triphosphate (Niessen et al 2002) is transferred with 
connexin subtype specific permeabilities. Gap junctions are also permeable to siRNA 
molecules of a specific connexin subtype from cell-to-cell thereby influencing gene 
expression in neighbouring cells (Valiunas et al. 2005). Moreover Wallner et al. (2009) 
also demonstrated the transfer of miRNA via gap junctions in HeLa cells which 
potentially represents a new mechanism for the control of gene expression by the 
cellular environment. 
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Differences in ion selectivity by the connexin subtypes to dyes of varying molecular 
mass and charge (e.g. Lucifer yellow, ethidium bromide and Alexa dyes) were shown in 
HeLa cells and Xenopus oocytes transfected with different connexins (Elfgang et al. 
1995; Cao et al. 1998; Valiunas et al. 2002; Weber et al. 2004). The flux of fluorescent 
dye through gap junctions is then measured by light microscopy to determine whether 
cells are coupled by gap junctions. These studies revealed that channels composed of 
each connexin display distinctive permeability properties. 
 
Compared to classical ion channels, gap junctions are not selective for specific species 
although they discriminate between anions and cations. They seem to work as an 
aquatic pore that enables ion exchange. Cx45 channels show equal permeability to 
caesium and K
+
 cations, but reduced flux for chloride ions indicating charge selectivity 
(Veenstra et al. 1995). Further studies demonstrate that Cx40 channels are cation 
selective (Beblo and Veenstra 1997), while channels composed of Cx43 exhibit no 
overall selectivity for either anions or cations (Wang and Veenstra 1997). 
  
1.4.4. Chemical gating 
The role of Ca
2+
 in cell uncoupling had initially been established from experimental 
data correlating loss of electrical and dye coupling to increased intracellular Ca
2+
 [Ca
2+
]i 
monitored by the Ca
2+
 indicator aequorin (Rose and Loewenstein 1975; 1976). This was 
later confirmed in a number of cell types including cardiac cells, cultured lens cells and 
osteoblasts (Peracchia 2004). Its role in uncoupling may be particularly important in 
protecting intact cells from membrane depolarisation and leakage of metabolites 
through gap junctions by disconnecting them from damaged cells (Rackauskas et al. 
2010). This process is called ‘healing-over’. Ca2+-mediated inhibition of intercellular 
communication has been confirmed in a number of cell models (De Mello 1975; Dahl 
and Isenberg 1980; Neyton and Trautmann 1985). Although it is established that Ca
2+ 
affects channel gating, the [Ca
2+
]i that activates the gating mechanism is still unclear 
and may depend on the connexin and cell type ranging from a concentration of 500nM-
400M (Peracchia 2004). The wide concentration range could be due the variation in 
effectiveness of the internal buffering systems and sometimes the increase in [Ca
2+
]i is 
too brief to activate the relatively slow gating mechanism. To enable a functional 
interaction between Ca
2+ 
and connexins, clusters of negatively charged amino-acid 
 49 
residues would be required to face the cytoplasm. Among connexins only a single 
amino acid residue (glutamate) faces the cytoplasm located at the transition between the 
fourth transmembrane (M4) domain and carboxyl-terminus. Despite there being six of 
these residues per connexon to bind to Ca
2+
 this may not be sufficient to mediate 
channel gating. It is likely that Ca
2+ 
acts through an intermediate and one potential 
candidate is calmodulin (Peracchia et al. 1983; Torok et al. 1997). 
 
Alterations to intracellular pH can also affect junctional conductance (Turin and Warner 
1977; Spray et al. 1981). Cellular uncoupling through pH dependent gating would 
protect neighbouring cells from the potentially damaging effects of intracellular 
acidification. Sensitivity to pH varies among cell types and is in part related to the type 
of connexin expressed. By using a method that monitors junctional conductance and pH 
at different levels of acidification, studies demonstrated that Cx32 is the least sensitive 
to changes in pH and Cx50 was the most sensitive (Liu et al. 1993; Stergiopoulos et al. 
1999). Connexin co-expression could also affect the pH sensitivity with properties 
unique to those of the individual connexins. For example Gu et al. (2000) demonstrated 
that mixing of Cx40 and Cx43 yields channels with increased sensitivity to pH. The 
molecular mechanism of pH gating is likely to involve the connexin cytoplasmic loop 
and carboxyl-terminal. Cx43 truncation abolishes pH sensitivity (Liu et al. 1993) but 
co-expression of the mutant connexin with the missing carboxyl-terminal sequence 
restores pH sensitivity and gating (Morley et al. 1996). Histidine residue at position 95 
in the cytoplasmic loop has been proposed to be involved in pH gating since 
substitution with a basic or uncharged residue reduces pH sensitivity (Ek et al. 1994). 
The proposed mechanism is that low-pH facilitates interaction of the carboxyl-terminal 
with a receptor domain elsewhere in the connexin molecule causing the channel to close 
(Liu et al. 1993; Ek et al. 1994; Morley et al. 1996). 
 
1.5. Gap junction function in cardiac tissue 
Flow of electrical current between cardiac muscle cells is facilitated through low 
resistance pathways formed by gap junctions ensuring mechanical responses are orderly 
and synchronous in the heart (Green and Severs 1993). Action potential propagation is 
initiated in the sinoatrial node where it spreads through the atria (~1.2m/sec) to the 
atrioventricular node (~0.05m/sec). This conduction delay in the atrioventricular node 
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ensures the ventricles contract after the atria. After this, conduction is accelerated 
through the His bundle and Purkinje fibres (~2-4m/sec) before entering the ventricles 
(~0.6m/sec) resulting in contraction. The precise orchestration of electrical flow through 
the different tissue compartments is governed by: (1) cell morphology and size and (2) 
specific expression and co-expression connexin patterns. Disruptions in any of these 
factors contribute to conduction abnormalities in the adult heart. 
 
1.5.1. Gap junction organisation in the normal adult heart 
In the working (contractile) myocardium, gap junctions are located at the intercalated 
disc in discrete zones of interaction between adjacent plasma membranes together with 
two types of adhesion junctions: (1) fascia adherens, to which myofibrils of adjacent 
cells are joined and (2) desmosomes, that serve as anchoring sites for intermediate 
filaments that form a mechanical scaffold within the cell (Figure 1.8 (A)) (Green and 
Severs 1993; Severs et al. 2008). The intercalated discs are situated where the cells abut 
in a step-like structure (Figure 1.8 (A)). This ensures that myofibrils of end-to-end cells 
are mechanically coupled via the fascia adherens junctions. Thin-section electron 
microscopy revealed that gap junctions occupy intervening portions of the disk step that 
lie parallel to the long axis of the cell. It should be noted that depending on the cell type 
gap junction organisation may differ slightly as shown in Figure 1.8 (B) and (C). For 
example in the normal atrial myocardium, gap junction organisation is variable with 
some confined to the intercalated disc as in ventricles while others show a spread along 
the lateral aspects of the cell (Severs et al. 2004a; 2008). Depending on the myocyte 
subtype gap junction size may vary. For instance in nodal cells the gap junctions 
composed of Cx45 are sparse and small in size (Masson-Pevet et al. 1979). Collectively 
this organisation of intercellular junctions at the intercalated disc together with tissue 
architecture (i.e. cell size and shape) results in the anisotropic propagation observed in 
the heart ensuring conduction is faster in the longitudinal direction than in the transverse 
axis. 
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Figure 1.8: Gap junction organisation at the intercalated disc 
The intercalated disc in a cardiac myocyte shown by thin section electron microscopy (A). The three 
junction types are indicated. Fasciae adherens occupy vertical zones of the disc, gap junctions and 
desmosomes are located mainly at the lateral facing zones. Image reproduced from Severs (2000). 
Reconstruction of serial optical sections through an isolated ventricular myocyte labelled for Cx43 
(green) illustrating the organisation of gap junctions in clusters at the intercalated disc in the classic 
step-like configuration indicated by the line at top left hand corner (B). Image reproduced from Severs 
et al. (2004b). Atrial cells are a lot slender than their ventricular counterparts. (C). Gap junction 
organisation is also a lot more varied while some are present at the ends of the intercalated disk and 
others are spread laterally (asterisks). Image reproduced from Severs et al. (2008). The nuclei are 
counterstained with propidium iodide in images (B) and (C). 
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1.5.2. Connexin co-expression in the healthy heart 
In mammalian hearts the main connexins expressed are Cx40, Cx43, Cx45 and Cx37  
(Figure 1.9) (Gros and Jongsma 1996; Severs et al. 2008). However Cx37 is restricted 
to vascular endothelium where it is co-expressed with Cx40 and as a result does not 
participate in conduction (Vozzi et al. 1999; van Kempen and Jongsma 1999; Simon 
and McWhorter 2002). Therefore this investigation will be focussed on Cx40, Cx43 and 
Cx45 and this sub-group will be referred to as the ‘cardiac connexins’ for the reminder 
of my thesis. 
 
 
Figure 1.9: Connexin co-expression patterns in the adult healthy heart 
Connexins are co-expressed in a tissue-specific manner. Cx43 is predominant throughout the working 
myocardium, Cx45 is mostly found within the specialised conduction system, commonly co-expressed 
with Cx40. Image adapted from Severs et al. (2008). 
 
In the adult heart Cx43 is the most abundant isoform expressed in myocytes of the 
working atrial and ventricular myocardium with exceptions being the sinoatrial and 
atrioventricular nodal cells (Figure 1.9 and Figure 1.10 (A)) (Vozzi et al. 1999; van 
Veen et al. 2001). In the atria Cx43 is co-expressed with Cx40 with low amounts of 
Cx45 also present. Double label immunogold labelling demonstrated that CX40 and 
CX43 are co-localised within the same gap junction plaque (Figure 1.10 (B)) (Severs et 
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al. 2001; Kanagaratnam et al. 2002). Cx40 expression is highly variable with levels in 
the right atrium 2 to 3 fold higher than the left (Vozzi et al. 1999; Dupont et al. 2001a). 
Working ventricular myocytes lack detectable Cx40 despite its high levels of expression 
during embryonic development (Gros et al. 1994; Vozzi et al. 1999; Coppen et al. 
2001b). However in the His-Purkinje conduction system Cx40 is strongly expressed 
where it forms high conductance channels with large gap junctions correlating with the 
fast conduction properties of this system (Gourdie et al. 1993; Gros and Jongsma 1996; 
Severs et al. 2001). 
 
 
 
Figure 1.10: Immunogold labelling of CX40 and CX43 in the different myocyte subtypes 
Immunogold thin-section electron microscopy demonstrated the presence of CX43 in the human 
ventricles (A) and both CX40 and CX43 in human atrial myocyte gap junctions (B). CX40 and CX43 
were differentiated by using gold particles of different width, 10nm and 5nm for CX40 and CX3 
respectively highlighted by the arrows. Image reproduced from Severs et al. (2005)  
 
Cx45 is expressed at low levels throughout the myocardium including the His-Purkinje 
conduction system where it co-localises with Cx40 (Davis et al. 1995; Coppen et al. 
1998b; 1999; Vozzi et al. 1999; von Maltzahn et al. 2009). Cx45 is also the sole 
connexin expressed in the sinoatrial and atrioventricular node forming small dispersed 
gap junctions (Coppen et al. 1999; Severs et al. 2001). These features together with the 
low conduction properties of Cx45 channels indicate relatively poor coupling in these 
areas (Elenes et al. 2001; Desplantez et al. 2004). A fourth connexin, Cx30.2 has been 
discovered in the mouse heart specifically at the sinoatrial and atrioventricular node but 
its human ortholog CX31.9 was not detected in the working myocardium and 
conduction system (Kreuzberg et al. 2005; 2009). This also highlights species 
differences in connexin expression particularly important when comparing small and 
large mammals possibly reflecting the need for impulse delay according to heart size 
(Severs et al. 2008). These differences need to be borne in mind when extrapolating 
functional data from animal models to the human.  
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1.5.3. Gap junction remodelling and cardiac disease 
Cardiovascular disease is the leading cause of death and disability in most industrialized 
countries of the developed and developing worlds. Disturbances in cardiac rhythm 
(arrhythmias) are a common, serious and often fatal complication of many forms of 
heart disease. Electrophysiological studies have shown the most dangerous disturbances 
of heart rhythm are re-entry arrhythmias in the ventricle, caused by slowed conduction 
and conduction block. A re-entrant circuit develops when the wavefront of propagation 
is partially blocked at a given position, causing rotation around this point and re-entry 
into the site of original excitation in a repetitive cycle (Kleber and Rudy 2004). Since 
gap junctions govern the electrical flow that leads to contraction of the heart, the 
question, first posed by Professor Severs and Green, was whether alterations of gap 
junction organisation and connexin expression could play a role in abnormal impulse 
propagation (Smith et al. 1991). Since that time, numerous studies have been conducted 
to examine this hypothesis and have identified gap junctions and connexin expression to 
be key contributors to the arrhythmic substrate alongside factors such as membrane 
excitability (i.e. voltage-gated ion channels), cell size and tissue architecture (Severs et 
al. 2008). 
 
Gap junction remodelling can be divided into two main categories: (1) altered 
distribution or organisation of gap junctions and (2) alterations in the amount and type 
of connexin expressed (Severs 2009). 
 
Gap junction remodelling in the ventricle 
Myocardial infarction results in a significant loss of cellular communication in the 
affected cells (Figure 1.11). Ultrastrucutral examination of the myocardial zone 
bordering the infarct scar tissue showed extensive loss of CX43 expression and 
organisation of gap junctions over the lateral surfaces of the cells first reported in 
patients with end-stage ischemic heart disease by Smith et al. (1991) (Figure 1.11). 
Similar areas of gap junction disarray are also associated with end-stage heart failure 
due to idiopathic dilated cardiomyopathy (Kostin et al. 2003) and in compensated 
hypertrophy due to valvular aortic stenosis (Kostin et al. 2004). These patterns of gap 
junction organisation have also been reported in animal models of ventricular heart 
disease including myocardial infarction in rat (Matsushita et al. 1999) and dog (Luke 
 55 
and Saffitz 1991; Peters et al. 1997; Kieken et al. 2009), heart failure in the dog (Akar et 
al. 2007) and hypertrophied ventricles in rats (Uzzaman et al. 2000; Emdad et al. 2001). 
Structural remodelling such as this is strongly associated with arrhythmia and slowing 
of conduction which could potentially increase the risk of re-entrant circuits (Peters et 
al. 1997; Jongsma and Wilders 2000; Severs 2009). 
 
 
 
Figure 1.11: Immunoconfocal microscopy of human ventricular myocardium from a patient 
with end-stage ischemic heart disease 
No CX43 signal can be detected within the infarct scar. In the surviving myocardium at the border of 
the infarct scar CX43 immunolabel is dispersed over the lateral borders of the cells rather than 
showing the normal polarisation at the intercalated disk highlighted by the enlarged picture. Image 
reproduced from Severs (2009). 
 
Alterations in gap junction organisation are often accompanied by changes in Cx43 
expression. Reduced CX43 protein and transcript levels have consistently been reported 
in patients with heart failure irrespective of whether the condition is due to idiopathic 
dilated cardiomyopathy (Dupont et al. 2001b), artery stenosis (Kostin et al. 2004), 
hibernating myocardium (Kaprielian et al. 1998) or other etiologies (Kitamura et al. 
2002). In addition alterations in gap junction size and density have consistently been 
identified as major features of gap junction remodelling. In the diseased human heart 
reduced gap junction size has been reported in the hibernating myocardium (Kaprielian 
et al. 1998) and hypertrophy (Kostin et al. 2004) together with the decrease in overall 
amount of CX43 immunolabelling (Peters et al. 1993; Kitamura et al. 2002; Kostin et al. 
2003). Alongside the reduction in CX43, elevated levels of CX45 (Yamada et al. 2003) 
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and CX40 have been shown in ventricles of patients with congestive heart failure due to 
ischemic cardiomyopathy (Dupont et al. 2001b). The significance of increased CX40 
and CX45 expression is still unclear but could represent a compensatory response to 
failing levels of CX43. 
 
Gap junction remodelling in the atria 
The most common atrial arrhythmia is atrial fibrillation, a condition in which wavelets 
of electrical activity propagate in multiple directions leading to disorganised 
depolarisation and ineffective atrial contraction (Zipes 1997). The condition is 
associated with progressive electrical, contractile and structural remodelling, including 
altered cell size and mitochondrial shape, loss of sarcomeres and perinuclear 
accumulation of glycogen (Severs et al. 2004a). Alterations of gap junctions and 
connexin expression, in particular that involving Cx40, are reported to feature in the 
remodelling process (Severs et al. 2004a). 
 
Studies on human atrial samples have revealed inconsistent results concerning the exact 
nature of gap junction remodelling in atrial fibrillation. In comparing patient samples 
with normal sinus rhythm to those with atrial fibrillation different studies report CX40 
protein levels to be elevated (Polontchouk et al. 2001), significantly reduced expression 
of transcript, protein and immunosignal (Nao et al. 2003; Wilhelm et al. 2006) or no 
change in CX40 when examined by immunofluorescent labelling (Kanagaratnam et al. 
2004) and western blot (Takeuchi et al. 2006). With regard to structural remodelling, 
gap junction lateralisation, heterogeneity and alterations in gap junction number have 
been reported in various studies (Polontchouk et al. 2001; Kostin et al. 2002; Takeuchi 
et al. 2006). Changes in junctional proteins such as N-cadherin and desmoplakin are 
reported to show similar changes in distribution to those of CX40 (Kostin et al. 2002) 
suggesting a spatial association between gap junctions and adhesive junctions during 
their re-organisation at the plasma membrane (Severs et al. 2004a). Studies in goat 
models of pacing-induced atrial fibrillation also identified heterogeneity in Cx40 
distribution with areas of low density Cx40 next to areas of higher (normal) density 
Cx40 and a reduced ratio of Cx40/Cx43 (van der Velden et al. 1998; 2000; Ausma et al. 
2003). However no lateralization of Cx40 observed in human samples was noted. 
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Discrepancies between studies on atrial fibrillation arise from the use of different animal 
models and species, different time courses when comparing samples, lack of antibody 
specificity, use of different patient sub-groups with different associated pathological 
conditions and interpretation of the data (Polontchouk et al. 2001; Kanagaratnam et al. 
2002; 2004; Duffy and Wit 2008; Severs et al. 2008). While it is recognised that gap 
junctions are contributing factors to the occurrence of atrial fibrillation, deciphering 
how their precise role requires more rigorous experimental approaches as proposed by 
Duffy and Wit (2008). 
 
One aspect not always fully appreciated is the need to distinguish between gap junction 
remodelling brought about as part of atrial fibrillation which potentially contribute to 
the perpetuation of the condition and gap junction features that may increase 
susceptibility to atrial fibrillation in the first place. For example, analysis of patient 
samples undergoing coronary artery bypass surgery without previous history of 
arrhythmias revealed elevated levels of CX40 are associated with a higher risk of the 
development of post-operative atrial fibrillation (Dupont et al. 2001a). In these samples 
no difference in protein and mRNA for CX43 and CX45 were detected between the 
atrial fibrillation and non-atrial fibrillation groups. To correlate connexin expression 
with conduction velocities (CV) in the human atrium, Kanagaratnam et al. (2002) 
compared CX40 and CX43 expression quantified by immunofluorescent labelling to 
atrial CV in patients undergoing cardiac surgery. Results showed that an increase in 
CX40 relative to the total connexin signal (CX40/[CX40+CX43]) is associated with a 
decrease in CV. The reason for this decrease in CV when a connexin of high 
conductance is expressed is not yet clear. 
 
1.5.4. Transgenic mouse models of cardiac connexins 
Transgenic mice have been developed in which the expression of specific connexins is 
ablated or one connexin type is substituted for another to study their roles in impulse 
propagation and cardiac morphogenesis. 
 
Transgenic Cx45 models 
The expression of Cx45 is critical for the normal development of the heart. Replacement 
of Cx45 with the lacZ reporter gene in transgenic mice resulted in heart failure and 
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embryonic death at day 10 (Kumai et al. 2000). Furthermore the mice displayed severe 
defects in cardiac looping, vascular developments and the endocardial cushion (also 
known as atrioventricular canal or septal defects) (Kruger et al. 2000; Kumai et al. 
2000). When deletion of Cx45 is restricted to the myocardium, development of the 
endocardial cushion is not disrupted but the mice still die from conduction block similar 
to those observed in non-conditional knockouts (Nishii et al. 2003). In the developing 
heart Cx45 is the earliest detectable connexin particularly in the conduction tissue and is 
the only connexin to be continuously expressed throughout the conduction system in the 
adult heart (Alcolea et al. 1999; Coppen et al. 2001a). As a result functional 
compensation by other cardiac connexins cannot occur in Cx45 knockout models. Over-
expression of cardiac specific Cx45 in transgenic mice did not result in structural 
malformations and contractile dysfunction but did show enhanced susceptibility to 
spontaneous and inducible arrhythmias and altered intercellular coupling (Betsuyaku et 
al. 2006). These results confirm the requirement of Cx45 in early cardiogenesis and the 
maintenance of electrical coupling in adult hearts. 
 
Transgenic Cx40 models 
Cx40 is a major determinant of cardiac development and electrical impulse propagation 
in the cardiac conduction system. To examine the function of Cx40 in the developing 
and adult mouse heart two independent approaches have been undertaken to generate 
Cx40 knockout mice (Kirchhoff et al. 1998; Simon et al. 1998). Cx40 knockout mice 
often die just after birth or as young adults due to developmental malformations; 
however many of the animals survive to adulthood (Kirchhoff et al. 2000; Gu et al. 
2003). The type of abnormalities observed may be dependent on the genetic background 
differences in the mice used to generate the models (Gu et al. 2003). Cx40 null mice 
displayed a range of malformations such as tetralogy of Fallot, endocardial cushion 
defects and myocardial hypertrophy (Kirchhoff et al. 2000; Gu et al. 2003). Structural 
abnormalities were also observed in heterozygous knockout mice but generally 
incidence of malformations was lower and less severe than for homozygous knockout. 
Thus it appears that although Cx40 is not essential for cardiac morphogenesis, its 
absence or limited expression increases the probability of cardiac malformations. 
 
Animals which lack Cx40 show delays in impulse conduction in the atria, 
atrioventricular node, His bundle and bundle branches (Kirchhoff et al. 1998; Simon et 
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al. 1998; Hagendorff et al. 1999; Verheule et al. 1999; VanderBrink et al. 2000; Leaf et 
al. 2008) in agreement with the distribution patterns of Cx40 (Gros et al. 2004). 
Furthermore, increased incidence of spontaneous and/or pacing induced atrial 
arrhythmias is apparent (Kirchhoff et al. 1998; Hagendorff et al. 1999; Verheule et al. 
1999; Bagwe et al. 2005). Recordings of electrical activation by optical mapping 
showed an abnormal pattern of excitation and propagation in the right atria of adult 
Cx40 knockout mice most likely due to the intraatrial conduction slowing and the high 
incidence of cardiac malformations found in these animals (Bagwe et al. 2005). 
Transgenic mice in which Cx40 was replaced by Cx45 resulted in slow conduction in 
the left atrium but normal CV elsewhere suggesting a chamber-specific role for Cx40 
(Alcolea et al. 2004). In Cx40 knockout mice no up-regulation was detected in 
transcripts and protein levels of the other cardiac connexins Cx43, Cx45 and Cx37 
(Kirchhoff et al. 1998; Bagwe et al. 2005). 
 
Results on impulse propagation differed from those obtained in the whole heart and in 
vitro cell models. To examine the functional relevance of Cx40/Cx43 co-expression 
Beauchamp et al. (2006) generated cultured strands of atrial myocytes derived from 
Cx40 and Cx43 knockout mice and measured CV using optical mapping. In contrast to 
observations made in the intact heart genetic ablation of Cx40 led to an increase in CV 
with a higher amount of Cx43 expression at the plasma membrane although the total 
Cx43 protein content remained unchanged. Kanagaratnam et al. (2002) also reported 
similar findings in human atria i.e. that decreased CX40/CX43 co-expression is 
accompanied by a paradoxical increase in CV. Differences in CV measurements are 
likely to depend on the experimental design and the connexin co-expression pattern. It 
is therefore plausible to obtain different results in a setting with reduced number of cells 
(Beauchamp et al. 2006) or in a restricted are of the atria (Kanagaratnam et al. 2002) in 
comparison to the whole heart (Kirchhoff et al. 1998). 
 
Transgenic Cx43 models 
The first transgenic mouse to be established was the germline deletion of both Cx43 
alleles (Reaume et al. 1995). The mice survive to term but die at birth from severe 
malformations of the right ventricular outflow tract which prevents blood flow to the 
lungs (Reaume et al. 1995). Despite morphological abnormalities, the foetal Cx43 
knockout heart is still able to function normally most likely due to the presence of Cx40 
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and Cx45 during embryonic development since conduction does not exclusively require 
Cx43 channels (Reaume et al. 1995; Van Kempen et al. 1996; Delorme et al. 1997; 
Alcolea et al. 1999). Studies on electrical impulse at various stages of embryonic 
development revealed no difference in CV at embryonic day 12.5 in Cx43 knockout and 
control mice (Vaidya et al. 2001). At embryonic day 15.5 there is gross reduction in CV 
in the right ventricle of the mutants and in both ventricles at embryonic day 17.5 which 
corresponds to a down-regulation of Cx40 expression. There also does not appear to be 
any significant alterations to total Cx45 expression in Cx43 knockout mice (Johnson et 
al. 2002a). 
 
Electrophysiological analysis of intercellular communication in cultured Cx43 knockout 
mice showed a reduction of 60% in macroscopic junctional conductance, impaired 
contractility and loss of dye coupling compared to wild type cells (Vink et al. 2004). 
Quantification of Cx40 and Cx45 mRNA transcripts showed no alterations in 
compensation to the lack of Cx43. A study by Beauchamp et al. (2004) on ventricular 
myocyte strands from germline Cx43 knockout mice provided further information on 
CV after the loss of Cx43. In this system, impulse propagation was reduced by 97% 
corresponding to a reduction in transjunctional conductance on cell pairs by a similar 
amount. Analysis of the single channel properties identified the presence of Cx45 to be 
the sole conductor in these myocytes after Cx43 knockout. Data from this work confirm 
that Cx43 channels are the principal conductors in ventricles of the mouse heart but 
conduction can still be maintained by low levels of Cx45 in the absence of Cx43 albeit 
at slow velocity. 
 
To investigate the role of Cx43 specifically in the myocardium, Gutstein et al. (2001a) 
generated mice with a cardiac-restricted inactivation of Cx43 using the Cre/Lox system. 
The mice were born with a normal heart and contractile function. Despite the 90% loss 
in Cx43, CV was markedly slow but propagation was still maintained until the onset of 
spontaneous ventricular tachycardia leading to premature death at two months after 
birth (Gutstein et al. 2001a). This suggests that although basic heart function can be 
maintained for a limited period through the expression of Cx45, Cx43 is critical in the 
formation of the arrhythmogenic substrate. 
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Heterozygous Cx43 mice have also been developed in neonatal and adult hearts which 
survive and breed normally (Guerrero et al. 1997). The level of Cx43 in heterozygous 
mice is approximately 50% of the normal amount of Cx43 (Guerrero et al. 1997; 
Thomas et al. 1998; Beauchamp et al. 2006). The levels of Cx40 and Cx45 were 
unaltered in Cx43 heterozygous hearts (Guerrero et al. 1997; Thomas et al. 1998; 
Beauchamp et al. 2004). However Johnson et al. (2002a) did report a reduction in the 
amount immunosignal area occupied by Cx45 in Cx43 both in heterozygous and 
homozygous knockout mice. Data on ventricular CV in Cx43 heterozygous mice vary 
considerably with studies either reporting slowed ventricular conduction (Guerrero et al. 
1997; Thomas et al. 1998; Gutstein et al. 2001b) while others detected no change in CV 
(Morley et al. 1999). Furthermore Thomas et al. (1998) reported no alteration in CV in 
the atria of Cx43 heterozygous mice suggesting that Cx43 conduction plays a 
subordinate role in atrial conduction. Effects of diminished Cx43 expression accelerate 
the onset and increase the incidence of arrhythmias when exposed to acute regional 
ischemia (Lerner et al. 2000). 
 
Using outbred cardiac-restricted knockout mice it was possible to study the gradual loss 
of Cx43 in the heart (Danik et al. 2004). No change in propagation was detected in 
animals expressing ≥ 40% of Cx43. Reductions in CV (50%) were only observed when 
Cx43 protein content was decreased to 18% of the control levels and 80% of these mice 
were inducible to lethal ventricular arrhythmias. Further studies in these cardiac-
restricted knockout mice suggested that a mismatch in the coupling between the 
Purkinje fibres (unaltered levels of Cx40 and Cx45) and the Cx43 deficient ventricular 
myocytes lead to altered activations and wavefront collisions (Morley et al. 2005).  
 
Taking these findings together, there is now clear evidence that gap junction 
remodelling and altered patterns of connexin expression do occur in certain categories 
of human heart disease and corresponding changes in animal models cause arrhythmia. 
In particular, reduced expression of ventricular Cx43 and hence alterations in the ratio 
of co-expression of different connexin types is of critical importance. Changes in 
connexin expression/co-expression ratios will be explored in greater depth in the work 
reported in this thesis. 
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1.5.5. Role of antiarrhythmetic peptides on gap junction communication 
As discussed in the section above, gap junctions plays a pivotal role in facilitating 
action potential propagation and disturbances in their expression and distribution 
contribute to conduction abnormalities (Dhein et al. 2010). Current antiarrhythmetic 
therapy (e.g. ion channel blockers) is hindered through a lack of efficiency and side 
effects, creating the need for a new generation of drugs (De Vuyst et al. 2011). In this 
section I focus on the key compounds that have been developed to improve gap junction 
communication. 
 
In 1980, Aonuma et al. identified a natural antiarrhythmetic peptide, AAP in bovine 
atrium, which increased synchronization between embryonic chicken cardiac myocytes 
(Aonuma et al. 1980). Since this discovery numerous derivatives have been synthesised 
of which AAP10 was chosen as the lead peptide. AAP10 (10-50nm) functions by 
increasing gap junctional conductance as shown in dual whole-cell voltage clamp 
studies performed on guinea pig (Dhein et al. 2001) and human atrial cardiac myocytes 
(Hagen et al. 2009). This increase in conductance was via: (1) preventing the 
dephosphorylation of Cx43 and promoting the phosphorylation of Cx43 at serine 368 
though protein kinase C- leading to the opening of the gap junction channels (De 
Vuyst et al. 2011) and (2) inhibit the removal of Cx43 from the cell membrane and/or 
enhances the formation of functional channels (Dhein et al. 2001). In addition to 
increased conductance AAP10 enhanced metabolic coupling, assessed by Lucifer 
yellow dye transfer (Hagen et al. 2009). The influence of AAP10 on intercellular 
communication was not a sudden effect but rather a progressive increase in conductance 
(5-10 minutes). It should be noted that APP10 is connexin specific and only improves 
electrical and metabolic coupling in Cx43 and Cx45 coupled cells but not in Cx40 
coupled cells (Hagen et al. 2009). 
 
Since the discovery of AAP10, the compound has been was chemically modified 
through a rotation-inversion to produce ZP123 (rotigaptide). Rotigaptide improves 
electrical coupling in a similar manner to AAP10 by increasing Cx43 synthesis and 
phosphorylation and by decreasing its degradation. Studies on animal models showed 
that rotigaptide prevented: (1) increased dispersion of action potential duration during 
ischemia and acidosis; (2) conduction slowing in ischemia; (3) re-entrant ventricular 
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tachycardia one to four hours after left anterior descending ligation in the open chest 
dog model and (4) reperfusion-induced arrhythmias due to the re-opening of the 
occluded artery (De Vuyst et al. 2011). The effects of both AAP10 and ZP123 on infarct 
size have also been studied on a rat and dog model. Treatment with the peptides resulted 
in a significant reduction in the infarct size together with increased gap junction 
expression in the diseased area (Haugan et al. 2006; Hennan et al. 2009).   
 
More recently GAP-134 a small dipeptide analog of ZP123 has been developed which 
has reduced atrial fibrillation with no effect on heart rate and arterial pressure in a dog 
model. However the mechanism of improved gap junction communication is unclear 
since there is no change in Cx43 and Cx40 transcript levels. GAP-134 is currently under 
clinical trials (phase 1 is complete) to be the first orally available gap junction modifier 
(De Vuyst et al. 2011). It should be taken into consideration that experimental and 
theoretical cell models show that action potential propagation can fail in well coupled 
cells if these form a large mass receiving a limited amount of current from a smaller 
source; under these conditions, reducing coupling in the ‘sink’ can actually overcome a 
conduction block (Rohr et al. 1997; Rudy and Shaw 1997). Thus the reduction of Cx43 
to decrease coupling could be part of a protective response that increases the safety of 
conduction in the diseased heart (Severs et al. 2008). Collectively these results illustrate 
the potential of antiarrhythmetic peptides to improve gap junctional communication.   
 
1.5.6. Action potential generation and propagation and gap junction remodelling 
in theoretical models 
The passage of electrical impulses through the myocardium can be considered as a 
reaction-diffusion system whereby action potentials generated by individual cells in 
response to a suprathreshold current stimulus creates a voltage difference between the 
excited and resting tissue. This potential difference then drives the action potential to 
excite the resting tissue thereby supporting the spread of excitation in a wave-like 
manner (Kleber et al. 2001; Kleber and Rudy 2004). 
 
Action potential generation 
In the cells of the sinoatrial and atrioventricular node the action potential shape is 
different to those observed in atria and ventricles (Figure 1.12 (A)). The action potential 
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upstroke is slow since Ca
2+
 ions are the major contributor for excitation since these cells 
express little or no sodium (Na
+
) current (Dobrzynski et al. 2007). The resting 
membrane potential is more depolarised (-50mV) compared with atrial and ventricular 
cells (~-80mV). Nodal cells undergo periodic oscillations of their membrane potential 
giving a slow depolarisation phase which drives the membrane voltage from the end of 
the repolarisation phase of an action potential towards the threshold potential where 
upon the next action potential is initiated (Mangoni et al. 2006). This pacemaker 
potential provides the sinoatrial node with automaticity and the capacity for 
spontaneous rhythmical self excitation. The hyperpolarisation-activated ‘funny’ current 
(If) has been implicated as the primary source of slow diastolic depolarising current 
(Herrmann et al. 2007; Verkerk et al. 2007) which activates at the termination of an 
action potential and deactivates during the upstroke of an action potential (Barbuti et al. 
2007; DiFrancesco 2006; Bucchi et al. 2006). T-type Ca
2+
 channels expressed in all 
cardiac tissue displaying automaticity including the sinoatrial could also be a potential 
candidate in providing the automaticity (Mangoni et al. 2006; Takebayashi et al. 2006; 
Vassort et al. 2006). 
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Figure 1.12: Membrane excitability currents that generate an action potential 
Heart rhythm is initiated in the sinoatrial node (SAN), the natural pacemaker region in mammals which 
produces electrical impulses that spread across the right (RA) and left atrium (LA) and towards the 
atrioventricular (AV) node where its velocity is reduced before passing on to the left (LV) and right (RV) 
ventricles (A). Representative action potentials are shown from sinoatrial node and atria (left) and from 
atrioventricular node and ventricles (right), respectively (A). Voltage-gated ion channels responsible for 
generating a cardiac action potential (B). The four main phases of the action potential are the resting (4), 
upstroke (0), plateau (2) and final repolarisation (3) phase. Rapidly activating K
+
 currents such as Ito and 
IKur are responsible for very rapid initial repolarization (phase 1). The slow upstroke at the end of phase 3 
in pacemaker cells, such as the sinoatrial node, is shown as a broken line. The inward currents, INa, ICa, 
and If, are shown in yellow boxes; the sodium-calcium exchanger (NCX) is also shown in yellow. The 
outward currents, IKAch, IK1, Ito, IKur, IKr, and IKs are shown in gray boxes  Image reproduced from Nattel 
and Carlsson (1997b). 
 
In the atria and ventricles Na
+
 is the main current responsible for the initial phase of the 
action potential and in membrane excitability and conduction (Figure 1.12 (A) and (B)) 
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(Shaw and Rudy 1997). The influx of Na
+
 ions into the cells depolarises the cell 
membrane and is responsible for the very rapid upstroke of the cardiac action potential. 
The speed at which Na
+
 enters the cells determines the upstroke velocity (dV/dtmax). 
Membrane depolarisation activates the L-type Ca
2+
 channels which not only contributes 
to the maintenance of the action potential plateau but is an essential component for 
muscle contraction (Fozzard 2002). Under normal conditions the intracellular Ca
2+
 
[Ca
2+
]i is low in the cell. Upon membrane depolarisation Ca
2+
 entry through the L-type 
Ca
2+
 channels triggers Ca
2+
 release from the sarcoplasmic reticulum (SR) through the 
ryanodine receptor (RyR) a process termed Ca
2+
 induced Ca
2+
 release (CICR). The 
combination of Ca
2+
 influx and release raises the [Ca
2+
]i sufficiently for a large amount 
of Ca
2+
 to bind to the myofilament protein troponin C, which then ‘switches on’ the 
contractile machinery (Bers 2002). The plateau phase of the action potential is followed 
by the repolarisation phase. This process relies on the slow inactivation of the Ca
2+
 
channels and the opening of the K
+
 channels (Widmaier et al. 2006; Grant 2009). The 
outward flow of K
+ 
ions from the cell returns the membrane potentials to its resting 
state. During this final phase muscle relaxation also takes place via a decrease in [Ca
2+
]i 
allowing Ca
2+
 to dissociate from troponin. Ca
2+
 removal from the cell is facilitated by: 
(1) the sarco-endoplasmic reticulum Ca
2+
-ATPase (SERCA) that pumps Ca
2+
 back into 
the SR; (2) Na
+
-Ca
2+
 exchanger (NCX) that pumps Ca
2+ 
out of the cell in exchange for 
importing Na
+
 into the cell at a ratio of 1:3; (3) plasma membrane Ca
2+ 
ATPase 
(PMCA) that removes Ca
2+ 
from the cell and (4) mitochondrial Ca
2+
 uniport that 
uptakes Ca
2+ 
into the mitochondria (Bers 2002). Figure 1.12 (B) is a schematic diagram 
of the ionic currents involved in generating the action potential. 
 
Action potential propagation 
After electrical excitation the transmission of action potential is facilitated through gap 
junction channels. In a theoretical, multicellular one-dimensional fibre of myocytes, 
impulse propagation can be defined in terms of ‘source-and-sink’ (Kleber and Rudy 
2004). During propagation an excited cell acts as a ‘source’ of electrical charge to the 
neighbouring cell which acts as a ‘sink’ to receive the electrical charge. A sufficient 
amount of charge must pass from the source to the sink in order to bring the latter to the 
threshold of depolarisation to trigger an action potential. At threshold, the sink becomes 
the source to a further cell downstream thereupon perpetuating the process of impulse 
propagation. 
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The source-and-sink relationship can be described in terms of the safety factor (SF) of 
conduction. The SF is defined as ‘a dimensionless parameter that indicates the margin 
of safety with which the action potential propagates relative to the minimum 
requirements for sustained conduction’ (Shaw and Rudy 1997). Successful propagation 
requires a SF of 1 whereby the source charge matches the current required by the sink to 
reach the threshold of depolarisation. If more current is generated by the source than is 
needed by the sink, the SF increase above 1 and conduction continues efficiently. 
However if SF falls below 1, conduction is impaired and block will occur. 
 
To elucidate the precise relationship between ion channel fluxes (Na
+
 and L-type Ca
2+
) 
and gap junction modulation of SF and excitability Luo and Rudy developed a useful 
ventricular cell model (Luo and Rudy 1994). The three main parameters used to 
characterise conduction were: (1) CV; (2) SF for conduction and (3) the dVm/dtmax. 
Figure 1.13 (A) presents the response to reduced membrane excitability by decreasing 
the availability of Na
+
 current. The upper plot in Figure 1.13 (A) shows that decreased 
membrane excitability reduced CV and the SF of conduction. The lower plot in Figure 
1.13 (A) shows that reducing the maximal conductance of the Na
+
 current results in a 
steep decrease in dVm/dtmax. By reducing the Na
+ 
conductance (gNa) only a modest drop 
in CV (1/3 of control values) was observed before conduction failure.  
 
When the intercellular coupling was reduced initially there was a significant increase in 
SF (Figure 1.13 (B), upper plot) although there is a decrease in intercellular coupling 
causing a concurrent reduction in CV. The dVm/dtmax also increased in a similar fashion 
to the SF with the progressive uncoupling of cells (Figure 1.13 (B), lower plot). The Na
+
 
channel kinetics remained largely unchanged indicating that alteration to depolarising 
membrane current was not the cause of the elevated SF and dVm/dtmax. Rather, these 
data demonstrate that intercellular coupling is a prime determinant of the source-and-
sink relationship within a multicellular fibre, which directly feedback on the properties 
of the membrane current. 
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Figure 1.13: Effects of reduced membrane excitability and intercellular coupling on conduction, 
SF and maximum upstroke velocity 
Image (A), top panel shows the relationship between velocity (solid line) and safety factor (broken 
line) with reduced membrane excitability. CV decreases threefold to 17cm/sec before conduction 
block. Image (A) bottom panel shows the steep decrease in action potential upstroke velocity 
(dVm/dtmax) as the gNa is reduced. Image (B), top panel shows the relationships between velocity (solid 
line), safety factor (broken line) and reduced gap-junctional conductance. Conduction velocity 
decreases 200-fold to 0.26cm/s before conduction block occurs. Image (B), bottom panel shows the 
relationships between action potential maximum upstroke velocity, Na
+
 currents and gap-junctional 
conductance. Reduced coupling had little effect on membrane currents, but significantly increased 
action potential upstroke velocity. Images reproduced from Shaw and Rudy (1997). 
 
Upon entering a cell at the sink location, the source current will depolarise the 
membrane and initiate an action potential. By reducing the intercellular coupling, the 
proportion of charge that remains in the sink cell increases in relation to that which may 
pass further downstream i.e. the sink volume is decreased. This elevates the amount of 
current available for local depolarisation, whereby SF and dVm/dtmax increase. At much 
higher levels of uncoupling, the resultant delay of charge transfer from the source to the 
sink means that more of the Na
+
 and Ca
2+
 channels responsible for action potential 
generation will inactivate before threshold is reached. This leads to the sharp reduction 
in SF and dVm/dtmax shown in Figure 1.13 (B). When uncoupling is sufficiently high 
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enough, conduction block will therefore occur. During reduced coupling the L-type 
Ca
2+
 channel plays a major role in sustaining conduction whereby there is a switch of 
intrinsic membrane processes from a Na
+
 based upstroke to a Ca
2+
 based one. This 
interplay between membrane and gap junction factors may mean that under some 
conditions one change (reduced coupling) may compensate for another (reduced 
excitability) (Shaw and Rudy 1997). 
 
One of the key features of the model proposed by Shaw and Rudy (1997) is that 
conduction can persist following profound reductions in intercellular coupling albeit at 
much lower velocities due to the increase in SF. This could also explain the 
observations in transgenic mouse hearts which have shown that almost complete 
ablation of connexin expression is required to promote arrhythmias. The theoretical 
model suggests that reductions in intercellular communication could enhance safe 
propagation by diminishing source-and-sink mismatches. This was proven by Rohr et 
al. (1997) using a very small volume of cells (source) connected to a large mass cells 
(sink) (Figure 1.14). Under control conditions the source was unable to depolarise the 
large sink due to a source-and-sink mismatch resulting in a unidirectional block. 
However the same source is freely able to depolarise the sink when partial uncoupling is 
induced so diminishing the source-and-sink mismatch. 
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Figure 1.14: Optical mapping of successful conduction across a source-and-sink mismatch 
through reduced intercellular coupling 
(A) video micrograph of the patterned growth myocyte culture used in this experiment. A narrow 
myocyte strand (source) neighbours a large rectangular myocyte monolayer (sink). (B) depicts the 
recording system used to measure conduction. The graded-colour scale represents the strength of an 
action potential fired by cells. Red colour denotes full-sized action potential; dark blue means there is 
an absence of depolarisation. (C) shows that under normal conditions, substantial source-and-sink 
mismatch causes conduction block within the myocyte strand. In (D) cells have been partially 
uncoupled by brief (1.5 minutes) superfusion with the gap junction inhibitor palmitoleic acid. 
Conduction is now successful. (E) further superfusion with inhibitor, causes complete uncoupling and 
conduction block. (F-H) demonstrate that as the inhibitor is removed and coupling is slowly restored, 
conduction is again successful and dependent on the degree of coupling. (I) after washout period, 
complete coupling is regained and unidirectional conduction block is re-established. Image modified 
from Rohr et al. (1997). 
 
In vivo, prominent examples of source-and-sink mismatches are the sinoatrial node-
atrial tissue and the Purkinje fibre-ventricles. At these locations, a small source must 
provide a large enough charge to activate depolarisation of a large mass. A 
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characteristic feature of the diseased human ventricle is a heterogeneously reduced level 
of Cx43 expression (Severs et al. 2004b; Dupont et al. 2001b). This may lead to 
premature activation through dispersion of action potential durations, mismatches of 
source-and-sink relationships and local conduction delays or block (van Rijen et al. 
2006). Although heterogeneously altered levels of connexin expression contribute to 
conduction abnormalities by causing large differences in electrical coupling, the exact 
relationships between intracellular resistance, CV and the specific expression of Cx40, 
Cx43 and Cx45 at these locations are yet to be determined. 
 
1.6. HL-1 cell model to study impulse propagation 
The functional correlates of connexin co-expression are difficult to elucidate in vivo due 
to: (1) the various cell morphologies/physiology in the conduction system; (2) the 
technical difficulties of measuring CV in specific regions of the heart and (3) the 
impossibility of changing levels of expression. Although work on transgenic mice has 
given valuable insight on the functional consequences of connexin expression in the 
healthy and diseased heart, the inability to modulate connexin co-expression ratios 
makes their uses limited. In addition computer simulations relating intercellular 
coupling and conduction cannot resolve the precise contributions of gap junction 
channels which display a variety of functional properties. Therefore in parallel with 
such studies in vitro cell models that permit the manipulation of connexin expression 
(e.g. RNA interference) to mimic co-expression patterns found in vivo would open new 
opportunities to advance our knowledge. 
 
In my work the in vitro system used to determine the role of each connexin and 
combination of co-expressed connexins that occur in the normal heart was the cardiac 
cell line HL-1. 
 
1.6.1. Development of the HL-1 atrial cell line 
The growth of cardiac muscle cells is classified into two stages of development: (1) 
embryogenesis during which the cells divide and; (2) postnatal development when 
functional demand on the heart is met by cell enlargement rather than proliferation with 
a complete loss in the ability of the cells to divide (Steinhelper et al. 1990; Borisov and 
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Claycomb 1995). As a result isolated neonatal or adult cells are unable to survive 
passaging in culture while retaining their differentiated phenotype. In attempts to 
develop a cardiac cell line that maintained long-term proliferation, several studies have 
looked into the transfection of large T oncogene of the monkey papovirus simian virus 
40 (SV40) (Amsterdam et al. 1988; Pfeifer et al. 1993). It is thought that the SV40 large 
T oncogene induces cell proliferation by its ability to complex with and repress the 
activity of tumour suppressor proteins pRb and p53 involved in regulating the cell cycle 
(Lanson, Jr. et al. 2000). Using this technique Claycomb et al. produced transgenic mice 
expressing the SV40 T oncogene under the control of a tissue specific human atrial 
natriuretic factor (ANF) promoter resulting in atrial hyperplasia (Steinhelper et al. 1990; 
Borisov and Claycomb 1995). ANF, a peptide hormone synthesised and stored in 
cardiac atria functions in regulating extracellular fluid volume and electrolytes (Field 
1988). 
 
The atrial cells under the control of an ANF promoter termed AT-1 were highly 
differentiated and exhibited rhythmic contractile activity (Steinhelper et al. 1990; 
Lanson, Jr. et al. 1992). However as the cells were tumour-derived the hyperplastic 
growth (up to 30-50% of the host body mass) was lethal to the mice. In addition AT-1 
cells could only be maintained through sub-cutaneous transplantation into syngenic 
animals and could not be passaged in culture or recovered from frozen stocks (Field 
1988; Steinhelper et al. 1990). To overcome these difficulties the HL-1 cell line was 
isolated from an AT-1 sub-cutaneous tumour and cultured (Claycomb et al. 1998). Cells 
from the excised tissue were plated in gelatin-fibronectin coated flasks and grown in an 
atmosphere of 5% CO2 at 37ºC. Once cells reached confluency, cultures were split 1:3 
and under selective conditions (e.g. retinoic acid and norepinephirine) were highly 
proliferative and allowed at least 240 passage while retaining a differentiated phenotype  
(Claycomb et al. 1998). 
 
HL-1 cells share several characteristics with primary cultures of cardiac myocytes. 
Electron microscopy revealed the cells were abundant in nascent myofibrils and areas 
rich in glycogen typical of mitotically active cells. At the various passages tested all 
cells possessed perinuclear ANF-containing granules, α-type myosin heavy chain, 
muscle specific desmin intermediate filaments, α-type cardiac actin and Cx43 
(Claycomb et al. 1998). Electrophysiological studies confirmed the presence of 
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functional voltage-gated ion channels (e.g. inward and delayed rectifier K
+
, L- and T-
type Ca
2+
 and If), [Ca
2+
]i release from the SR and spontaneous action potentials (Sartiani 
et al. 2002; Claycomb et al. 1998; Akhavan et al. 2003; Xia et al. 2004). The genes 
expressed in the HL-1 cells are depicted diagrammatically in Figure 1.15. These 
features, together with their ability to retain or maintain their differentiated 
characteristics during continuous passage in culture, make them an ideal in vitro model 
to study various aspects of cardiac cell biology (White et al. 2004). 
 
 
Figure 1.15: Schematic depiction of the key characteristic features in a HL-1 cell 
The HL-1 cells display a cardiac phenotype with the expression of a number of cardiac myocyte 
markers such as -myosin heavy chain and -actin, both key components of the contractile apparatus. 
Cells expressed ANF granules normally secreted by atrial cells in vivo in response to stressful stimuli 
such as hypoxia and hyperglycemia. They were also able to generate action potentials showing that 
they express the necessary ion channels required for excitability (sodium (INa), L- (ICa,L) and T-type 
(ICa,T) Ca
2+
, potassium (IK) and hyperpolarising-activated ‘funny’ current (If)). Cells displayed [Ca
2+
]i 
oscillations indicative of a functional SR and Ca
2+
 handling proteins. HL-1 could be a useful model to 
study the role of various receptors in cell signalling pathways such as - and -adrenergic receptors. A 
number of transcription factors are also expressed such as Nkx2.5, GATA-4, c-Myc, Tbx-5 and 
MEF2C. Collectively these featured make the HL-1 cell line a useful in vitro model to study cardiac 
physiology and pathophysiology. Image modified from White et al. (2004). 
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1.7. Scope of thesis  
I set out to investigate the functional significance of distinctive connexin co-expression 
patterns characteristic of the different myocyte subtypes. Using the HL-1 cell model we 
were able to manipulate connexin expression using RNAi technology and assign CV to 
each of the different connexin combinations using microelectrode arrays (MEA). To 
address the role of connexin expression in impulse propagation this investigation was 
performed with the following objectives in mind: 
1. To sub-clone the HL-1 cells due to heterogeneity of the original cell line   
2. To characterise voltage-gated ion channels mainly involved in cell 
depolarisation and [Ca
2+
]i release which are key components in action potential 
generation and contractile activity. 
3. To examine connexin distribution patterns, co-expression ratios and investigate 
the possible gap junction channel types in terms of connexin composition.  
4. To determine CV in the HL-1 clones, homogeneity of wavefront propagation 
and pacemaker location.  
5. To manipulate connexin expression levels and determine the effects of altered 
expression on CV. 
 
General methods that were routinely used to fulfil the goals of the investigation are 
described in Chapter 2. These include cell culture procedures, immunofluorescent 
labelling and confocal microscopy, western and northern blotting. The main body of the 
experimental work is presented in Chapters 3-7. These chapters each contain a focused 
introduction, a description of the specific methods undertaken for the particular 
investigations, the experimental results and a concise discussion. Some of the 
techniques that were specific to the work in a chapter are described in more detail when 
used. 
 
The HL-1 cells needed to be cloned to create more homogenous populations in order to 
relate experimental data to the chosen gene expression and exclude differences due to a 
heterogeneous cell line. It was important to establish that the HL-1 clones were able to 
express functional voltage-gated ion channels and the relevant Ca
2+
 handling proteins 
determined by whole cell patch-clamp and northern blotting respectively confirming the 
clones were of cardiac myocyte origin (Chapter 3). Gap junction expression levels and 
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connexin co-expression patterns were analyzed by western and northern blotting and 
immunofluorescence confocal microscopy (Chapter 4). Action potential propagation 
was measured in all the HL-1 clones using MEA in combination with optical mapping 
(Chapter 5). To correlate connexin expression to CV, RNAi using short interfering 
RNA (siRNA) was used to decrease connexin expression (Chapter 6). The functional 
consequences of altered connexin expression levels were assessed by MEA. A summary 
of the main findings, their significance and future directions for this study are discussed 
in Chapter 8. 
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CHAPTER 2. 
General methods 
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2.1. Introduction 
This chapter gives a detailed description of all the general procedures used throughout 
the investigation such as immunocytochemistry, western blotting, and northern blotting 
for the characterisation and functional assessment of the HL-1 clones. Specific 
methodological detail such as the optimisation of the microelectrode arrays and RNA 
interference are given in the relevant individual chapters. All chemicals and reagents 
were supplied by Sigma-Aldrich and VWR unless otherwise stated and were of the 
highest analytical grade. 
 
2.2. Cell culture techniques 
2.2.1. Culture maintenance of the HL-1 clones 
All sterile procedures were carried out in a laminar flow safety cabinet. The HL-1 
clones were cultured in Claycomb medium supplemented with 10% foetal bovine serum 
(FBS), 4mM L-glutamine, penicillin (100 units/ml), streptomycin (100mg/ml) and 
10μM norepinephrine maintained in an atmosphere of 5% CO2 at 37ºC. A list of the 
reagents used to prepare the Claycomb medium is presented in Table 2.1. Cultures were 
maintained at high density and split every four to five days when confluency was 
reached and cells were visibly contracting under microscope examination with the 
exception of clone 2. Flasks were pre-coated with 0.02% gelatin, 5mg/ml fibronectin in 
distilled water (dH2O) to help cells adhere to the surface and be passaged repeatedly 
while maintaining their contractile phenotype (White et al. 2004). To passage a 25cm
2
 
flask, the cell monolayer was washed with phosphate-buffered saline (PBS) and 
incubated with 2ml of 1x trypsin-EDTA (5mg/ml trypsin, 2mg/ml EDTA, PBS) for 
approximately 3 minutes at 37ºC for partial detachment of cells. The trypsin together 
with cellular debris produced by the cells was removed by aspiration and replaced with 
fresh trypsin (0.5ml). The flask was returned to the incubator for a further 5 minutes for 
complete cell detachment. Trypsin activity was blocked by 1x trypsin inhibitor from 
glycine max (soya bean) at a ratio of 10l per 1cm2 of cells. Flasks were rinsed 
thoroughly with Claycomb medium to ensure high cell recovery and a new flask seeded 
approximately by a 1:2 or 1:3 dilution. 
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For experiments where a specific cell density was required, cells were trypsinised as 
above, centrifuged (130gmax, 5 minutes room temperature) in serum free Dulbecco's 
Modified Eagle Medium (DMEM). The cell pellet was re-suspended in the appropriate 
volume of Claycomb medium and seeded in the suitable culture vessels (e.g. 24 well-
plate and 35mm dishes). 
 
Table 2.1: List of reagents used to prepare the Claycomb medium 
 
Reagent Concentration 
Total protein 261mg/l 
Bovine albumin 48.85mg/l 
Non-essential amino acids 0.1mM 
Fetuin 165mg/ml 
Transferrin 31.8mg/ml 
Retinoic acid g/l 
Human insulin (recombinant) 15g/l 
Long R
3
IGF-1 (recombinant) g/l 
Long EGF (recombinant) g/l 
Cholestrol 1.96mg/ml 
Linoleic acid 0.78mg/ml 
-Oleyl--pal--phosphatidylcholine 1.96mg/ml 
Ascorbic acid 0.3mM 
 
Table modified from White et al. (2004) 
 
2.2.2. Cryopreservation of the HL-1 clones 
For freezing, sub-confluent cell monolayers in 75cm
2
 flasks were detached as above 
with the proportion and volumes of trypsin and trypsin inhibitor adjusted; centrifuged 
(130gmax, 5 minutes room temperature) and the cell pellet re-suspended in 5ml FBS 
containing 5% dimethyl sulphoxide (DMSO) (v/v). Aliquots of 1ml were transferred 
into cryovials before freezing at -80ºC for a maximum of 24 hours and subsequent long-
term storage in liquid nitrogen. For revival, cryopreserved cells were thawed at 37ºC, 
diluted in Claycomb medium and plated in a 25cm
2
 flask. Medium was changed 3-4 
hours post-seeding to remove any dead cells and prevent any DMSO toxicity. Thawing 
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of each aliquot resulted in an approximately 30-40% confluent 25cm
2
 flask after one 
day in culture. 
 
2.3. DNA Engineering to obtain probes for northern blot 
2.3.1. Preparation of freshly saturated E. coli ER2925 cells 
Freshly saturated cells were prepared by inoculating 20ml of Luria-Bertani (LB) broth 
(10g/l bacto tryptone w/v, 5g/l bacto yeast extract w/v, 10g/l sodium chloride w/v, 
100µl 10M sodium hydroxide v/v) with 500l of frozen ER2925 cells (New England 
BioLabs) overnight at 37ºC with shaking at 350rpm using a rotary shaker. For future 
use and long-term storage freshly saturated bacteria were frozen at -80ºC in 1ml 
aliquots after addition of glycerol at a final concentration of 15% (v/v). 
 
2.3.2. Preparation and transformation of competent E. coli ER2925 cells 
The calcium chloride method originally described by Cohen et al. (1972) was used to 
prepare and transform competent E. coli to allow the cloning of various DNA 
fragments. The principle behind this technique is that bacterial cell membranes are 
permeable to chloride ions but impermeable to Ca
2+
 ions. Thereby as the chloride ions 
enter the cell, water molecules accompany the charged particles causing the cells to 
swell. Through this alteration of the cell wall, bacteria are more likely to incorporate 
plasmid DNA and such cells are said to be ‘competent’. A freshly saturated ER2925 
culture stored at -80ºC was thawed and 250µl of cells dispensed into a 50ml falcon tube 
containing 25ml LB broth. The culture broth was incubated at 37ºC on a rotary shaker at 
350rpm for approximately 2 hours. When an optical density of 0.3 when read at 600nm 
was reached, the culture was immediately cooled on ice for 10-20 minutes. This was to 
ensure the number of viable cells per 1ml did not exceed 10
8
 therefore preventing the 
bacteria from entering the late log phase of growth which decreases transformation 
efficiency. Cells were pelleted by centrifugation at 1500gmax for 10 minutes at 4ºC, 
rinsed thoroughly with 0.1M ice-cold calcium chloride (0.45μm filtered) and re-
centrifuged. From this stage the bacteria were competent and all plastic ware used 
during experiments had to be ice-cold to maintain competency. The resulting pellet was 
re-suspended in 1ml of 0.1M calcium chloride using ice-cold tips and incubated 
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overnight on ice at 4ºC to reach maximal competency and increase transformation 
efficiency. 
 
50ng of purified plasmid DNA was used for each transformation, re-suspended in a 
maximum volume of 10µl Tris-EDTA (TE) (10mM tris w/v, 1mM EDTA v/v) pH 8. 
DNA was first transferred to a sterile 14ml round-bottomed tube (Falcon 2059) and 
stored on ice for 30 minutes. Using ice-cold pipette tips, 200µl of competent cells were 
added to the DNA, gently mixed and incubated on ice for 30-45 minutes. Cells were 
heat shocked for exactly 90 seconds at 42ºC. 800µl of LB broth was added to the cells 
and incubated for a further 45 minutes at 37ºC with agitation at 250rpm to allow cells to 
recover and initiate expression of the ampicillin resistance gene encoded by the plasmid. 
Transformed cells were selected by plating up to 200µl of the transformed mixture onto 
LB-agar plates (1.5% agarose w/v, LB broth) containing 100µg/ml ampicillin and 
incubated overnight at 37ºC. Positive controls were prepared with cells transformed 
with 25ng ultra clean plasmid DNA (pcDNA 3.1 V5/His A, 5.5kB). This protocol 
typically yields 1-3 x 10
6 
transformed colonies per 1µg of supercoiled plasmid DNA. 
Cells transformed without plasmid DNA were used as negative controls. The resistant 
colonies were transferred using a bacteriological transfer loop to 50ml falcon tubes 
containing 15ml LB broth and incubated overnight at 37ºC with agitation at 250rpm to 
obtain a freshly saturated culture. Cultures were screened for successful transformation 
by small-scale DNA preparations (mini-prep) and/or used to inoculate larger cultures 
for large-scale plasmid DNA production (maxi-prep). 
 
2.3.3. Small-scale preparations of plasmid DNA (mini-prep) 
For small-scale isolations and rapid screening of the clones, mini-preps were used to 
yield up to 50g DNA. The alkaline lysis method initially described in 1979 by 
Birnboim and Doly was used for isolating plasmid DNA. 2ml of culture was transferred 
to a 2ml Eppendorf tube and spun at 22,000gmax for 2 minutes at room temperature. 
This step was repeated twice using a total of 6ml of the freshly saturated culture. The 
bacterial pellet was re-suspended in 200l of alkaline lysis solution I (25mM tris pH 8 
w/v, 50mM glucose w/v and 10mM EDTA v/v) by vigorous vortexing to give a 
homogenous suspension. 400l of alkaline lysis solution II (2M sodium hydroxide v/v, 
1% sodium dodecyl sulphate (SDS) w/v) was added to the cell suspension and 
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incubated for 30 minutes with gentle rocking. At alkaline pH and in the presence of 
SDS the cellular membranes and proteins are solubilised and the plasmid DNA 
denatured. The cellular debris and genomic DNA was precipitated by the addition of 
300l alkaline lysis solution III (5M potassium acetate w/v, glacial acetic acid v/v) with 
gentle shaking and incubation on ice for 5-10 minutes. Potassium acetate helped 
neutralise the alkaline solution enabling the re-naturing of single-stranded DNA to 
double-stranded DNA. This is a selective process whereby only small circular plasmid 
DNA can re-nature and dissolve easily in solution and precipitate the dodecyl sulphate 
protein complexes. A white insoluble precipitate forms consisting of chromosomal 
DNA and SDS/protein complexes that were removed by centrifugation at 22,000 gmax 
for 5 minutes. The supernatant containing the plasmid DNA was transferred to a fresh 
tube. 
 
Plasmid DNA was extracted with 1 volume of phenol buffered to pH 8 and then with 1 
volume of chloroform:isoamyl alcohol (25:1) v/v. Samples were vortexed vigorously to 
denature the protein and remove contaminants that would interfere with the restriction 
digestion step later in the procedure. The chloroform helped separate the phenol and 
aqueous phases. The aqueous phase was collected after centrifugation at 22,000gmax 
for 5 minutes. Plasmid DNA in the aqueous phase was precipitated by mixing with an 
equal volume of propan-2-ol v/v followed by incubation at -20ºC for 1 hour. After 
centrifugation the DNA/RNA pellet was washed with 1ml of 75% ethanol v/v and 
vortexed. Pellets were recovered by centrifugation, air-dried and re-suspended in 30l 
of TE pH 8 with 25g/ml RNase A to digest contaminant RNA. Clones were screened 
using restriction endonucelease digestion and agarose gel electrophoresis as described in 
section 5 of this chapter. 
 
2.3.4. Large-scale preparations of plasmid DNA (maxi-prep) 
To obtain large amounts of pure plasmid DNA maxi-preps were used giving a yield of 
1-3mg from a 500ml culture. 100l of cells from a freshly saturated culture containing 
the plasmid either kept at 4ºC or freshly thawed from -80ºC was seeded into 500ml LB 
broth with ampicillin 100g/ml and incubated overnight at 37ºC on a rotary shaker at 
250rpm. Cells were collected by centrifugation (1500gmax, 15 minutes) in 50ml falcon 
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tubes with the supernatant discarded after each spin and replaced with a further fresh 
50ml culture until all the culture was collected in a single tube. The final pellet was re-
suspended, lysed and debris precipitated in alkaline lysis solutions I (10ml), II (20ml) 
and III (15ml) respectively. Debris was removed by centrifugation at 1500gmax for 15 
minutes at 4ºC and the supernatant divided into 2 fresh 50ml falcon tubes. Nucleic acids 
were precipitated using 0.6 volume (of the 45ml of alkaline lysis solutions) of propan-2-
ol with incubation at room temperature for 10-15 minutes and centrifugation at 
4000gmax for 15 minutes at 4ºC. 
 
Pellets were washed in 10ml 75% ethanol and re-centrifuged (4000gmax, 15 minutes 
4ºC). The alcohol was carefully aspirated and pellets briefly air-dried before re-
suspension in 2.5ml TE pH 8. 2.5ml of 5M lithium chloride was used to precipitate high 
molecular mass RNA. After centrifugation at 4000gmax for 10 minutes at 4ºC the 
supernatant was transferred to a fresh 15ml falcon tube, and nucleic acids were 
precipitated with 1 volume (5ml) of propan-2-ol and centrifuged (4000gmax, 10 
minutes 4ºC). Pellets were rinsed in 75% ethanol and re-centrifuged. To remove any 
remaining RNA contaminants, pellets were re-suspended in 500l TE pH 8 containing 
25g/ml RNase A and incubated for 45 minutes at room temperature. To purify plasmid 
DNA, samples were precipitated with 600µl of polyethylene glycol (13% PEG v/v, 
1.6M sodium chloride) for 15 minutes and centrifuged (22,000gmax, 10 minutes 4ºC). 
PEG selectively precipitates plasmid DNA leaving short RNA and DNA fragments in 
the supernatant. Small pellets were re-suspended in 400l TE pH 8 and extracted with 
phenol pH 8 (1 volume). Samples were thoroughly mixed by vortex and centrifuged 
(22,000gmax, 10 minutes). The upper aqueous phase containing the DNA was 
collected, purified with 400l phenol:chloroform (1:1 v/v ratio) and re-centrifuged 
(22,000gmax, 10 minutes). The aqueous phase was further purified with 1 volume of 
chloroform. After centrifugation the upper aqueous phase was recovered and the 
plasmid DNA was precipitated with 100l of 10M ammonium acetate and 500l of 
propan-2-ol with incubation on ice for 15 minutes. Pellets were recovered by 
centrifugation at 22,000gmax for 10 minutes at 4ºC, washed in 750l 75% ethanol, re-
centrifuged for 5 minutes and air-dried. Purified plasmid DNA was re-suspended in 
200l of TE pH 8 and the optical density determined at a 1:250 dilution. Samples were 
measured at an absorbance of 260nm and 280nm. An optical density of 1.0 at 260nm 
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(A260) is equivalent to 50μg of DNA and purity of the sample was assessed from the 
ratio of A260/A280. Pure plasmid DNA preparation gave a ratio of approximately 1.8. 
 
2.3.5.  Restriction endonuclease digestion 
Analysis of the plasmids obtained from mini- and maxi-preparations was carried out 
using restriction endonuclease digestion and the resulting bands visualised using 
agarose gel electrophoresis. 
 
As a general rule in enzymatic digestions the concentration of enzyme used should 
never exceed 10% of the total volume and 1 unit of enzyme will cut 1g of a 3Kb 
plasmid in 1 hour at 37ºC. For mini-prep analysis ~1l (1g) of DNA from the 30l of 
mini-prep culture was digested in a total volume of 20l containing 10 units of the 
appropriate enzyme (Roche) in the corresponding restriction enzyme buffer (up to a 
maximum of 2l) (Roche) and dH2O for 1-2 hours at 37C. The restriction enzyme was 
the last component added to the mixture preventing any possible damage caused by 
contact with the undiluted buffer. 
 
2.3.6. Agarose gel electrophoresis 
Analysis of the restriction digest was carried out by agarose gel electrophoresis. An 
agarose gel of 1% shows good resolution of DNA fragments of between 500bp and 
5000bp in size. A 1% agarose (LE, Analytical grade, Promega) w/v gel containing 1x 
Tris acetate-EDTA (TAE) buffer (40mM tris-acetate pH 8, 1mM EDTA) v/v and 
0.5g/ml ethidium bromide v/v was prepared. Ethidium bromide was used to visualise 
the DNA during electrophoresis because of its ability to intercalate between the stacked 
bases of DNA. 4l of (~0.2µg) DNA was loaded per lane from a 20l restriction-
digestion mixture to allow visualisation of the electrophoretic pattern. Samples were 
prepared in 0.1 volume of 10x loading buffer (0.1% xylene cyanole w/v, 0.1% 
bromophenol blue w/v, 50% glycerol v/v, 0.5% SDS w/v, 1x TAE v/v) and 
electrophoresed in running buffer containing 1x TAE v/v and 0.5g/ml ethidium 
bromide v/v at a voltage of 100V. DNA markers of known fragment size were also run 
on the gels to analyse accurately the size of the digest products. Two sets of markers 
were used. Lambda DNA cut with EcoRI and HindIII (Sigma) gives clear bands 
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between 21,226bp and 125bp in size. pBR332 DNA cut with HaeIII gives bands 
between 587bp and 123bp in size. DNA bands were visualised using an UV 
transluminator and recorded on Polaroid film. 
 
2.3.7. Recovery of DNA to be used as probes 
To purify DNA inserts to be used as probes coding sequences were removed from the 
plasmid DNA by restriction enzyme digestion and isolated by agarose gel 
electrophoresis. As an example, preparation of the probe used to detect mRNA for the 
L-type Ca
2+
 channel is described in Figure 2.1. In brief the plasmid map for L-type Ca
2+
 
channel had two restriction sites flanking the coding sequence for EcoR1 and EcoRV. 
Each enzyme cut the plasmid at those single sites. Digestion was carried out using 9µg 
of pCI-neo L-type, 10 units of each EcoR1 and EcoRV and a restriction enzyme buffer 
that was compatible with both enzymes. 
 
Digested fragments were resolved by agarose gel electrophoresis. The gel was prepared 
using a 1% lower melting point (~65ºC) agarose w/v in 1x TAE and 0.5g/ml ethidium 
bromide v/v. DNA fragments were visualised using a UV transluminator and the bands 
of correct size were cut out of the gel using a clean razor blade. The gel band was 
transferred to an Eppendorf tube, diluted to 500l TE pH 8 and melted at 75ºC for 10 
minutes. Samples were vortexed extensively to ensure all the DNA was solubilised and 
snap-frozen in liquid nitrogen. Samples were thawed at room temperature with vigorous 
vortexing and the agarose removed by centrifugation (22,000gmax, 10 minutes 4ºC). In 
this condition agarose forms a tight pellet and the DNA remains in solution. DNA was 
precipitated with 0.1 volume 3M sodium acetate pH 5.2 and 1 volume of propan-2-ol 
and recovered with centrifugation (22,000gmax, 10 minutes 4ºC). The DNA pellet was 
washed with 500l 75% ethanol, centrifuged 22,000gmax, 10 minutes 4ºC) and 
solubilised in 30l TE pH 8. There is an approximate 25% loss of DNA during the 
probe recovery that needs to be taken into account to ensure the final concentration of 
DNA is at 2.5µg/µl. 
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2.4. Analysis of mRNA expression by northern blotting 
Northern blotting was used to detect and quantify the mRNA transcribed in the HL-1 
clones in relation to Ca
2+
 handling proteins and connexin expression. 
 
2.4.1. Sample preparation 
Cells were grown in 100mm dishes and cultured to the required densities. Cultures were 
washed in PBS and lysed in 750μl of Solution D (4M guanidinium thiocyanate w/v, 
25mM sodium citrate pH 7 w/v, 0.5% sodium lauryl sarcosinate w/v, 1% 2-
mercaptoethanol v/v) to solubilise all cellular components and denature endogenous 
RNases that are released during cell lysis. Samples were scraped into 2ml Eppendorf 
tubes and stored at -20ºC until further use. 
 
 
Figure 2.1: Plasmid map of L-type Ca
2+
 channel 
The plasmid map containing cDNA for the L-type Ca
2+
 channel has two restriction sites flanking the 
coding sequence for EcoR1 and EcoRV (A). Plasmid digestion was carried out using restriction 
enzymes EcoR1 and EcoRV in the enzyme buffer compatible for both enzymes and the fragments 
resolved in low melting point gel electrophoresis (B). The smaller of the two DNA fragments 
(2136bp) in the gel was cut with a sharp blade and precipitated for northern blot analysis.   
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2.4.2. RNA extraction and quantification 
All glassware used for RNA extraction was baked overnight at 180ºC to remove any 
contamination by RNases. 
 
RNA was extracted using the acid guanidium-phenol-chloroform (AGPC) technique 
(Chomczynski and Sacchi 1987) with modifications. After cell lysis in Solution D, 
RNA was acidified with a 0.1 volume of 2M sodium acetate pH 4 and precipitated with 
1 volume phenol pH 4.5 and 0.2 volume chloroform:isoamyl alcohol (25:1 v/v). This 
step separates the RNA into the aqueous phase from DNA and protein which is retained 
in the phenol phase at acidic pH. Samples were vortexed extensively, left to stand on ice 
for 15 minutes and centrifuged at 22,000gmax for 15 minutes at 4ºC. The RNA was 
precipitated from the aqueous phase with 1ml propan-2-ol for 1 hour or overnight at -
20ºC. The pellets were recovered by centrifugation (22,000gmax, 15 minutes 4ºC) and 
solubilised in 400μl of Solution D. RNA was re-precipitated with 0.1 volume of 3M 
sodium acetate pH 5.2 and 1 volume of propan-2-ol and incubated for 1 hour at -20ºC. 
Samples were centrifuged (22,000gmax, 15 minutes 4ºC) and the pellets washed in 
750μl 75% ethanol v/v. The RNA pellets were recovered by centrifugation and re-
suspended in 100% formamide (30-60μl). Formamide provides a chemically stable 
environment for RNA and protection against degradation by RNases. Samples were 
stored at -20ºC for long-term storage. 
 
To measure the concentration and purity of the RNA extracted, samples were diluted 
1:400 in TE pH 8 and the absorbance measured at 260nm and 280nm. A reading of 1.0 
optical density at A260 is equivalent to 40μg/ml of RNA. The absorbance ratio of 
A260/A280 is used to assess RNA purity and an A260/A280 ratio of 2.0 is indicative of 
highly purified RNA. 
 
2.4.3. Northern blotting 
RNA was denatured and separated according to size in a denaturing formaldehyde 
agarose gel. For each sample, 5g of total RNA was diluted in a volume of 5l 100% 
formamide and mixed with an equal volume of RNA loading buffer (40mM MOPS pH 
7-7.5 w/v, 10mM sodium acetate v/v, 36 % formalin v/v, 2mM EDTA v/v, 0.02µg 
ethidium bromide v/v, 10% tracking dye v/v) and denatured at 75ºC for 10 minutes. 
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Samples (10l) were loaded on a 1% agarose gel (1% agarose w/v, 20mM MOPS pH 7-
7.5 w/v, 5mM sodium acetate v/v, 18% formalin v/v, 1mM EDTA v/v) and run at 70V 
in running buffer (20mM MOPS pH 7-7.5 w/v, 5mM sodium acetate v/v, 18% formalin 
v/v, 1mM EDTA v/v). Formaldehyde maintains RNA in a denatured state by forming 
unstable Schiff bases with single imino groups of guandine residues. After migration the 
18S and 28S ribosomal RNA subunits on the gel were visualised under the UV 
transluminator and recorded on Polaroid film to quantify the amount of nucleic acid 
present. The gel was equilibrated twice in a plastic container with 10x saline sodium 
citrate (SSC) (1.5M sodium chloride, 150mM sodium citrate pH 7-7.5) on a rocker for 
30 minutes each. The RNA gel was capillary blotted overnight in 10x SSC onto a 
Hybond N nylon membrane (Amersham) using the set-up illustrated in Figure 2.2. After 
northern blotting the membrane was rinsed briefly in 2x SSC (300mM sodium chloride, 
30mM sodium citrate pH 7-7.5) and dried thoroughly at 37ºC. RNA was cross-linked to 
the membrane by UV irradiation on a transluminator for 5 minutes before further 
processing. This was the optimal time developed in our lab to ensure each membrane 
could withstand more than one round of hybridisation and washing without the 
significant loss of the bound nucleic and subsequent hybridisation signal. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Apparatus set-up for northern blotting procedure 
 
Nylon membrane 
Filter paper 
Absorbent paper 
Formaldehyde gel 
10x SSC 
Buffer 
Weight 
Wick 
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2.4.4. Probe synthesis and hybridisation 
For each hybridisation 25-50ng of DNA probe was diluted in 30µl ultra-pure water 
(MilliQ) and denatured at 95ºC for 10 minutes. The DNA was used as a template to 
synthesise radioactive probes using a Mega Prime DNA Labelling kit (Amersham, GE 
Healthcare) and -32P-labelled dCTP radionucleotides prepared according to 
manufacturer’s instructions. Unincorporated nucleotides were removed by gel filtration 
chromatography using a Micro Bio-Spin 30 chromatography column (prepared 
according to manufacturer’s instructions from Bio-Rad). The hybridisation buffer was 
prepared containing 7% SDS, 0.5M sodium phosphate, and 1mM EDTA. To prevent 
any SDS from precipitating the buffer was pre-warmed at 65ºC for a minimum of 30 
minutes in a hybridisation oven with gentle rocking. Membranes were blocked in the 
warmed buffer for a further 30 minutes to which the radiolabelled probe was added and 
incubated overnight at 65ºC. After hybridisation, membranes were briefly rinsed in 2x 
SSC, washed twice with 0.5x SSC (75mM sodium chloride, 7.5mM sodium citrate pH 
7/7.5) and 0.1% SDS at 65ºC for 1 hour per wash and placed in clear a plastic envelope. 
Membranes were exposed using X-OMAT imaging films (Kodak) in intensifying screen 
cassettes (Amersham) at -80ºC. 
 
Membranes were dehybridised in a boiling solution of SDS 0.1% in ultra-pure water 
(MilliQ) and left on a rocker until room temperature was reached. This step was 
repeated until no, or minimal, radioactivity was detected using a Geiger counter and the 
membranes ready to be re-hybridised with a new probe. 
 
2.5. Analysis of protein expression by SDS-PAGE and western blotting 
Sodium dodecyl sulphate polyacrylamide gel electrophoriesis (SDS-PAGE) and western 
blotting was used to detect: 
(1) Total connexin expression 
(2) The ratio of junctional to non-junctional connexins 
(3) Connexin co-expression ratio 
(4) Co-immunoprecipitation studies on connexon interaction and 
(5) Effects of RNA interference on connexin expression 
This technique utilizes the specific binding of SDS to protein through its hydrophobic 
alkyl chain at a ratio of 1.4g SDS per 1g of protein to form a rod-like micelle structure. 
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This unique property gives the denatured protein a large net negative charge 
approximately proportional to its mass. The denatured proteins are then separated 
according to size using gel electrophoresis, which are then immunoblotted onto a 
membrane and the target proteins detected using the appropriate primary and secondary 
antibodies. 
 
2.5.1. Sample preparation 
Total connexin expression 
Cells were seeded in either 60mm dishes or 6-well plates and grown to the required 
confluency. Cultures were washed twice in PBS and lysed in solubilisation buffer SB20 
(20% SDS w/v, 0.1M Tris pH 6.8 v/v, 10mM EDTA v/v) at a ratio of 10l per 1cm2 of 
cells. Cell lysates were sonicated (LSL sonicator, Heat systems-Ultrasonics, Inc) at high 
power for 10-15 seconds to shear the genomic DNA and reduce viscosity.  The solution 
was allowed to clear and 10-20l was removed for protein quantification before storage 
at -20ºC. 
 
Differential solubilisation of junctional and non-junctional connexins 
To assess the ratio of junctional to non-junctional connexins, cells were initially treated 
with mild non-ionic detergent Triton X-100 that was able to solubilise single connexons 
and molecular connexins without causing them to dissociate into their component 
connexins (Musil and Goodenough 1991). Junctional connexons that are still docked as 
channels are resistant to solubilisation with Triton X-100. The final step was to treat the 
remaining cellular material with SDS that solubilises the remaining connexins, which 
represent the connexin present at the junction. 
 
Cells were seeded in six-well plates and grown to full confluency. Samples were 
scraped directly from the medium in which they were cultured using a cell scraper and 
transferred to a 15ml falcon tube. The wells were rinsed thoroughly with complete 
DMEM (10% FBS, 4mM L-glutamine, penicillin (100units/ml) and streptomycin 
(100mg/ml)) to recover any remaining cells and added to the falcon tube. Cells were 
centrifuged at 700gmax for 5 minutes at 4ºC and the supernatant carefully aspirated 
with minimal disruption to the pellet. Cell pellets were re-suspended in 2ml of complete 
DMEM and transferred to a 2ml Eppendorf and centrifuged (22,000gmax, 5 minutes 
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4ºC). The medium was aspirated and the cell pellet was washed in PBS and centrifuged 
(22,000gmax, 5 minutes 4ºC). Cell pellets were directly re-suspended in solubilisation 
buffer containing Triton X-100 (1% Triton X-100 v/v, 40mM Tris pH 8 v/v, 150mM 
sodium chloride v/v, mammalian protease inhibitor cocktail 1:250 v/v (Sigma)) at a 
ratio of 5l per 1cm2 of cells. Samples were homogenised by vortexing and sonication 
at low power. 
 
To solubilise the non-junctional connexons samples were incubated on ice for 30 
minutes with vortexing every 5-10 minutes. Samples were centrifuged at 22,000gmax 
for 30 minutes at 4ºC after which the supernatant containing the non-junctional 
connexons was removed and kept on ice. The remaining pellet was lysed directly in 
SB20 in exactly the same volume that was used to solubilise the non-junctional 
connexons. Samples containing the junctional connexons were sonicated at low power 
until the pellet was dispersed and left to clear at room temperature. To provide an 
estimate for total protein content an equal volume of the junctional and non-junctional 
samples were mixed together which was used later for protein estimation. For ease of 
use later during SDS-PAGE sample preparation, each the samples obtained from the 
two extraction steps were mixed with an equal volume of detergent (solubilisation 
buffer containing Triton X-100 or SB20) to give a final concentration of 1 volume SDS: 
1 volume Triton X-100. For example 30µl of sample from the Triton X-100 extraction 
was mixed with 30µl SB20. This was crucial because a difference in detergent 
concentration will affect the migration of protein during gel electrophoresis. 
 
Co-immunoprecipitation 
For co-immunoprecipitation to study connexon interaction the extraction procedure 
used was very similar to that used for the differential solubilisation technique described 
above. Cells were initially treated with mild detergent Triton X-100 followed by lysis in 
urea that causes the gap junctions to split into their component membranes, thereby 
dissociating gap junction channels into their respective connexons while preserving 
their structure (Manjunath et al. 1984; Zimmer et al. 1987; El Aoumari et al. 1990). 
 
In brief cells were scraped directly in the medium, washed in PBS and lysed in 
solubilisation buffer containing Triton X-100 as described above. Samples were 
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centrifuged (22,000gmax, 30 minutes 4ºC) and the supernatant removed. At this stage 
10µl of sample was taken for protein estimation. The insoluble pellet was re-suspended 
in solubilisation buffer containing urea (4M urea v/v, 1% Triton X-100 v/v, 40mM Tris 
pH 8 v/v, 150mM sodium chloride, and mammalian protease inhibitor cocktail 1:250 
v/v). The volume used was exactly the same as that used to solubilise the non-junctional 
connexons. The pellet was dispersed by sonication and the sample incubated with gentle 
vortexing for 1 hour at room temperature. Any denatured connexin was removed by 
centrifugation (22,000gmax, 30 minutes 4ºC). The supernatant was retained for co-
immunoprecipitation described in Chapter 2, section 6. 
 
2.5.2. Estimation of protein concentration 
Protein concentration in the lysed samples was measured using the Bio-Rad DC 
colorimetric assay based on the original method by Lowry et al. (1951). The reaction is 
based on two reactions; (1) the protein reacting with the alkaline copper tartrate 
(solution A) and (2) the subsequent reduction of Folin reagent (solution B) by the 
copper treated protein. Colour development is primarily due to amino acids tyrosine and 
tryptophan producing a blue colour with an absorbance of 750nm. 
 
All samples were diluted either 1:10 or 1:20 (v/v) with dH2O giving a final SDS 
concentration of 1 or 2%. For the standard curve, 1mg/ml bovine IgG standard was 
prepared from a stock solution of 2.5mg/ml in the appropriate IgG standard buffer to 
give a final detergent concentration equivalent to that of the samples. Using this 1mg/ml 
solution, serial dilutions of 0.5, 0.25, 0.125 and 0.0625mg/ml were prepared in dilution 
buffer. A blank (0 mg/ml) was also prepared using 20l of dilution buffer. The IgG 
standard and dilution buffer used was dependent on the extraction procedure and the 
exact volumes for each of the detergents are listed in Table 2.2. 
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Table 2.2: Buffers used for protein estimation 
 
Extraction procedure IgG standard buffer Dilution buffer 
Total protein 
40µl IgG sol. + 55µl dH2O + 
5µl SB20  
950µl dH2O + 50µl SB20 
Differential solubilisation 
40µl IgG sol. + 50µl dH2O + 
5µl Triton X-100* + 5µl SB20 
900µl dH2O + 50µl SB20 + 50µl 
Triton X-100* 
Co-immunoprecipitaion 
40µl IgG sol. + 55µl dH2O + 
5µl Triton X-100*  
950µl dH2O + 50µl Triton X-100* 
 
*Triton X-100 = solubilisation buffer containing Triton X-100 
 
For the assay, 20l of the diluted standard or sample was added to 100l of Solution A' 
(prepared by mixing 20l of Reagent S with 1ml Solution A) followed by 800l of 
Solution B. Samples were mixed thoroughly and the colorimetric reaction was left to 
develop for 30-45 minutes at room temperature. The absorbance of each standard and 
sample was read at 750nm. An example of how the quantification was performed on the 
samples using the IgG protein standard solutions is described in Figure 2.3.   
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Figure 2.3: Typical standard curve for the Bio-Rad DC assay using the IgG standard  
Using the Bio-Rad DC colorimetric assay, absorbances of the known standard protein concentrations 
(1-0.125g/l) (A) were measured at 750nm. This data was used to plot a linear regression with 
protein concentration on the ‘x’ axis and absorbance on the ‘y’ axis (B). The resulting equation (y = 
0.4448x + 0.0054) from the linear regression was used to calculate the protein concentration in sample 
1as illustrated in (C). 
 
2.5.3. SDS-PAGE  
Sample preparation 
All samples were prepared in loading buffer, as shown in Table 2.3 and incubated for 45 
minutes at 37ºC to ensure complete protein denaturation. SDS functions by disrupting 
non-covalent interactions within a polypeptide chain releasing the individual protein 
molecules and solubilising them in a detergent solution. Samples were also treated with 
reducing agent 2-mercaptoethanol to break all the disulphide bridges formed between 
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cysteine residues of the protein. Bromophenol blue loading dye allowed protein 
migration to be visualised since it moves through the gel at approximately the same 
speed as glycine the smallest known amino acid. 
 
Table 2.3: Loading buffers used for sample preparation 
 
Extraction  procedure Loading buffer 
Total protein extraction/  
Co-immunoprecipitation 
965µl SB20 + 25µl 2-mercaptoethanol + 10µl 
bromophenol blue 
Differential solubilisation 
500µl SB20 + 465µl Triton X-100* + 25µl 2-
mercaptoethanol + 10µl bromophenol blue 
 
*Triton X-100 = solubilisation buffer containing Triton X-100 
 
Gel preparation 
Gels were prepared according to Laemmli (1970) using the Hoefer Mini Gel system. 
The key advantage of using this system is that it concentrates all of the protein 
complexes within a sample into a very small volume which greatly increases the gel’s 
resolution. SDS was present in all gels and buffers at a concentration of 0.1% to ensure 
the proteins retain a rod-like structure during migration. 
 
The percentage of acrylamide used for gel electrophoresis was determined by the 
molecular mass of the target proteins. For example proteins of smaller size that would 
move rapidly through a gel require a higher percentage of acrylamide with a greater 
degree of cross-linking thereby slowing protein migration. To detect connexin 
expression a 12.5% separating gel (12.5% acrylamide v/v, 375mM tris pH 8.8 v/v, 0.1% 
SDS v/v) was prepared to which 0.05% ammonium persulphate v/v and 0.005% 
N,N,N',N'-tetramethylethylenediamine (TEMED) v/v was added to polymerise the gel. 
The preparation was poured between 1mm glass and metal plates leaving a gap of 
approximately 3.5cm from the top of the glass plate for the stacking gel. The separating 
gel was layered with 1ml of propan-2-ol on top of each gel to flatten it. After 
polymerisation the alcohol was removed and the gels were rinsed thoroughly with 
dH2O. A 4.5% stacking gel (4.5% acrylamide v/v, 125mM tris pH 6.8 v/v, 0.1% SDS 
v/v) with 0.1% ammonium persulphate v/v and 0.01% TEMED v/v was poured directly 
on top of the separating gel and 15- or 18- well combs inserted. The individual gels 
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were separated and transferred to the Hoefer gel running apparatus (Mighty Small II 
SE250/SE260). The upper and lower reservoirs were filled with 1x electrophoresis 
running buffer (0.192mM glycine w/v, 25mM trizma base w/v, 0.1% SDS v/v). To 
estimate the molecular weight of protein samples coloured molecular markers (Precision 
Plus Protein Kaleidoscope standards, Bio-Rad) diluted in the same loading buffer as the 
samples were run on each gel. Figure 2.4 shows the distribution of these markers on a 
typical gel. Unused lanes were filled with identical volumes of loading buffer to ensure 
all samples migrated at the same rate and the width of the bands was constant. 
Electrophoresis was initiated at 60V (~15mA per electrophoresis chamber) until the dye 
front reached the separating gel when the voltage was increased to 100-150V (~50mA 
per electrophoresis chamber) and terminated when the bromophenol blue front was 
approximately 0.5cm from the bottom of the separating gel. 
 
 
Figure 2.4: Precision plus molecular mass standards for western blot procedure 
 
2.5.4. Western blotting and immunodetection of protein expression 
Protein transfer 
Protein samples were electrophoretically transferred onto polyvinylidene fluoride 
(PVDF) membranes (Millipore). While gel electrophoresis was taking place PVDF 
membranes were cut to a similar size of the gel, wetted in methanol and equilibrated in 
transfer buffer (192mM glycine w/v, 25mM trizma base w/v, 10% methanol v/v, 0.01% 
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SDS v/v) for a minimum of 1 hour. Prior to assembly of the transfer apparatus the nylon 
scouring pads, blotting paper and equilibrated membranes were immersed in transfer 
buffer that had been pre-cooled on ice. To ensure efficient transfer the PVDF 
membranes were gently rubbed to remove any bubbles. The gel was rinsed quickly in 
transfer buffer, set up in a sandwich (Bio-Rad) as shown in Figure 2.5 and placed in a 
pre-filled tank containing the pre-cooled transfer buffer. Protein transfer was carried out 
overnight at 6V/cm with stirring in the presence of a cooling device. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5: Apparatus set-up for western blotting procedure 
The direction of current flow is indicated below the apparatus diagram. 
 
Immunodetection 
After transfer, membranes were briefly washed with dH2O. Membranes were incubated 
in blocking solution (20mM tris pH 7.6 v/v, 150mM sodium chloride v/v, 0.1% tween20 
v/v, 4% non fat dried milk w/v) for 1 hour at room temperature. All primary and 
secondary antibodies were prepared in blocking solution. Membranes were incubated 
with the relevant primary antibody, as shown in Table 2.4, for 2 hours with the 
exception of the Cx45 antibody which was left overnight at 4ºC. Membranes were 
washed (three times for 10 minutes) with tris-buffered saline (TBS)-Tween buffer 
(20mM tris pH 7.6 v/v, 150mM sodium chloride v/v, 0.1% tween20 v/v) to remove any 
unbound primary antibody. 
 
-ve +ve 
 Plastic Holder   
 Scouring Pad   
 Blotting Paper   
 PVDF membrane   
 Gel   
 Electrode plate   
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Alkaline phosphatase-conjugated secondary antibodies, as shown in Table 2.5, were 
added to the membranes and incubated for 1 hour. Membranes were washed (three 
times for 10 minutes) with TBS-Tween followed by a final wash (three times for 15 
minutes) in TBS (20mM tris pH 7.6 v/v, 150mM sodium chloride v/v) to remove the 
tween20 that causes a smearing effect of the insoluble precipitate. Membranes were 
developed using an alkaline phosphatase buffer (100mM tris pH 9.5 v/v, 100mM 
sodium chloride v/v, 5mM magnesium chloride v/v) containing 165g/ml 5-bromo-4-
chloro-3-indolyl-phosphate (Promega) and 330g/ml nitro-blue-tetrazolium (Promega) 
for 45 minutes at room temperature. The reaction was terminated by washing the 
membranes in dH2O and placed between filter paper to dry. 
 
Table 2.4: Primary antibodies used in western blot studies 
 
Primary 
antibody 
Company 
Host 
organism 
Dilution 
Sample protein 
required  
Cx40 
(polyclonal) 
Santa Cruz Goat 1:500 0.125-0.5µg 
Cx43 
(polyclonal) 
Sigma Rabbit 1:1500 0.5-1µg 
Cx45 
(monoclonal) 
Q14E  
(MAB19-11-5) 
Mouse  1:50 15-20µg 
ZO-1 
Invitrogen 
(61-7300) 
Rabbit  1:1000 10-15µg 
 
Table 2.5: Secondary antibodies used in western blot studies 
 
Secondary  
antibody 
Company 
Host  
Organism 
Dilution 
Rabbit IgG-alkaline 
phosphatase conjugated 
Pierce Donkey 1:2000 
Goat IgG-alkaline  
phosphatase conjugated 
Pierce Rabbit 1:2000 
Mouse IgG-alkaline 
phosphatase conjugated 
Pierce Goat 1:2000 
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Coomassie blue staining 
Equal loading of protein samples was verified using a total protein content staining. For 
staining, gels were loaded with 3-5g of protein and dried between sheets of gel drying 
film for long-term storage. After electrophoresis, the polyacrylamide gel was immersed 
in a coomassie blue solution (0.1% coomassie blue w/v, 50% methanol v/v, 5% acetic 
acid v/v) overnight with gentle rocking at room temperature. The following day the gel 
was de-stained (50% methanol v/v, 10% acetic acid v/v) to remove any background dye 
and washed in dH2O until all protein bands were visible and the remainder of the gel 
was transparent. 
 
Membranes and coomassie blue gels were scanned and digital images recorded.  Protein 
quantification was performed using Sigma gel (Jandel Scientific). 
 
2.6. Quantification of Cx40 and Cx43 co-expression ratio using the V5 tag  
To quantify the relative expression levels of Cx40 to Cx43, a system was established in 
our laboratory by Dr N. Thomas and Dr G. Rowlinson that used HeLa cells transfected 
either with Cx40, Cx43 or with a V5 ‘tagged’ version of these connexins (Rowlinson et 
al. 2007; Thomas 2007). The V5 tag encodes two separate components: (1) a V5 
epitope, which is a 14 amino acid sequence derived from proteins of the Simian virus 
type 5 (SV5) and (2) a polyhistidine peptide stretch. The V5 tag provided a common 
epitope enabling the same antibody to detect different molecules. The amounts of 
tagged connexins were then standardised using the V5 signal intensity and thereafter the 
tagged and untagged connexins were detected together using specific anti-connexin 
antibodies. This allowed us to calculate the levels of native Cx40 and Cx43 in these 
transfectants. The HeLa cell lysates were then diluted such that each sample contained 
an identical number of connexin units per unit volume. These standardised lysates were 
loaded alongside the test samples for detection and quantification. This quantification 
technique also permitted the comparison between membranes blotted at different times. 
As an example, quantification of the Cx40 and Cx43 co-expression ratio in clone 6 
(total, junctional and non-junctional fractions) is described in Figure 2.6.   
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Figure 2.6: Quantification of Cx40 and Cx43 co-expression ratio is clone 6 
Two western blot gels were prepared loaded with the same sample (clone 6) detecting for Cx40 and 
Cx43 in the junctional (J) and non-junctional (NJ) fractions (A). In both the gels 0.125g of the Cx40-
V5tag and 0.55g of Cx43-V5tag were also loaded, which ensured each of the standards contained an 
identical number of connexin molecules per unit volume (A). These values for protein loading were 
established from work previously done in the lab (Rowlinson et al. 2007; Thomas 2007). Densitometric 
analysis was performed on the samples and standards (B and C). The density values obtained from the 
standards (Cx40: 712 arbitrary units (au) and Cx43: 996au) were then used to calculate the relative 
expression levels of Cx40 (C, top panel) and Cx43 (C, bottom panel) in the samples (e.g. Cx40 clone 6 
junctional: ((817*100)/663 = 123au).    
 
2.7. Protein interaction studies using co-immunoprecipitation 
Co-immunoprecipitation is a biochemical technique used to determine protein-protein 
interactions. The technique uses an antibody to precipitate the target protein and co-
immunoprecipitate interacting proteins. Antibodies that are specific for the protein they 
are raised against are bound to protein A or G (Pierce) immobilized on cross-linked 
agarose resin. Protein A and G are proteins of microbial origin that bind to the fragment 
crystallizable (Fc) region of mammalian immunoglobulin molecules. The main 
difference between the two molecules is in their binding specificities and affinities. In 
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our studies we used protein A for polyclonal rabbit antibodies (anti-Cx43 and anti-ZO-
1) and protein G for the polyclonal goat Cx40 antibody and monoclonal mouse Cx45 
antibody. Beads with the bound antibodies are added to a cell lysate and the proteins 
specific to the antibodies are precipitated. After desorption of the protein-antibody 
complex, the co-immunoprecipitated protein(s) can be identified by SDS-PAGE and 
western blot. All co-immunoprecipitation experiments were performed with Dr K. 
Grikscheit. 
 
Immunoprecipitation protocol 
Proteins were extracted into their junctional and non-junctional fractions and the protein 
content estimated. For co-immunoprecipitation, the junctional fraction extracted in 
solubilisation buffer containing urea was desalted using the Bio-Rad® P-6DG desalting 
gel. Desalting was necessary to remove the urea as it significantly reduces the binding 
efficiency of the antibody to both the beads and any specific interacting proteins in the 
lysate. 1ml of the Bio-Rad desalting gel (packed volume) was added to Zeba spin 
columns (Pierce) and centrifuged at 1000gmax for 4 minutes. To equilibrate the 
columns, solubilisation buffer containing Triton X-100 was added and the column 
centrifuged for 2 minutes at 1000gmax. Buffer that had passed through the column was 
discarded. An additional 2 minutes of centrifugation (1000gmax) was required to ensure 
complete removal of the dead volume of buffer. This ensured when the samples were 
added to the column the starting volume was equal to the final volume. The junctional 
sample was added to the column and collected after centrifugation (4 minutes, 
1000gmax). 
 
All samples (junctional and non-junctional) were pre-cleared before use in co-
immunoprecipitation experiments in order to reduce non-specific binding to Protein A 
or Protein G resin. For pre-clearing 25µl of Protein A or G resin was washed twice with 
PBS and once with solubilisation buffer containing Triton X-100. The sample was 
added to the beads and incubated at 4°C for 2 hours on a rotary mixer. Samples were 
separated from the beads by centrifugation (2 minutes, 1000gmax 4°C) and were then 
ready for co-immunoprecipitation. 
 
For each co-immunoprecipitation reaction, 25μl of Protein A or Protein G was washed 
with PBS and recovered by centrifugation (1000gmax, 2 minutes 4°C). This step was 
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repeated twice. After washing, Protein A or G resin was added to the relevant primary 
antibody (2.5μg of antibody per reaction) in 1ml PBS and mixed on a rotary shaker for 
1.5 hours at room temperature. When using the monoclonal Cx45 antibody that was 
produced in our laboratory, a volume of 1ml culture supernatant from the antibody 
producing hybridoma was used per co-immunoprecipitation reaction. The mixture 
containing the beads and antibody was washed twice with PBS and once with 
solubilisation buffer containing Triton X-100. Any residual solubilisation buffer 
containing Triton X-100 was removed by centrifugation (1000gmax, 2 minutes 4°C) to 
prevent dilution of the mixture. 100-200μl of pre-cleared sample was incubated with the 
beads-antibody mixture overnight at 4°C on a rotary mixer. The following day samples 
were centrifuged (1000gmax, 2 minutes 4°C) and the supernatant (unbound fraction) 
collected. Before the protein complexes (bound fraction) were desorbed, the samples 
were washed five times with solubilisation buffer containing Triton X-100. Loading 
buffer was added to the beads and vortexed for 30 seconds, heated at 95°C for 5 minutes 
and the beads removed by centrifugation (1000gmax, 5 minutes). The bound fraction 
was collected in the supernatant. The volume of electrophoresis loading buffer 
(containing 20% SDS) used was dependent on the volume of lysate originally added to 
the beads. For example 30µl of lysate will be mixed with 30µl of loading buffer. 
 
Proteins were detected by SDS-PAGE and western blot as described in section 5 of this 
chapter. For each blot negative controls were loaded containing: (1) only the beads; (2) 
antibody with the beads and (3) beads with the sample. This was necessary to help 
identify bands derived from the beads (Protein A or G) and immunoglobulin chains of 
the antibodies. 
 
2.8. Morphological characterisation using immunofluorescent labelling and 
confocal laser scanning microscopy 
Immunoconfocal microscopy was used to study the expression patterns of various 
cardiac phenotypic markers and the localisation/co-localisation of gap-junction proteins 
Cx40, Cx43 and Cx45. 
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2.8.1. Preparation and fixation of cells 
Cells were cultured and grown to the required density on gelatin-fibronectin coated 
13mm plastic coverslips (Thermanox) in a 24-well plate. Plastic coverslips were used as 
an alternative to glass to improve cellular attachment and distribution across the surface. 
Immunolabelling requires four major steps: (1) fixation of cells; (2) blocking of non-
specific binding sites; (3) application of primary antibodies and (4) application of 
secondary antibodies. 
 
Fixation: Cells were washed twice in PBS containing 1.5mM calcium chloride to help 
maintain cellular adhesion through Ca
2+
 dependent adhesion molecules. Depending on 
the antigen being examined and the properties of the antibody required for labelling two 
methods of fixation were used: (1) application of ice-cold methanol (~0.5ml per well for 
10 minutes at room temperature) fixes cells by precipitating cellular proteins and 
permeablising the membranes simultaneously and (2) addition of 2% paraformaldehyde 
(freshly prepared in PBS) for 20 minutes at 4ºC fixes cells by forming covalent bonds 
between the formaldehyde groups from the reagent and the free amino groups of the 
cellular proteins thereby creating a scaffold. Formaldehyde has an advantage over 
alcohol fixation as it provides a greater preservation of cellular architecture and 
intracellular markers. After formaldehyde fixation cells were washed in PBS and 
required a membrane permeabilisation step using 0.5% Triton X-100 in PBS for 15 
minutes at room temperature. 
 
Blocking: Following fixation cells were washed thoroughly with PBS and treated with 
blocking solution (1% bovine serum albumin (BSA) w/v in PBS) for 1 hour at room 
temperature to prevent non-specific antibody binding. 
 
Primary antibody incubation: Cells were incubated with the appropriate primary 
antibody diluted in blocking solution at either 37ºC for 2 hours or overnight at 4ºC. For 
the Cx45 antibodies, incubation was always overnight at 4ºC. See Table 2.6 for 
information regarding the primary antibodies used in this study. 
 
Immunolabelling using two or three primary antibodies on the same sample was also 
applied in the study, which included: 1) two or three connexin subtypes and 2) zonula 
 103 
occludens-1 (ZO-1) with a single connexin subtype. For the connexin triple labelling 
(Cx40/Cx43/Cx45) the connexin antibody was applied first followed by the appropriate 
species-specific secondary antibodies linked to fluorophores of different spectra (e.g. 
FITC and Cy3). The following protocol for labelling was used. 
(1) Cx45 antibody 
(2) Guinea pig IgG- CY3 antibody 
(3) Cx43 antibody 
(4) Mouse IgG- FITC antibody 
(5) Cx40 antibody 
(6) Rabbit IgG- CY5 antibody 
For the ZO-1/ connexin labelling, the connexin antibody was applied first followed by 
the anti-ZO-1. 
 
Secondary antibody incubation: Cells were washed thoroughly with PBS and 
incubated in the corresponding fluorophore-conjugated secondary antibody diluted in 
blocking solution at either 37ºC for 1 hour or overnight at 4ºC. For the double labelling 
a mixture of the appropriate species-specific secondary antibodies were applied 
simultaneously and incubated overnight at 4ºC. See Table 2.7 for information regarding 
the secondary antibodies used. Coverslips were washed extensively in PBS and left 
overnight at 4ºC before mounting. 
 
Coverslips were removed from the wells using clean forceps and the excess PBS was 
removed by pressing the edges of the coverslips against a paper towel. For mounting 
plastic coverslips were sandwiched between a glass slide and plastic coverslip with drop 
of Citifluor (Agar Scientific) mounting medium on either side and sealed with nail 
varnish ready for analysis. 
 
Controls: To confirm the specificity of labelling, omission of the primary antibody in 
the presence of the secondary antibody was inspected for background fluorescence. For 
multiple labelling negative controls included using each primary antibody with 
matching and non-matching secondary antibodies. All secondary antibodies were 
confirmed to be species specific for their individual primary antibody. A variety of 
experiments were also conducted for each multiple labelling protocol to optimise the 
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order and combination for primary and secondary antibody application and the 
incubation conditions. 
 
2.8.2. Confocal laser scanning microscopy 
Immunolabelled sections were examined using a Leica TCS 4D confocal laser-scanning 
microscope. Indocarbocyanine (CY3), cyanine 5.18 (CY5) and fluorescein 
isothiocyanate (FITC) fluorophores were excited by wavelengths of 568nm, 647nm and 
488nm channels respectively. Images were recorded by single- or sequential dual/triple-
channel scanning. For multiple labelling, signals were assigned corresponding colours 
and co-localisation of these signals resulting from the superimposition of the two 
colours gave a third colour. For example co-localisation of red and green resulted in a 
yellow signal. Each image was presented as projection views of a number of optical 
sections of 0.5μm thickness (when using a 63x lens), encompassing signal from the 
whole depth of the sample. 
 
2.9. Statistical analysis  
Statistical analyses were carried out using Microsoft Excel and GraphPad Prism version 
4.00. Comparison of a pair of data sets was performed by an unpaired t-test, and 
comparison between groups of data with one-way analysis of variance, Tukey’s 
multiple comparison test.  Statistical differences were judged significant at p < 0.05. 
Data was expressed as mean ± standard error of the mean and n signifies the number of 
times an experiment was repeated. 
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Table 2.6: Primary antibodies used for immunocytochemistry 
 
Primary antibody Company Host organism Dilution 
Cx43 
(monoclonal) 
Chemicon Mouse 1:250 
Cx40 
(polyclonal) 
Santa Cruz Goat 1:250 
Cx40 
(polyclonal) 
S15C (R84) Rabbit 1:250 
Cx45 
(monoclonal) 
Q14E 
(MAB19-11-5) 
Mouse 1:25 
Cx45 
(polyclonal) 
Q14E (GP42) Guinea Pig 1:250 
ZO-1 
(polyclonal) 
Santa Cruz Rabbit 1:250 
α-actinin 
(monoclonal) 
Sigma Mouse 1:250 
Desmin 
(polyclonal) 
Sigma Rabbit 1:250 
 
Table 2.7: Secondary antibodies used for immunocytochemistry 
 
Secondary antibody Company Host organism Dilution 
Mouse IgG- 
CY3 
Jackson Goat 1:250 
Rabbit IgG- 
CY3 
Jackson Donkey 1:250 
Goat IgG- 
CY3 
Jackson Rabbit 1:250 
Mouse IgG- 
FITC 
Jackson Sheep 1:250 
Rabbit IgG- 
CY5 
Chemicon Donkey 1:250 
Rabbit IgG- 
FITC 
Jackson Donkey 1:250 
Guinea pig IgG-  
CY3 
Chemicon Donkey 1:250 
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CHAPTER 3. 
Do the HL-1 clones behave like atrial myocytes? 
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3.1. Introduction 
The understanding of cardiac action potential generation and propagation has been 
hindered by a lack of cellular models that allow simple molecular interventions such as 
plasmid transfection. Cardiac function is commonly studied in isolated cardiac 
myocytes, including those from transgenic animals. However long-term cultures of 
myocytes isolated from adult hearts lead to progressive changes in phenotype, as the 
cells move through de-differentiated and re-differentiated states, limiting their uses 
(Mitcheson et al. 1998; White et al. 2004). Some of these limitations can be overcome 
by using the cardiac muscle cells HL-1 derived from proliferating atrial myocytes AT-1 
(Field 1988). The HL-1 cells have the ability to divide and retain a cardiac myocyte 
phenotype (Claycomb et al. 1998). Several studies have illustrated the biological and 
electrophysiological features of the original HL-1 cell line including the ability to 
generate action potentials and to express a number of cardiac myocyte markers such as 
α-myosin heavy chain, desmin and connexin43 (Cx43) (Claycomb et al. 1998; Sartiani 
et al. 2002; Akhavan et al. 2003; Xia et al. 2004). The generation of the HL-1 cell line is 
described in greater detail in Chapter 1, section 6. 
 
The HL-1 cells are tumour-derived and are likely to contain cells blocked at various 
developmental stages of differentiation (Trosko et al. 1993) and therefore cultures are 
functionally heterogeneous. To overcome this problem Dr Dupont selected clones from 
low-density HL-1 cultures that were visually beating and therefore showed evidence of 
electrical automaticity and functional cellular Ca
2+
 regulatory systems. More 
homogenous cell lines were established in this way. This was essential so that 
experimental data could be reliably attributed to the chosen variation of gene expression 
and to exclude differences due to a heterogeneous cell line. 
 
The purpose of the work described in this chapter was to produce a general description 
of the newly generated HL-1 clones to ensure they displayed phenotypic characteristics 
consistent with cardiac cells that could be used to study impulse propagation. We show 
that the HL-1 clones: (1) display cardiac specific filamentous proteins -actinin and 
desmin which contribute to cell shape and morphological integrity; (2) express the  
transcripts for Ca
2+
 handling proteins including L-type Ca
2+ 
channel, sodium-calcium 
exchanger (NCX), ryanodine receptor 2 (RyR2) and sarco-endoplasmic reticulum Ca
2+
-
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ATPase (SERCA) which are key components of cellular Ca
2+ 
homeostasis and 
excitation-contraction (EC) coupling; (3) display rhythmic release of intracellular Ca
2+ 
([Ca
2+
]i) and have caffeine-releasable stores indicating a functional sarcoplasmic 
reticulum (SR); (4) express functional ion channel proteins involved in the upstroke and 
plateau phases of an action potential and (5) display the hyperpolarisation-activated 
‘funny’ current (If), involved in the generation and control of the slow diastolic 
‘pacemaker potential’. 
 
3.2. Materials and methods 
Cell culture procedures were routinely followed as described in Chapter 2, section 2. 
Northern blot was used to measure the mRNA levels of the Ca
2+
 handling subunits 
(Chapter 2, section 4). Immunoconfocal microscopy was performed to analyse the 
expression patterns of various cardiac phenotypic markers (Chapter 2, section 8). 
 
3.2.1. Sub-cloning 
To obtain homogenous cell lines, clones from the original HL-1 cell line were selected 
for their ability to spontaneously contract. Cells were split at very low density (1:250, 
1:500) and although most of the cells never divided, some could be visualized as 
colonies after 2-3 weeks in culture. Further daily microscopical examination revealed 
several colonies of cells that were spontaneously contracting. These were isolated using 
cloning rings, grown and passaged at a ratio of 1:3. Of the six clones obtained (clone 1 
to clone 6), clone 5 did not survive the cloning procedure, clones 1 and 2 stopped 
contracting upon passaging and clones 3, 4 and 6 maintained a stable contractile 
phenotype. The appearance of spontaneous contraction was dependent upon the time in 
culture, with clone 6 displaying spontaneous contraction within 15-20 hours after 
seeding while cells from clones 3 and 4 required growth to almost full confluency (3-4 
days). The sub-cloning was performed by Dr E. Dupont. 
 
3.2.2. Patch-clamp technique 
The patch-clamp technique in the whole-cell configuration was used to study the active 
membrane electrical properties (ionic currents, action potential) in clones 2 and 6. There 
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are two modes in patch-clamp: (1) voltage clamp and (2) current clamp which will be 
discussed later in this section. 
 
Preparation of cells 
Cells were seeded at low density in Claycomb medium on gelatin-fibronectin coated 
35mm glass bottom dishes with a 14mm microwell in the centre (MatTek Corporation).  
It was important to seed the cells at low density to ensure single cells were obtained. 
This was achieved by re-suspending a 25cm
2
 flask of confluent cells in 5ml Claycomb 
medium and adding 50-100l of the cell suspension to every 35mm dish prepared. 
Experiments were always performed 24-48 hours after seeding to allow the cells time to 
recover from the trypsin and no later than 72 hours. This is because after a few days 
cells seeded for patch-clamp experiments become flatter and more fragile.  
 
Electrophysiological apparatus 
All electrophysiological experiments were performed using an Axopatch-2B system 
(Axon Instruments). Pipettes were pulled from borosilicate glass capillaries (GC150F-
15, Harvard Apparatus LTD) using a horizontal puller (DMZ Universal, Zeitz-
Instruments GmbH). They were then fire polished and when filled with pipette solution 
had a tip resistance of 2-6 M. The filled pipette was connected to a x0.1 gain 
headstage amplifier (HS-2, Axon Instruments) by a silver-silver chloride (Ag/AgCl) 
wire. The reference earth electrode was also made using an Ag/AgCl wire and placed in 
the superfusion chamber while connected to the headstage amplifier ground terminal. 
The Ag/AgCl wires were made from polytetrafluoroethylene-coated silver wire 
(Goodfellow, Cambridge Cambs). The chlorided Ag wire functions as a redox electrode 
with a reaction between silver metal (Ag) and its salt, silver chloride (AgCl). To 
chloride the wires some of the insulation coating was removed and the wire exposed to 
concentrated domestic bleach overnight. The electrodes are simple to produce, 
inexpensive and are generally not toxic to the biological preparations and have stable 
potentials. They allow the current to be transformed from a flow of electrons at the 
electrode to a flow of ions in solution by means of a reversible chemical reaction 
completing the circuit (Equation 3.1). 
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Equation 3.1: Electrode reaction 
  eAgClClAg  
Ag = silver; Cl
- 
= chloride ions; AgCl = silver chloride; e = electrons 
 
A Faraday cage was used to isolate the microscope and the pipette head stage from 
electrical noise (usually 50Hz) from various sources (e.g. computer and power cables). 
 
Whole-cell configuration in single cell and cell pairs 
There are a variety of patch-clamp configurations that can be used to study ion 
channels. See Figure 3.1 for a summary of the patch-clamp configurations available. In 
this investigation all experiments were performed using the whole-cell configuration, 
which allows the cytoplasmic and extracellular ionic environments of the cell to be 
controlled and modified. 
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Figure 3.1: A summary of the patch-clamp configurations available to study ion channels 
After a gigaseal configuration has been established a variety of patch-clamp configurations can be formed 
depending on what you want to study. For example activity of all the ion channels in a cell membrane can 
be studied using whole-cell configuration when the membrane under the pipette tip in gigaseal formation 
is ruptured. Outside-out and inside-out configurations refer to the extracellular and intracellular side of 
the membrane, respectively, and out refers to the bath. In these configurations only the patch of 
membrane attached to the pipette can be studied, which reduces the amount of ion channels studied.  
 
The cell preparation was first placed onto the stage of the inverted microscope (Nikon 
Diaphot-TMD). The pipette connection to the amplifier was achieved by a pipette 
holder that allowed a syringe to be attached. This could provide small positive pressures 
to the pipette fluid to remove any contaminants from its tip and ensure a clean contact 
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with the cell membrane. Using a coarse manipulator, the pipette was lowered into the 
bath solution and a small oscillating test pulse of 10mV for 10ms was delivered down 
the patch electrode resulting in a visible square current pulse on the oscilloscope (Figure 
3.2 (A) and (B)). At this stage the junctional potential caused by the difference in ion 
composition in the pipette and bath solution was compensated and then assumed not to 
change during the course of the experiment. 
 
Using Ohm’s law (Equation 3.2) the pipette resistance was calculated. 
 
Equation 3.2: Ohm’s law 

V  R I 
V = voltage; R = resistance; I = current 
 
To form the whole-cell configuration the pipette tip was positioned near the membrane 
of the cell under study using a fine manipulator. When the tip of the pipette touched the 
cell membrane, a little suction was applied using a syringe to form a high resistance seal 
or gigaseal (G). A good seal was crucial for: (1) preventing any leak current passing 
between the patch pipette and adjacent membrane and (2) decreasing recording noise 
that may affect data analysis. The pipette current produced by the initial test pulses 
decreased indicating an increase of the pipette resistance due to the seal between the 
pipette and the cell membrane (Figure 3.2 (C)). Once the current recording indicated the 
formation of a good seal, the whole-cell configuration was achieved by rupturing the 
small patch of membrane in the pipette mouth using a small amount of suction applied 
by the syringe or a ‘zap’ of electrical current of 1.5V for 100s. After the whole-cell 
configuration was formed, the pipette and cell membrane capacitances were 
compensated by zeroing the capacitive currents (Figure 3.2 (D) and (E)). Current data 
was expressed in terms of current density, by normalisation to the cell capacitance and 
expressed as pA/pF. The size of the pipette current is related to the surface area of the 
cell and as a general rule ~1F is equal to 1cm2 of cell membrane. Peak currents were 
measured during the voltage protocols and current densities (pA/pF) were obtained by 
dividing the peak current by the cell capacitance obtained from the Clampex function. 
Once the whole-cell configuration was established two modes of recording, voltage 
clamp (to record currents) and current clamp (to record voltage) could be applied. 
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Figure 3.2: Pipette current responses to the voltage test pulse during the different stages of the  
whole-cell formation 
A small oscillating rectangular test pulse of 10mV for 10ms was applied (A) resulting in a pipette 
current on the oscilloscope (B) when the pipette was placed in the bath. As the pipette neared the cell 
membrane there was an increase in the current resistance (C) until a gigaseal configuration was 
formed (D). Whole-cell configuration (E) was established after the application of a little negative 
pressure. 
 
Single cell voltage clamp 
The technique of controlling the voltage across a cell membrane and measuring the 
transmembrane current was first developed in the 1940s by Cole and Marmont and later 
used by Hodgkin and Huxley to describe the initiation and propagation of action 
potentials in neurons (Hodgkin and Huxley 1952). Under voltage clamp, the current 
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flowing across the cell membrane is measured by means of a feedback system that 
maintains a set potential difference between the two electrodes (pipette and bath 
electrode). The current required to maintain the membrane potential at a command 
voltage is equal and opposite to the sum of the transmembrane ionic fluxes through ion 
channels (e.g. sodium (Na
+
), Ca
2+
, potassium (K
+
) channels) and electrogenic symports, 
antiports and co-transporters (NCX, Na
+
- K
+ 
ATPase). 
 
A series of voltage clamp protocols were designed to activate the specific ion channels 
under investigation. These will be described in greater detail in the results section. 
 
Current clamp: During current clamp experiments cells were at their resting membrane 
potential. Current pulses (positive or negative) 1-2ms in duration were applied to the 
cells to elicit action potentials. These were performed by Dr. T Desplantez. 
 
Data acquisition 
Experimental protocols for voltage and current clamp were controlled using the 
Clampex version 6.0.3. Data was analysed using Clampfit 8.2 (Axon Instruments), 
Microsoft Excel and GraphPad Prism and n signifies the number of cells patched. Data 
acquisition rates were typically 3.33kHz with the amplifier filter set to record a medium 
bandwidth (Frequency = 300Hz). Data obtained was acquired simultaneously on an 
IBM compatible computer running Clampex. Signals were digitised using a 12-bit 
analogue-digital converter (Digidata 1200b, Axon Instruments) interfacing between the 
computer and apparatus. For the purposes of illustration membrane currents in the 
figures were further filtered using a low-pass Gaussian filter for clarity. 
 
3.2.3. [Ca2+]i measurements 
Ca
2+
 transients were measured in HL-1 clones with the fluorescent Ca
2+
 indicator fluo-4 
(Molecular Probes, Invitrogen). The Ca
2+
 measurements were performed with Dr K. T. 
MacLeod. 
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Preparation of cells 
Cells were seeded at a 1:3 dilution in Claycomb medium, on 35mm glass bottom dishes 
with a 14mm microcells in the centre. All experiments were performed 48 hours after 
seeding. 
 
Ca
2+
 staining and confocal laser scanning microscopy 
Stock solutions of fluo-4 AM (50g) were prepared in dimethyl sulfoxide (DMSO) 
(50l) and thoroughly mixed. 10l of the stock solution (5g/ml of medium) was added 
to the cell preparation and incubated in an atmosphere of 5% CO2 at 37ºC for 20 
minutes. The carboxylate groups on Fluo-4 are transformed into acetoxymethyl acetate 
esters forming fluo-4 AM, which is membrane permeant. Once inside the cell the 
acetomethyl acetate groups are hydrolysed by ubiquitous intracellular esterases 
producing the Ca
2+
-sensitive polyanion, fluo-4. Any dye remaining in the loading 
solution was washed off with phosphate-buffered saline (PBS) and replaced with fresh 
Claycomb medium (Ca
2+
 concentration in Claycomb medium: 0.2g/l). Cells were 
incubated for a further 20 minutes in an atmosphere of 5% CO2 at 37ºC to ensure de-
esterification was complete before being mounted on a confocal laser scanning 
microscope (Bio-Rad Radiance 2000) for analysis. For the controls, cell preparations 
were perfused with normal Tyrode and fluorescence measured across groups of cells 
using line scans at an excitation wavelength of 488nm and a recording wavelength of 
520nm. When required, cells were also treated with caffeine (10mM) (added as a solid 
to the normal Tyrode solution) by rapid perfusion to demonstrate caffeine-releasable 
stores of Ca
2+
. The intensity of fluorescence recorded was dependent on the amount of 
dye loaded into the cells and the [Ca
2+
]i. 
 
Confocal data acquired was analysed using ImageJ, Clampfit 8.2, Microsoft Excel and 
GraphPad Prism. 
 
3.2.4. Experimental solutions 
The extracellular solutions used for patch-clamp and [Ca
2+
]i
 
measurements had an ionic 
composition that mimicked that of extracellular fluid in vivo or in culture. A modified 
Tyrode solution containing a high K
+
 concentration was also used to measure If. During 
experiments the cells were continuously perfused with Tyrode solution at 37ºC and 
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rapid solution exchange was assured by a gravity-fed multi-solution exchange system. 
See Table 3.1 for the composition of extra- and intracellular solutions used. 
 
Specific currents flowing through ion channels were identified using pharmacological 
methods. Current flowing through the cardiac form of the Na
+
 channel (Nav1.5) is 
sensitive to 1mM procaine hydrochloride, which was added as a powder to normal 
Tyrode. Mibefradil (5µM) was used to inhibit the low voltage-gated T-type Ca
2+
 
channels (Cav3.2) and nifedipine (10µM) was used to identify L-type Ca
2+
 channels 
(Cav1.2). Mibefradil and nifedipine were prepared as stock solutions in DMSO at a 
concentration of 20mM. The final concentration of DMSO in the superfusate was less 
than 0.1%. No DMSO-mediated effect was observed. Caesium (Cs
+
) (4mM) was used 
to block If which was added as a powder to the modified Tyrode. Solutions containing 
the ion channel inhibitors were always freshly prepared before use. 
 
Table 3.1: Ionic composition of the extracellular and intracellular solutions 
 
Reagent  
Normal Tyrode (mM) 
(pH 7.4) 
Modified Tyrode (mM) 
(pH 7.4) 
Pipette solution (mM)  
(pH 7.2) 
Sodium chloride 140 140 10 
Potassium chloride 4 25 -- 
Calcium chloride 2 2 1 
Sodium pyruvate 2 2 -- 
Glucose 5 5 -- 
Magnesium chloride 1 1 -- 
HEPES 5 5 5 
Barium chloride -- 2 -- 
Nickel chloride -- 2 -- 
Potassium aspartate -- -- 130 
EGTA -- -- 10 
Magnesium-ATP -- -- 3 
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3.3. Results 
3.3.1. Morphological characterisation of the HL-1 clones 
Figure 3.3 illustrates the cellular morphology of two of the clones 2 (A) and 6 (B) by 
phase contrast microscopy. Both clones had a similar cell size and shape. As expected 
for an immortal cell line, the HL-1 clones were able to proliferate in culture. Clones 2 
and 6 had an average cell capacitance of 15pA/pF (n = 26) and 13pA/pF (n = 29) 
respectively. No significant difference was observed in the cell capacitance between the 
two clones (p > 0.05). Highlighted in image (B) is a cell undergoing mitosis 
demonstrating that the cells can be serially passaged. 
 
 
Figure 3.3: Phase contrast micrographs of clones 2 and 6  
Phase contrast images of clones 2 (A) and 6 (B) isolated from the original HL-1 cell line. Both clones 
displayed similar (homogenous) characteristics in cell size and shape. The circle in (B) is a cell 
undergoing mitosis.   
 
As mentioned above, of the five clones isolated, clones 1 and 2 lost the ability to 
contract upon passaging. To try to explain these differences in contractility, 
immunofluorescent labelling was performed to visualise the sarcomeric and cytoskeletal 
organisation in a non-contracting (clone 2) and contracting (clone 6) clone. Cardiac 
specific filamentous proteins -actinin and desmin were expressed at high levels as 
expected for a cell of myocytic origin (Figure 3.4). These two markers were chosen 
because both -actinin (located at the Z-disc of the sarcomeric assembly) and desmin 
 118 
(plays an essential role in muscle architecture) are specific for muscle cells (e.g. cardiac 
and skeletal muscle). 
 
There were clear visible differences in the organisation of -actinin between the two 
clones. Clone 6 displayed the classic sarcomeric organisation with the clear-banded 
patterns in comparison to clone 2, where the -actinin was associated with the cell 
membrane (Figure 3.4 (A) and (B)). Desmin was present as a fibre around the nucleus, 
however the intermediate filaments appeared more delicate and finer in clone 2 (Figure 
3.4 (C)) than in clone 6 (Figure 3.4 (D)). The fibres in both clones were larger than what 
is observed in neonatal myocytes (Zhang et al. 2005). 
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3.3.2. Molecular characterisation of Ca2+ handling proteins 
The amounts of mRNA coding for the major proteins involved in Ca
2+
 handling were 
analysed by northern blot in all HL-1 clones and compared to RNA extracted from a 
adult mouse heart (Figure 3.5). Levels of transcript expression for NCX, α1C subunit of 
the L-type Ca
2+
 channel, α1H subunit of the T-type Ca
2+
, RyR2 and SERCA2 were 
similar in clones 1, 3, 4 and 6 and in the mouse heart. In clone 2 transcripts for NCX, 
α1C subunit of the L-type Ca
2+
 channel, RyR2 and SERCA2 were expressed at lower 
 
 
Figure 3.4: Immunofluorescent labelling of α-actinin and desmin in clones 2 and 6 
The upper panel are immunoconfocal images of α-actinin in clones 2 (A) and 6 (B). There were 
visible differences in the organisation of α-actinin between the two clones. Clone 6 displayed the 
classic sarcomeric organisation in comparison to clone 2, where the α-actinin was associated with the 
cell membrane.  The bottom panel are images for desmin clone 2 (C) and 6 (D). In both clones 
desmin was associated as a fibre around the nucleus. 
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levels in comparison to the mouse heart. The probes labelled a single mRNA band at the 
size expected. Different exposure times were required to obtain similar signal intensities 
but this also helped to estimate the relative levels of transcript expressed in the HL-1 
clones. Normalised expression of mRNA for each of the Ca
2+
 handling proteins is 
summarised in Table 3.2. The values were compared with the mouse heart noted as 
100% and expressed as a percentage of this value (n = 2). The RNA samples were 
stained with ethidium bromide to visualise the 18S and 28S ribosomal RNA bands, 
check the equivalent loading of samples and measure the molecular mass of the bands 
obtained. 
 
 
Figure 3.5: Transcript analysis of Ca
2+ 
handling proteins in the HL-1 clones 
Northern blot analysis of total RNA extracted from the HL-1 clones and mouse heart (indicated on top 
of the picture). Membranes were hybridised with probes for NCX, L-type Ca
2+
 channel, T-type Ca
2+
 
channel, RyR2 and SERCA2 as indicated on the left of the picture. Membranes were stained with 
ethidium bromide to visualize the ribosomal RNA bands 18S and 28S, check equivalent loading of 
samples and measure the molecular mass of the bands. 
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Table 3.2: Summary of transcript analysis of Ca
2+
 handling proteins  
normalised to the adult mouse heart 
 
3.3.3. Rhythmic oscillation of [Ca2+]i in clones 2 and 6 
Cells were loaded with the Ca
2+
-sensitive dye fluo-4 and [Ca
2+
]i fluctuations were 
monitored by confocal imaging in line scan mode. For each experiment a single line 
scan was placed over a group of cells and the resulting Ca
2+
 transients measured for 
13.3s (each line scan was completed in 1.33ms and 10,000 lines were collected). The 
fluorescence measured was an average pixel value from the cells along the line of 
interest. Therefore the measurements will be influenced by changes in background 
fluorescence and cellular debris floating across the line during the recording period. The 
size of the transients will also be affected by the synchronisation of the cells whereby if 
in one cell the transient occurs before that in the neighbouring cell the average 
amplitude will be affected. To circumvent these problems line scans were only 
performed in stable areas of the culture and on cells beating synchronously.   
 
Figure 3.6 (A) and (B) illustrates the changes in fluorescence intensity of fluo-4 
measured in cells displaying spontaneous rhythmic oscillations of [Ca
2+
]i
 
in clones 2 and 
6 respectively. Fluorescence changes were normalised to the background (resting) 
fluorescence (F/F0). No significant differences was found in the amplitude of [Ca
2+
]i 
transients in both clones (clone 2: 1.7 ± 0.05 F/F0; clone 6: 1.8 ± 0.04 F/F0; p = 0.3; n = 
5 and 6 respectively).  
 
 
   
Probe 
Size of 
band 
Exposure 
time 
1 (%) 2 (%) 3 (%) 4 (%) 6 (%) 
NCX ~ 7kB 4 hours 78 ± 10 38 ± 4 70 ± 5 66 ± 4 64 ± 1 
L-type ~ 8kB 4 hours 85 ± 14 25 ± 7 61 ± 9 74 ± 9 68 ± 10 
T-type ~ 5kB 1.5 hours 109 ± 23 80 ± 11 93 ± 17 81 ± 16 104 ± 6 
RyR2 ~ 16kB 24 hours 65 ± 4 29 ± 8 95 ± 9 61 ± 9 45 ± 2 
SERCA2 ~ 4kB 4 hours 58 ± 1 22 ± 1 119 ± 9 75 ± 2 82 ± 7 
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Figure 3.6: Confocal line scan images of Ca
2+
 transients in clones 2 and 6 
Traces (A) and (B) show spontaneous rhythmic oscillations of [Ca
2+
]i in clones 2 and 6 after staining with fluo-4. Quantification of the traces showed that both clones had a 
comparable [Ca
2+
]i release (clone 2: 1.7 ± 0.05 F/F0 ; clone 6: 1.8 ± 0.04 F/F0; p = 0.3; n = 5 and 6 respectively). The values for [Ca
2+
]i release were represented as 
fluorescence changes normalised to the background (resting) fluorescence (F/F0). For the purposes of illustration, recordings were filtered using the Butterworth (8-pole filter) 
with a -3dB cutoff filter at 60Hz. 
 123 
However there were significant differences in the time course of the Ca
2+
 transients 
between the two clones including the time to peak (clone 2: 222 ± 27ms; clone 6: 59 ± 
2ms; p < 0.0001; n = 5 and 6 respectively); time to 50% relaxation from the peak (clone 
2: 382 ± 40ms; clone 6: 157 ± 6ms; p < 0.0001; n = 5 and 6 respectively) and time to 
90% relaxation from the peak (clone 2: 541 ± 45ms; clone 6: 397 ± 14ms; p = 0.002; n 
= 5 and 6 respectively). 
 
SR Ca
2+
 content was assessed with the rapid application of 10mM caffeine to the 
extracellular solution and monitoring the resultant Ca
2+ 
release (Figure 3.7). Since all 
recordings were performed on spontaneous Ca
2+
 transients one caveat of this study was 
that we were unable to determine if the SR Ca
2+ 
was depleted from the previous 
contraction. In both clones application of caffeine evoked a rapid increase in Ca
2+
 
release into the cytoplasm by similar levels (clone 2: 1.8 ± 0.12 F/F0; clone 6: 2.0 ± 0.14 
F/F0; p = 0.3; n = 4 and 5 respectively). The effects of caffeine were reversible upon 
perfusion with Tyrode and [Ca
2+
]i returned to control levels.  
 
 
It should be taken into account that Fluo-4 is a non-ratiometric dye whereby the 
fluorescence intensity is sensitive to factors such as: (1) calcium buffering within a cell; 
(2) homogeneity of the dye loading; (3) incomplete hydrolysis of the conjugated cell-
permeant ester and (4) photobleaching (Paredes et al. 2008). To eliminate these 
 
 
 
 
Figure 3.7: Caffeine-releasable stores in clones 2 and 6 
Clones 2 and 6 have caffeine-releasable intracellular stores of Ca
2+
. When 10mM caffeine was 
applied to the cells marked by the arrow there was an increase in [Ca
2+
]I levels by similar levles.  
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variables, ratiometric dyes need to be considered (e.g. Indo-1) for future experiments 
which function by undergoing a shift in either their excitation or emission wavelength 
upon Ca
2+
 binding (Paredes et al. 2008). The [Ca
2+
]i is then calculated by ratioing the 
fluorescence intensities at the two wavelengths.     
 
3.3.4. Action potential characteristics in clones 2 and 6 
Action potentials were recorded from cells in clones 2 and 6 under whole-cell current 
clamp conditions. Figure 3.8 shows a typical action potential recorded upon stimulation 
of 1Hz. It should be noted that action potentials were recorded in only one cell patched 
in clone 2 since a large proportion of cells elicited no action potentials even after 
electrical stimulation. However cells in clone 6 always produced action potentials upon 
stimulation. Clone 6 had a mean action potential duration measured at 50% 
repolarisation (APD50) of 17 ± 6ms with an overshoot of 28 ± 5mV (n = 4). Clone 2 had 
a resting membrane potential that was more depolarised of -43 ± 6 mV (n = 20) 
compared with clone 6 at -67mV ± 2mV (n = 25). 
 
 
 
Figure 3.8: Action potential characteristics in clones 2 and 6 
A typical action potential recorded from clones 2 and 6 under whole-cell current clamp with 
stimulation at a frequency of 1Hz. 
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3.3.5. Characterisation of voltage-gated ion channels in clones 2 and 6 
L-type Ca
2+
 currents  
To assess the function of some of the ion channels knowing their relative amounts of 
mRNA we used whole-cell patch-clamp techniques to examine their Ca
2+
 currents. The 
Ca
2+ 
current data was kindly provided by Dr N. Ullrich. A series of voltage steps from a 
holding potential of -50mV up to 60mV were evoked to elicit the L-type Ca
2+
 current 
Figure 3.9 (A). The voltage dependence and pharmacological sensitivity of the L-type 
Ca
2+
 current recorded in clones 2 and 6 is illustrated in Figure 3.9 (B) and (C) 
respectively. Both clones showed evidence of nifedipine-sensitive inward currents 
suggesting the presence of L-type Ca
2+
 channels (Figure 3-9 (B)). Subtracted currents 
were obtained from the normal Tyrode trace minus the nifedipine sensitive trace. The 
plots of the mean data from the subtracted current that yield a current-voltage 
relationship (I-V) showed no significant difference in the maximum sizes of the currents 
in both clones (clone 2: -0.89 ± 0.07 pA/pF; clone 6: -0.86 ± 0.04 pA/pF; p = 0.7; n = 5 
and 14 respectively). However maximal current activation was obtained at different 
voltages (clone 2: 10mV; clone 6: -10mV). Currents from clone 6 had a more negative 
reversal potential when compared to clone 2. 
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Figure 3.9: Voltage-gated L-type Ca
2+
 currents recorded from clones 2 and 6 
Cells were clamped at a holding potential of -50mV and a series of voltage steps were imposed 
(represented by the dashed lines) to 60mV at 10mV increments (A). Current traces were recorded 
when cells were perfused with normal Tyrode [NT] and nifedipine in clone 2 (B) and clone 6 (C)). 
The subtracted current represented the traces recorded in normal Tyrode trace minus the Tyrode 
containing nifedipine. The current-voltage (I-V) curve was plotted using the subtracted current values 
expressed as current density (pA/pF). There was no difference in the maximum sizes of the nifedipine-
sensitive current (clone 2: -0.89 ± 0.07 pA/pF; clone 6: -0.86 ± 0.04 pA/pF; p = 0.7; n = 5 and 14 
respectively).  
 
T-type Ca
2+
 currents  
T-type Ca
2+
 currents were evoked by voltage clamp steps from a holding potential of -
80mV to a pre-step of -40mV and subsequent steps to 40mV in 5mV increments (Figure 
3.10 (A)). Clones 2 and 6 both had mibefradil-sensitive inward currents that peaked at -
25mV as shown in Figure 3.10 (B) and (C) respectively. This was somewhat more 
positive than a typical T-type Ca
2+
 current which has a peak current at around -30mV 
(Vassort et al. 2006) There was no significant difference in the maximum sizes of the 
mibefradil-sensitive current (clone 2: -0.94 ± 0.04 pA/pF; clone 6: -0.89 ± 0.03 pA/pF; 
p = 0.3; n = 8 and 10 respectively). 
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Figure 3.10: Voltage-gated T-type Ca
2+
 currents recorded from clones 2 and 6 
Depolarising voltage pulses from -80 to a pre-step of -40mV followed by 5mV increments 
(represented by the dashed lines) to 40mV (A) was used to evoke T-type Ca
2+
 currents from clones 2 
(B) and 6 (C) shown together with the respective current obtained in the presence of mibefradil. A 
membrane holding potential of -40mV was used to inactivate the Na
+
 channels. I-V curves plotted on 
the subtracted current (pA/pF) demonstrated a peak inward current obtained at -25mV. There was also 
no difference in the maximum sizes of the mibefradil-sensitive current (clone 2: -0.94 ± 0.04 pA/pF; 
clone 6: -0.89 ± 0.03 pA/pF; p = 0.3; n = 8 and 10 respectively).  
 
Na
+
 currents 
Representative Na
+
 currents are shown in Figure 3.11 for both clones 2 and 6. 
Sequential voltage clamp steps were imposed from a holding potential of -120mV to 
50mV in 10mV increments (Figure 3.11 (A)), to fully activate the Na
+
 current. Cells 
were clamped at -120mV to ensure the Na
+
 channels were closed and ready to be 
activated. The fast inward current obtained from clones 2 and 6 was sensitive to 1mM 
procaine resulting in an almost complete block (Figure 3.11 (B) and (C) respectively). 
In the presence of procaine clone 6 often showed some remnant of an inward current, 
activating in similar ranges as that observed for Ca
2+
 currents. The I-V curves were 
plotted from the subtracted current of the normal Tyrode and procaine traces. In both 
clones Na
+
 currents were activated at a threshold of -60mV. There was no significant 
difference in the maximum values of the activated current (clone 2: -77.5 ± 6.1pA/pF; 
 128 
clone 6: -85.0 ± 14.3 pA/pF; p = 0.6; n = 15 and 9 respectively). Currents were 
maximally activated in clone 2 at -30mV and in clone 6 at -20mV in clone 6. The 
reversal potential appeared to be very similar in both clones (clone 2: ~55mV; clone 6 
~60mV). 
 
 
 
Figure 3.11: Voltage-gated Na
+
 currents recorded from clones 2 and 6 
Cells were clamped at a holding potential of -120mV and a series of voltage steps were imposed 
(represented by the dashed lines) to 50mV at 10mV increments (A). Current traces were recorded 
when cells were perfused with normal Tyrode (NT) and Na
+
 channel blocker procaine (blue traces for 
clone 2 (B) and red traces for clone 6 (C). The I-V curves were plotted for both clones with no 
significant difference in the current size of the procaine-sensitive currents (clone 2: -77.5 ± 6.1pA/pF; 
clone 6: -85.0 ± 14.3 pA/pF; p = 0.6; n = 15 and 9 respectively). 
 
If currents 
Cells were voltage clamped and hyperpolarised for 1.5s from a holding potential of -
40mV to more negative potentials ranging from -60 to -130mV in 10mV increments. 
Representative current traces recorded from clones 2 and 6 are shown in Figure 3.12 (A) 
and (B) respectively. If current was not present in any of the cells patched in clone 2 (n 
= 20). Clone 6 had an inward current that slowly activated with time upon 
hyperpolarisation to more negative potentials. We observed a complete block of the 
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current elicited at peak activation of -130mV by perfusing the cells with 4mM Cs
+
. This 
effect was reversible by perfusing the cells with modified Tyrode. The I-V curve shows 
the Cs
+
 sensitive current (modified Tyrode current subtracted from the Cs
+ 
current) as a 
function of the holding potential and we observed a peak current activation of –32 ± 
4pA/pF; n = 16. In clone 6 If was not present in every cell, but we did observe a non-
inactivating inward current with an amplitude that increased as the potential became 
more negative similar to those present in the original HL-1 cell line (Sartiani et al. 
2002). These currents were confirmed to be Cs
+ 
insensitive. 
 
 
Figure 3.12: Voltage-gated If currents recorded in clones 2 and 6 
Cells were hyperpolarised for 1.5 seconds from a holding potential of -40mV to more negative 
potentials from -60 to 130mV (indicated by the dashed lines) in 10mV increments (A). In clone 2 (B) 
we did not observe If in any the groups of cells patched (n = 20) in modified Tyrode (MT). Currents 
elicited in clone 6 perfused with modified Tyrode displayed a Cs
+
 sensitive current with an amplitude 
that increased as the potential became more negative. Mean If activation points were obtained at each 
membrane potential and the values were represented as pA/pF. Clone 6 had a peak current activation 
of –32 ± 4pA/pF; n = 16. 
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3.4. Discussion 
The HL-1 cells are a unique cardiac myocyte cell line derived from proliferating atrial 
myocytes of transgenic mice. However, this transformed, tumorigenic line contains cells 
that are blocked at different stages of differentiation (Trosko et al. 1993). Thus it was 
necessary to produce a more homogeneous cell line to allow better correlation of change 
of function with molecular intervention. In this chapter the morphological features and 
electrophysiological characteristics of the HL-1 clones are described with a particular 
focus on clones 2 and 6. 
 
After several passages, of the five clones obtained contractile activity in clones 1 and 2 
declined with the other clones starting spontaneous contraction at different times in 
culture. To explain these differences in contraction, we investigated two key features: 
(1) Ca
2+
 entry in the cell triggering Ca
2+
 induced Ca
2+
 release (CICR) from the SR 
which directly activates the myofilaments causing contraction (Bers 2002; Endo 2009) 
and (2) the localisation of myofibrillar and cytoskeletal proteins (e.g. desmin, myosin, 
and actin) (Kostin et al. 2000). 
 
We started by comparing the cytoskeleton of the two clones and found that in clone 2 
the sarcomeric-banded organisation of α-actinin was replaced by a sub-membranous 
distribution, likely explaining the lack of contractility (Zhang et al. 2005; Skwarek-
Maruszewska et al. 2009). Desmin a marker for myofibril integrity and maturation, also 
appeared to be more delicate and finer in clone 2 as previously described in non-
contracting cells (Kostin et al. 2000; Bar et al. 2004; Paulin and Li 2004; Pelloux et al. 
2006). The delicate fibres in clone 2 may also be a cause of the lack of contraction as 
studies on embryonic hearts showed that desmin associated with the Z-line only after 
the hearts started to beat (Zhang et al. 2005). Desmin knock-out studies have 
demonstrated that the mice develop hypertrophy with disorganised myofibrils and 
altered configurations of the intercalated discs. The mitochondria are also abnormal in 
morphology and function as they appear swollen and accumulate between the 
myofibrils. Desmin may also be involved in supporting sacromere alignment or force 
transmission indicating the importance of the protein in maintaining muscle function 
and structural integrity (Li et al. 1997; Paulin and Li 2004). Morphological alterations 
of other cytoskeleton proteins (e.g. actin, desmin, titin) associated with reduced 
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contractile function have been reported in studies on heart failure (Hein et al. 2000). It is 
likely that both these differences in sarcomeric skeleton (α-actinin) and cytoskeletal 
proteins (desmin) may contribute to loss of contractility and cellular integrity in clone 2 
(Kostin et al. 2000; Zhang et al. 2005). 
 
As mentioned before, [Ca
2+
]i plays a key role in the E-C coupling whereby electrical 
excitation is transduced into contraction (Bers 2002). Since clone 2 does not contract we 
looked into possible differences in the Ca
2+
 release process between the two clones. 
Using line scan confocal microscopy both clones displayed spontaneous Ca
2+ 
transients 
with similar amplitudes when monitored using fluo-4. In the heart the amount of [Ca
2+
]i 
released is governed by: (1) Ca
2+
 influx through the L-type Ca
2+ 
channel activated upon 
membrane depolarisation and (2) SR Ca
2+ 
release triggered by the initial Ca
2+
 influx 
(Venetucci et al. 2007). Analysis of current densities for the L-type Ca
2+
 channel and 
SR Ca
2+
 content assessed by application of caffeine were comparable in both clones. 
This was despite cells from clone 2 expressing less mRNA coding for L-type Ca
2+
 
channel, RyR2, the SR Ca
2+ 
release channel. Thus there seemed to be no direct 
correlation between the amount of messenger expressed and the functional protein 
perhaps indicating different post-transcriptional regulations between the two clones. 
 
Although the role of T-type Ca
2+ 
channels is unclear in atrial cells these channels could 
contribute to the influx of Ca
2+
. No difference was observed in the mRNA expression 
levels and current density in both clones. It is also thought that T-type Ca
2+
 currents 
contribute very little to the initial Ca
2+ 
influx triggering
 
contraction since no expression 
of functional channels is present in adult ventricular myocardial cells (Hermsmeyer et 
al. 1997; Vassort et al. 2006). However the existence of T-type Ca
2+
 channels in both 
clones 2 and 6 does support the view that such channels play a more important role in 
cell growth (Hermsmeyer et al. 1997), cell cycle progression (Rodman et al. 2005), cell 
development (Zhang et al. 2003) and pacemaker generation (Mangoni et al. 2006). 
Evidence for this comes from the prominent expression of T-type Ca
2+
 channels in the 
developing embryo and foetus but declines during maturation particularly in ventricular 
myocytes (Vassort et al. 2006). T-type Ca
2+
 channels are also found during ventricular 
hypertrophy and subendothelial thickening and Ca
2+
 entry through these channels may 
contribute to arrhythmias (Nuss and Houser 1993; Hermsmeyer et al. 1997; 
Takebayashi et al. 2006). The presence of T-type Ca
2+
 channels in cardiac tissue 
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displaying automaticity make them a possible candidate to provide an inward 
depolarising current during the slow diastolic depolarisation phase in pacemaker 
generation (Vassort et al. 2006). Although I have not investigated the various roles of T-
type Ca
2+
 channels, the HL-1 clones provide an ideal cellular model for such a study. 
 
Another regulator of [Ca
2+
]i content is via NCX which is expressed by all the HL-1 
clones. NCX is primarily involved in muscle relaxation in combination with SERCA in 
lowering [Ca
2+
]i concentration to resting levels (Venetucci et al. 2007). It functions by 
exporting one Ca
2+
 ion out of the cell in exchange for importing three Na
+
 ions into the 
cell. Since NCX was expressed at high levels in all the HL-1 clones with the exception 
of clone 2 it could potentially play a key role in pacemaker generation. During diastolic 
depolarisation SR Ca
2+ 
can be
 
released spontaneously through RyR2. This release 
locally activates NCX, which in turn produces a ‘booster inward current’ thereby 
depolarising the membrane, allowing threshold to be reached and an action potential to 
be triggered (Bogdanov et al. 2001). To confirm and study the functional role of NCX 
in pacemaker generation, further patch-clamp experiments will need to be performed. 
 
Cells from clone 6 had average resting membrane potentials of -75mV ± 3mV as 
expected for a cell of atrial origin (Shih 1994). However cells in clone 2 were more 
depolarised with a resting membrane potential of -43 ± 6mV similar to values observed 
in nodal cells (DiFrancesco 2005). We were only able to record a single action potential 
in clone 2 upon electrical stimulation. This was despite the cells displaying spontaneous 
Ca
2+ 
transients. The lack of action potential generation in clone 2 could be explained by 
differences in cell density. During experiments for patch-clamp cells are isolated into 
single cells and for Ca
2+ 
measurements cells are seeded in large aggregates. Moreover 
we also demonstrate in Chapter 5 that cells in clone 2 are able to produce extracellular 
field potentials detected by MEA when seeded at high density. This factor of seeding 
density is crucial in the HL-1 cell line since the development of spontaneous contraction 
is very much dependent on the development stage of the culture and cell density 
(Claycomb et al. 1998; Hong et al. 2008). 
 
The action potential characteristics of clone 6 in terms of the shape were comparable to 
those obtained from the original HL-1 cell line (Sartiani et al. 2002) and of mouse atrial 
cells (Knollmann et al. 2007). The action potential overshoot was considerably higher 
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than those recorded in the original HL-1 (Sartiani et al. 2002) and HL-5 cell line also 
derived from the AT-1 cell line (Xiao et al. 2006). Action potential durations (APD50) 
were also variable between clone 6, the HL-1 cell line and the HL-5 cells. These results 
are conflicting since one would expect all three cell lines to have similar action potential 
characteristics as they were originally derived from the AT-1 cell line (Claycomb et al. 
1998; White et al. 2004). This illustrates the heterogeneity of the original cell lines and 
highlights the importance of sub-cloning enabling a more accurate analysis of the 
experimental results. Compared with clone 6, neonatal mouse hearts displayed similar 
action potential durations (Nuss and Marban 1994) and with larger overshoots (Nuss 
and Marban 1994; Xiao et al. 2006). The large overshoot in neonatal mouse hearts 
could be explained by the presence of larger Na
+
 currents when compared with the HL-
1 clones (Nuss and Marban 1994). 
 
The action potential amplitude and upstroke in the heart is determined by the Na
+
 
current (Herfst et al. 2004) through the opening of Nav1.5 channels (Abriel 2010). 
Current densities in clones 2 and 6 were not significantly different when cells were 
clamped at -120mV to ensure all the Na
+
 channels were in their closed state ready to be 
activated. However it should be noted in clone 2 resting membrane potentials were more 
depolarised compared with clone 6. Thus over this voltage range the number of Na
+
 
channels that are likely to be open are considerably reduced (Grant 2009). This in turn 
could potentially lower the current density and action potential amplitude affecting 
action potential propagation since Na
+
 currents are primarily responsible for membrane 
excitability in the heart (Shaw and Rudy 1997). 
 
In clones 2 and 6 recordings of Na
+
 sensitive currents were comparable in activation 
values and reversal potentials mirrored by a similar overshoot in action potentials. In 
comparison to studies on adult atrial myocytes and neonatal mouse hearts, the HL-1 
clones displayed maximum activation ranges at more positive potentials (Nuss and 
Marban 1994; Feng et al. 1996; Mille et al. 2009). Similarly the current reversal 
potentials were also a lot more positive in the HL-1 clones compared to neonatal mouse 
strains (Mille et al. 2009). The currents particularly in clone 2 had a slow inactivation 
compared with cardiac Na
+
 currents. These differences could be due to recording 
conditions but for a more detailed comparison the inactivation of these currents will be 
need to studied more systematically. It is possible that splice variants of the normal 
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cardiac SCN5A gene encoding Nav1.5 may exist in the HL-1 clones that differ in 
protein synthesis, assembly and post-translation modifications producing some subtle 
alterations in their function (Herfst et al. 2004). It is also possible that the HL-1 clones 
are comparable to an embryonic phenotype unable to express the Na
+
 channels 
characteristic of adult cardiac myocytes. 
 
We also demonstrated the presence of If, that activates upon voltage hyperpolarisation 
and slowly depolarises the membrane up to threshold for firing a new action potential 
(DiFrancesco 2005). We were only able to record If in clone 6 and not in clone 2. In 
clone 6, If activated at a negative membrane potential of -60mV and its amplitude 
increased at more negative potentials with maximum activation at –130mV. The 
electrophysiological characteristics of If were similar to those found in the original HL-1 
cells (Sartiani et al. 2002) and cardiac pacemaker cells (DiFrancesco 1993). The current 
was also blocked by Cs
+
 (Denyer and Brown 1990; Sartiani et al. 2002; Xiao et al. 
2006). If was not always present in clone 6 which was consistent with findings in the 
original HL-1 cells with If present in only 30% of the cells patched (Sartiani et al. 2002) 
and in 39% of the HL-5 cells (Xiao et al. 2006). This was also confirmed by our action 
potential data since most of the cells exhibited a flat diastolic potential rather than a 
spontaneous diastolic depolarisation phase expected in the presence of If (Dobrzynski et 
al. 2007). Cellular heterogeneity with respect to the presence of If has been reported in 
myocytes isolated from native cardiac tissues such as the sinoatrial node (Denyer and 
Brown 1990) and atrial tissue (Zhou and Lipsius 1992). To correlate the presence of a 
spontaneous diastolic depolarisation to If, recordings of action potentials and If will need 
to performed on the same cells. Although we did not study the relationship between If 
and automaticity it is unlikely that it is fully responsible for the pacemaker current 
generated in the HL-1 clones and that other ion currents may contribute to the initiation 
of action potentials. For example despite If being absent in clone 2 these cells were still 
able to display spontaneous Ca
2+
 transients. Studies by Lakatta et al. have implicated the 
localised rhythmic oscillations of [Ca
2+
]i by the SR that cross-talks with other 
mechanisms (e.g. NCX) to regulate the automaticity of the heart (Lakatta et al. 2003). 
 
In summary we have shown that the HL-1 clones express many of the Ca
2+
 handling 
proteins, display spontaneous Ca
2+
 transients, have a functional SR and have majority of 
the cardiac ionic currents. Lack of contractility in clone 2 is most likely caused by the 
 135 
lack of sarcomeric organisation rather than Ca
2+
 influx triggering cardiac excitation 
since no difference was found when compared to clone 6. Compared with freshly 
isolated primary cultures the HL-1 clones exhibit properties that are comparable to a 
neonatal phenotype. The HL-1 clones provide a useful model to study cardiac channel 
regulation and functional expression including pacemaker automaticity and the specific 
roles [Ca
2+
]i and If play in this process. Since we have established that the HL-1 clones 
have the necessary ion channels required to generate action potentials, the next stage of 
my investigation was to study gap junctions and their component connexins that link 
together individual myocytes, forming the pathways for action potentials propagation. 
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CHAPTER 4. 
Characterisation and quantification of connexin 
expression/co-expression in the HL-1 clones 
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4.1. Introduction 
As in most tissue and organs multiple connexins are expressed in the heart. The three 
principal cardiac connexins, connexin40 (Cx40), Cx43 and Cx45 are found in a 
chamber-related and myocyte-specific manner (Gros and Jongsma 1996; Severs et al. 
2006). Connexins can form functional gap junction channels by themselves however co-
expression of more than one connexin subtype raises the possibility of different channel 
type formations (White and Bruzzone 1996; Cottrell and Burt 2005). As discussed in 
Chapter 1, section 3, if a cell co-expressed two connexin subtypes that were free to 
associate in a random fashion there are fourteen possible connexon types that could be 
formed i.e. 12 heteromeric connexons composed of both connexin subtypes and 2 
homomeric connexons made up of solely one or the other connexin (Brink et al. 1997; 
Cottrell and Burt 2005). 
 
The ability of connexons to form junctional channels is a selective process dependent on 
the constituent connexin subtypes (Gros and Jongsma 1996). Several 
electrophysiological and biochemical studies have shown the formation of heteromeric 
gap junction channels in a variety of cell expression systems and tissue. Co-
immunoprecipitation and cell pair data on A7r5 vascular smooth muscle cells 
demonstrated that heteromers are formed between Cx40 and Cx43 and exhibit channel 
and voltage gating properties unique from homomeric-homotypic Cx40 or Cx43 
channels (He et al. 1999). This data was confirmed by Beyer et al. in HeLa transfectants 
(Beyer et al. 2001; Valiunas et al. 2001). Examples of heteromer formation between 
other connexin subtypes include Cx46-Cx50 in the lens (Jiang and Goodenough 1996), 
Cx26-Cx32 in the rodent liver (Bevans et al. 1998) and Cx43-Cx30 in astrocytes (Nagy 
et al. 1997). 
 
Although there is a wealth of data supporting the formation of Cx40 and Cx43 
heteromeric formation, studies have reported conflicting results as to whether 
connexons composed of Cx40-Cx43 form heterotypic channels. For example in 
Xenopus oocytes, there was no gap-junctional communication detected between paired 
oocytes expressing Cx40 and Cx43 using dual cell patch-clamp (Bruzzone et al. 1993; 
White et al. 1995). However in the same expression system high levels of conductance 
were recorded when oocytes expressing Cx40 or Cx43 were paired with Cx37. This 
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highlights the ability of connexins to distinguish one connexin subtype from another. In 
HeLa cells there was no Lucifer yellow dye transfer observed after microinjection 
between Cx40 and Cx43 expressing cells (Elfgang et al. 1995). Lack of gap junction 
formation between HeLa cells expressing Cx40 and Cx43 on apposed plasma 
membranes was also demonstrated by immunofluorescence (Haubrich et al. 1996; 
Rackauskas et al. 2007a). However electrophysiological studies by Valiunas et al. 
(2000) and Cottrell et al. (2001) did demonstrate the formation of functional heterotypic 
channels between Cx40 and Cx43 in HeLa and RIN cells transfected with Cx40 and 
Cx43 respectively albeit with conductance at significantly lower levels than homotypic 
channels composed either Cx40 or Cx43. 
 
In contrast the presence of functional heterotypic channels between Cx45 and Cx40 or 
Cx43 have consistently been reported (White and Bruzzone 1996; Rackauskas et al. 
2007a). When ROS cells that naturally express Cx43 were transfected with Cx45, there 
was a reduction in dye permeability by the formation of heteromeric-heterotypic 
channels (Koval et al. 1995). Similar observations were also made in our laboratory on 
the rat liver epithelial cell line (RLE) that endogenously express Cx43 and are 
transfected to co-express Cx45 (RLE Ind45) (Grikscheit 2010). Using fluorescent 
imaging and electrophysiological data from HeLa transfectants Cx45 readily formed 
junctional channels with Cx40 or Cx43 (Rackauskas et al. 2007a; Valiunas et al. 2000). 
Cell pair data in HeLa and N2a transfectants have also demonstrated the presence of 
heterotypic channels between Cx43 and Cx45 that were functionally distinct from 
homotypic channels composed of Cx43 or Cx45 (Elenes et al. 2001; Desplantez et al. 
2004). Similar findings were also reported by Martinez et al. (2002a) in HeLa cells 
using Lucifer yellow dye permeability, affinity purification and cell pair data.  
 
Collectively these studies indicate that heteromeric-heterotypic channels characterised 
by different electrical properties (e.g. unitary conductance, voltage gating, dye transfer) 
may have the potential to regulate the extent of cell-to-cell communication between 
cells co-expressing more than one connexin subtype. The ability or inability of certain 
connexin combinations to form heterotypic channels could also limit or segregate 
communication between cells in close physical contact (White et al. 1995; Elfgang et al. 
1995). 
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Intercellular communication at the gap junction plaque is also regulated by factors that 
affect the abundance, size and cellular distribution of gap junction channel aggregates 
(Hunter et al. 2005). For instance connexin expression may be regulated at the 
transcriptional (e.g. interaction of transcription factors with target elements in 
controlling gene expression) or post-transcriptional level (e.g. connexin synthesis, 
oligomerisation and degradation) (Saffitz et al. 2000; Oyamada et al. 2005). Recently 
the role of connexin interacting proteins have been highlighted and, in particular zonula 
occludens-1 (ZO-1) in mediating the formation, extent and size of gap junctions (Hunter 
et al. 2005; Laing et al. 2005). In HeLa cells inhibition of Cx43 with ZO-1 lead to large 
extensive gap junctions and this effect was reversed when the capacity to interact was 
restored (Hunter et al. 2005). It has also been shown in our laboratory that in patients 
with congestive heart failure there was an increased interaction between Cx43 and ZO-1 
associated with a reduction and decrease in size of Cx43 gap junctions (Bruce et al. 
2008). These findings raise the potential role of ZO-1 as a mediator in gap junction 
remodelling in the heart.  
 
From this background we set out to: (1) quantify the connexin expression in the HL-1 
clones; (2) quantify the connexin co-expression (Cx40/Cx43) ratio and compare it with 
human atrial samples; (3) characterise the connexin expression/co-expression patterns 
of Cx40, Cx43 and Cx45; (3) assess if Cx40 and Cx43 do form heteromers; and (4) 
assess the level of co-localisation between ZO-1 and Cx40, Cx43 and Cx45. 
 
4.2. Materials and methods 
HL-1 clones were routinely cultured as described in Chapter 2, section 2. Connexin 
transcripts were detected by northern blot technique (Chapter 2, section 4). Expression 
of connexin protein was detected by western blot technique (Chapter 2, section 5). 
Connexin co-expression ratios were quantified according to methods described in 
Chapter 2, section 6. Connexin protein interactions were studied using co-
immuoprecipitation (Chapter 2, section 7). The HL-1 clones were also characterised by 
immmunofluorescence to study the distribution of Cx40, Cx43 and Cx45 and co-
localisation of ZO-1 with Cx40, Cx43 and Cx45 (Chapter 2, section 8).  
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4.3. Results 
4.3.1. Molecular and biochemical characterisation of connexin expression 
Transcripts for Cx40, Cx43 and Cx45 (Figure 4.2 (A)) were present in the HL-1 clones. 
All the probes labelled a single mRNA band at the size expected. Different exposure 
times were required to obtain similar signal intensities and helped estimate the relative 
levels of transcript expressed in the HL-1 clones. The RNA samples were loaded with 
ethidium bromide to visualise the ribosomal RNA bands (18S and 28S) and verify the 
samples were loaded equally for quantification. All the HL-1 clones expressed Cx40, 
Cx43 and Cx45 at varying levels but retained the general characteristics of a cardiac 
myocyte (n =2). Although the data was not sufficient for a statistical analysis, in all the 
clones Cx40 transcript levels were higher compared with the adult mouse heart. This 
was expected since Cx40 in the mouse heart is only expressed in small amounts of the 
tissue including the atria and endothelial cells (Gros and Jongsma 1996) and we were 
comparing the whole heart tissue to the HL-1 clones. Cx43 and Cx45 were found at 
similar levels to those in the mouse heart. A summary of the connexin transcript levels 
is shown in Table 4.1. The mRNA expression levels were normalised to the mouse 
heart, which was taken as the control at 100%. To detect and quantify Cx40 and Cx43 
expression in clone 2, membranes were exposed for a considerable length of time 
(Cx40: 24 hours; Cx43: 2 days). 
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Figure 4.1: Transcript and protein analysis of connexin expression in the HL-1 clones 
Northern analysis of connexin mRNA expression in the HL-1 clones and adult mouse heart (A) 
Membranes were hybridised with probes for Cx40, Cx43 and Cx45 as indicated on the left of the picture. 
The three connexins were expressed at varying levels by all the HL-1 clones. Membranes were stained 
with ethidium bromide to visualize the ribosomal RNA bands 18S and 28S. Western blot analysis of 
Cx40 and Cx43 (B). The Cx40 antibody detected a single band migrating at 40kDa expressed at similar 
levels in all the HL-1 clones except clone 2. Cx43 analysis obtained a single band migrating at 43kDa. As 
with Cx40, Cx43 was present at similar levels in all HL-1 clones with the exception of clone 2. The clone 
numbers for transcript analysis and protein expression are indicted at the top of the picture. There is a 
positive correlation of connexin transcript to protein expression for Cx40 and Cx43 (C). 
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Table 4.1: Summary of connexin transcript expression normalised to the mouse heart 
 
To assess whether connexin expression was regulated at the transcriptional or 
translational stage, Cx40 and Cx43 protein levels were measured and compared to the 
corresponding levels of mRNA transcribed in the HL-1 clones (Figure 4.2 (B)). Levels 
of Cx40 and Cx43 expression were similar in all the HL-1 clones with the exception of 
clone 2 where the signal was lower. Figure 4.2 (C) shows analysis of the relationship 
between Cx40 and Cx43 transcript and the corresponding protein expressed. The 
protein and mRNA expression levels were normalised to clone 1. There was a positive 
correlation for both Cx40 and Cx43 suggesting that the mRNA steady state levels 
determines the connexin protein level.Cx45 remained undetectable with our western 
blot protocol indicating that Cx45 expression levels were at least twenty times lower 
than Cx40 or Cx43. 
 
4.3.2. Quantification of Cx40/Cx43 co-expression ratio in the junctional and non-
junctional fractions 
To determine the relative amount of Cx40 and Cx43 that was present within gap 
junction plaque (the ‘junctional’ fraction) and elsewhere in the cell (the ‘non-junctional’ 
fraction) differential solubilisation extraction using Triton X-100 was performed. The 
total, junctional and non-junctional samples were loaded for clones 2 and 6 and 
immunoblotted for Cx40 and Cx43 (Figure 4.2 (A). The total sample was equivalent to 
the junctional and non-junctional samples mixed together in an equal volume. The sum 
of intensities for the junctional and non-junctional bands equalled the respective total 
samples. Densitometric analysis of the immunoblots revealed that approximately 60% 
of the total Cx40 expressed was present at the junction for clones 2 and 6 (clone 2: 55 ± 
15%; clone 6: 60% ± 2%) and 40% in the non-junctional fraction (clone 2: 45 ± 15%; 
clone 6: 40% ± 3%) (Figure 4.2 (B)). These differences were not statistically significant 
(p > 0.05). For Cx43, the amount of connexin present in the junctional (clone 2: 53 ± 
Probe 
Size of 
 band 
Exposure 
 Time 
1 2 3 4 6 
Cx40 ~ 3kB 4 hours 353 ± 14 46 ± 5 190 ± 43 286 ± 21 332 ± 18 
Cx43 ~ 3kB 24 hours 78 ± 2 18 ± 5 68 ± 12 69 ± 7 87 ± 3 
Cx45 ~ 2kB 5 days 123 ± 7 51 ± 5 7 ± 3 132 ± 2 145 ± 3 
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3%; clone 6: 50 ± 13%) and non-junctional fractions was approximately 50:50 in both 
clones (clone 2: 47 ± 15%; clone 6: 50 ± 3%) (Figure 4.2 (C)). 
 
 
 
Figure 4.2: Quantification of Cx40 and Cx43 levels in the junctional and non-junctional 
fractions in clones 2 and 6 
Differential solubilisation using Triton X-100 was used to separate the non-junctional (NJ) connexin 
from the junctional (J). All fractions were compared to the total (T) connexin expression. Immunoblots 
show analysis of clones 2 and 6 probed for Cx40 and Cx43 (A). Quantification of the junctional and 
non-junctional fractions indicated that a greater proportion of Cx40 was present in the junctional 
membrane in both the clones (B) but the differences were not statistically different (p > 0.05). For 
Cx43, there was approximately an equal amount of connexin present in both fractions (C). 
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4.3.3. Immunoconfocal analysis of connexin expression/co-expression patterns 
The localisation of Cx45 (Figure 4.3) and co-localisation of Cx40 and Cx43 (Figure 4.4) 
was examined by immunofluorescent labelling and confocal microscopy. In all three 
clones immunostaining for Cx40, Cx43 or Cx45 gave labelling at the cell interface 
between neighbouring cells representing gap junctions. There was also some perinuclear 
distribution within the cytoplasm likely representing connexins within the biosynthetic 
pathway. 
 
Cells from clone 2 appeared to form gap junctions with predominantly Cx45 (Figure 4.4 
(A)). Labelling for Cx45 was homogenous but at low levels across the cell monolayer in 
all the clones with the exception of clone 3. 
 
 
Figure 4.3: Immunofluorescent labelling of Cx45 in clones 2 and 6 
In both clones 2 (A) and 6 (B), Cx45 was expressed homogenously at low levels at the cell interface 
between neighbouring cells representing gap junctions. 
 
The co-localisation of Cx40 and Cx43 was examined by double immunofluorescent 
labelling. Clone 2 expressed Cx40 and Cx43 at low levels with large areas of the culture 
giving no positive staining (Figure 4.4 (A)), confirming the data obtained by northern 
and western blot. In clones 3 (Figure 4.4 (B)) and 6 (Figure 4.4 (C) expression for both 
Cx40 and Cx43 was heterogeneous in an interface-to-interface basis indicated by the 
different colours. For example the gap junctions of one interface were prominently 
labelled for Cx40 (red) while at a different interface of the very same cell, Cx43 (green) 
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predominated or a mixture of the two connexins (yellow). Although we can observe 
these distinctive patterns of different interfaces of the same cell, there was little 
variation within an individual interface where one cell abuts to another. Labelling was 
red, green or yellow but seldom more than one colour. 
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Figure 4.4: Immunoconfocal analysis of Cx40/Cx43 co-expression in the HL-1 clones 
Images show double labelling for Cx40 (red) and Cx43 (green) in clones 2, 3 and 6. Labelling was 
weak in clone 2 since it expressed low levels of Cx40 and Cx43 (A). In clones 3 (B) and 6 (C) 
expression for both Cx40 and Cx43 was heterogeneous. A single cell may display very different 
distribution patterns on opposite interfaces. This is highlighted by the star in (B) where one interface 
displays a predominance for Cx43 (green) while at a different interface of the same cell there was a 
mixture of the two signals (yellow). 
 147 
Triple labelling of Cx40, Cx43 and Cx45 in clone 6 was used to examine their relative 
co-localisation. The three connexins when visualised separately within the same area 
typically revealed similar labelling patterns (Figure 4.5 and Figure 4.6). The triple 
labelling image was generated by superimposing the image for each connexin subtype 
indicating that at specific cell interfaces all three connexins co-localise to form gap 
junctions, but the relative amount of signal for each connexin varied substantially from 
one cell interface to the next (Figure 4.5 and Figure 4.6, panel (A)). 
 
To demonstrate the varying degrees of co-localisation three different interfaces from the 
triple labelling were separated to allow simultaneous visualisation of Cx40 and Cx43, 
Cx40 and Cx45 and Cx43 and Cx45 (Figure 4.5 and Figure 4.6, panel (B)). Labelling 
for Cx40 and Cx43 gave a single colour per interface within a given cell with some 
interfaces predominantly showing Cx40 label while others largely showed labelling for 
Cx43 or a mixture of the two confirming the co-localisation pattern obtained earlier. 
Labelling for Cx40 and Cx45 showed isolated spots of Cx40 only (blue), Cx45 only 
(red) and a mixture of the two (purple) at different cell interfaces and within an 
individual interface. A similar pattern was also observed for Cx43 (green) and Cx45 
(red) with some areas of overlap of the two signals (yellow). In contrast to the Cx40 and 
Cx43 labelling no major differences in the labelling patterns at the different cellular 
interfaces were apparent. In certain areas of the cell monolayer all three connexins co-
localised within the same gap junction plaque to generate a white colour. 
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Figure 4.5: Co-localisation of Cx40, Cx43 and Cx45 in clone 6 to illustrate the spatial distribution patterns of all three connexins (Example 1) 
Each connexin can be seen in the individual channels within the same area and the triple labelling image was generated by superimposing the image for each connexin 
subtype (A). To demonstrate the varying degrees of co-localisation at each cell interface, sections 1, 2 and 3 highlighted from triple labelling were separated into dual images 
of Cx40/Cx43, Cx40/Cx45, Cx43/Cx45 and triple image of Cx40/Cx43/Cx45 as indicated on the left of the image (B). 
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Figure 4.6: Co-localisation of Cx40, Cx43 and Cx45 in clone 6 to illustrate the spatial distribution patterns of all three connexins (Example 2) 
Another example of triple labelling from a different group of cells to confirm the various colours per cell interface observed when signals for Cx40, Cx43 and Cx45 are 
superimposed (A). Sections 1, 2 and 3 indicated by the white boxes from triple labelling were separated into Cx40/Cx43, Cx40/Cx45, Cx43/Cx45 and Cx40/Cx43/Cx45 
images indicated on the left of the image (B). 
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4.3.4. Cx40 and Cx43 form heteromers in clone 6 
To assess the levels of heteromers formed, cells from clone 6 were extracted into their 
junctional and non-junctional fractions. The fractions were subjected to 
immunoprecipitation with a Cx40 antibody (Figure 4.7). Samples containing the total 
amount of junctional and non-junctional fractions together with their respective bound 
(sample bound to the connexin antibody that is specifically adsorbed on the beads) and 
unbound (sample not bound to the connexin antibody) fractions were loaded for western 
blot analysis. When the Cx40 antibody was immobilised on the beads we found that 
approximately 19 ± 1.0% of the junctional fraction and 7 ± 1.0% of the non-junctional 
fraction formed heteromers with Cx43 Figure 4.7 (A) and (B)). These differences were 
statistically different (n = 3; p < 0.001). 
 
 
 
Figure 4.7: Cx40 and Cx43 form heteromers in clone 6 
The total (T), junctional (J) and non-junctional (NJ) fractions were subjected to immunoprecipitation 
(IP) with a Cx40 antibody (A). The bound (B) and unbound (UB) samples from the non-junctional and 
junctional fraction were loaded for western blot (WB) analysis. Detectable levels of Cx40 interacting 
with Cx43 were observed in both the non-junctional and junctional fractions. Bar chart depicting the 
level of Cx40 and Cx43 interaction in the junction (19% ± 1.0) and non-junction (7% ± 1.0) is 
illustrated in (B) (n = 3; p < 0.001). 
4.3.5. Connexin interaction with ZO-1 protein 
Co-localisation of ZO-1 with Cx40, Cx43 and Cx45 can be visualised using 
immunoconfocal microscopy in clone 6 as shown in Figure 4.8. ZO-1 was expressed at 
high levels at the plasma membrane and was localised exclusively at inter-cellular 
contacts. ZO-1 showed varying degrees of co-localisation with Cx40 (A), Cx43 (B) and 
Cx45 (C) to give a yellow colour when the two signals overlapped. Isolated spots of 
ZO-1, Cx40, Cx43 or Cx45 signals were observed highlighted by the enlarged images in 
Figure 4.8 (D), (E) and (F). 
 
In certain areas, closer inspection of the ZO-1 co-labelling with connexin indicated that 
ZO-1 was located at the edge of the gap junction plaque forming a ‘belt’ along the gap 
junctions (Figure 4.9). This observation is in keeping with the proposed role of this 
protein in accretion of connexons to the plaque thereby regulating gap junction size 
(Hunter et al. 2005). ‘Holes’ in the labelled junction may represent areas in which 
patches of gap junction membrane have been internalised for degradation (Falk et al. 
2009). 
 
Although the immunofluorescence images demonstrated varying degrees of co-
localisation of ZO-1 with Cx40 and Cx43, this did not demonstrate an interaction. To 
determine the extent of any interaction between the proteins co-immunoprecipitation 
experiments were carried out in clone 4 (Figure 4.10). Clone 4 was used in this figure to 
illustrate that although all the clones have different expression profiles regarding the ion 
channels and connexins, they still retain the characteristics of a myocyte cell line. A 
ZO-1 antibody was used to precipitate ZO-1 from the junctional and non-junctional 
fractions and any interaction with Cx40 and Cx43 were detected by western blot 
analysis (Figure 4.10). Cx40 and Cx43 were also detected in the bound and unbound 
samples. In the bound fraction, Cx40 and Cx43 interacted with ZO-1 in both the 
junctional and non-junctional fractions. However this interaction was significantly 
lower in the junction in comparison to the non-junctional sample. In general there also 
appears to be a greater level of interaction of ZO-1 with Cx40 in contrast to Cx43.
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Figure 4.8: Co-localisation of ZO-1 with Cx40, Cx43 and Cx45 in clone 6 
ZO-1 is expressed exclusively at the cell interface and only when there is cell-to-cell contact. Double 
labelling of ZO-1 with Cx40 (A) and Cx43 (B) and Cx45 (C) showed varying degrees of co-
localisation. Images (D), (E) and (F) represent enlarged views of ZO-1 interaction with Cx40, Cx43 
and Cx45 respectively. At a specific cell interface it can be observed that there are certain areas of 
connexin (red) or ZO-1 only (green) and fraction where each signal overlaps (yellow) indicating co-
localisation. These areas as highlighted by the arrows. 
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Figure 4.9: Localisation of ZO-1 at the edges of the plaque 
Cells were co-labelled with Cx43 (A) and ZO-1 (B). When the individual signals were superimposed 
(C) ZO-1 appeared to be restricted to the edges of the plaque (indicated by the arrow) with Cx43 
expressed in the centre of the plaque. 
 
 
 
Figure 4.10: Co-immunoprecipitation of ZO-1 with Cx40 and Cx43 in clone 4 
Proteins were extracted into their junctional (J) and non-junctional (NJ) fractions in clone 6. Both the 
fractions were subjected to co-immunoprecipitation with the ZO-1 antibody and detected for Cx40 
(top immunoreplica) and Cx43 (bottom immunoreplica). Cx40 and Cx43 were tested in the total (T), 
unbound (UB) and bound (B) samples in both the junctional and non-junctional fractions. There were 
detectable levels of Cx40 interacting with ZO-1 in both fractions. However for Cx43, interaction with 
ZO-1 was greater in the non-junctional sample compared with the junctional fraction. Remnants of the 
IgG heavy chain from the antibody used for co-immunoprecipitation are visible in the bound fractions, 
but are readily distinguishable from Cx43 signal, which is the smaller of the two bands. Image was 
kindly gifted by Dr K. Grikscheit.  
 
4.4. Discussion 
Differential patterns of connexin expression is thought to confer distinctive electrical 
properties and play a fundamental role in the orderly spread of current flow (Severs et 
al. 2008). Thus it was important to distinguish the connexin expression/co-expression 
patterns in the HL-1 clones before their role in action potential propagation could be 
studied. The data presented in this chapter characterised the HL-1 clones in terms of: (1) 
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connexin expression (mRNA and protein levels); (2) connexin co-expression patterns; 
(3) connexin heteromerisation and (4) connexin interaction with ZO-1. This information 
can then be utilised to exploit each clone; their individual properties making them 
suitable for different experiments. 
 
Northern and western analysis confirmed that the HL-1 clones expressed a combination 
of Cx40 and Cx43 with the exception of clone 2. Only cells from clone 2 displayed 
major differences with the other clones and adult mouse heart with considerably lower 
levels of Cx40 and Cx43 mRNA. The differences in Cx40 expression between the HL-1 
clones and the mouse heart can be accounted for the fact that Cx40 only represents a 
small proportion of the total connexin expression in vivo where Cx43 is the predominant 
connexin. Cx40 expression is restricted to the atria, bundles within the conduction 
system and endothelial cells whereas in the working ventricular muscle it is almost 
completely absent (Duffy et al. 2006; Severs et al. 2008). The connexin expression 
pattern was very similar to that observed in normal mouse atria indicating a relatively 
normal connexin expression in HL-1 derived atrial myocytes (Coppen et al. 1998a). 
Cx45 could only be detected by northern blot. Based on the exposure times required to 
obtain signal intensities similar to that of Cx40 and Cx43, levels of Cx45 messenger 
were considerably lower in all the HL-1 clones as reported in vivo (Vozzi et al. 1999). 
From the quantification system developed in our laboratory that uses tagged HeLa 
transfectants with known amounts of connexin (Severs et al. 2006; Thomas 2007) we 
estimated that Cx45 protein was expressed at least twenty times lower than Cx40 and 
Cx43. Quantitative immunofluorescence could be performed to measure Cx45 
expression in each of the clones. In this study there were an insufficient number of 
images recorded for a complete quantification and statistical analysis.   
 
We found a positive correlation between the level of mRNA and the corresponding 
protein levels suggesting that connexin expression was predominantly regulated at the 
transcriptional level similarly to what has been reported in the human myocardium 
(Vozzi et al. 1999; Dupont et al. 2001a). Connexin gene expression is regulated by a 
variety of factors. These include (1) transcription factors TATA box-binding protein, 
specificity protein 1/3 (Sp1/Sp3) and activator protein-1 (AP-1) expressed to regulate 
basal expression and possibly modulate large changes in expression; (2) chemical and 
biological substances such as cAMP, phorbol esters and retinoids and (3) cell-type 
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specific transcription factors (e.g. Nkx2.5) which bind to connexin gene promoters 
(Beyer and Berthoud 2009; Oyamada et al. 2005). However further experiments will be 
required to deduce the exact mechanism involved in connexin synthesis. 
 
Further western blot analysis of the junctional and non-junctional connexins provided 
data on the relative amounts of Cx40 and Cx43 docked as channels compared with 
those in intracellular trafficking pathways and as single connexons present in the plasma 
membrane. For Cx40 there was a higher proportion present in the junctional fraction 
than the non-junctional fraction. By contrast Cx43 was expressed at an equal amount in 
both fractions. There also appears to be some phosphorylation of Cx43 at the junctional 
fraction. However to substantiate the amount of phosphorylation, phosphatase inhibitors 
will need to be used and the samples run on higher resolutive western blot gels 
containing 8-10% acrylamide (Musil et al. 1990). There are also a range of antibodies 
that are available targeting specific residues only when phosphorylated (e.g. S368) 
(Solan et al. 2003).  
 
Immunoconfocal visualisation of Cx40, Cx43 and Cx45 provided us with an overall 
distribution pattern. Single labelling demonstrated that Cx40 and Cx43 were 
heterogeneously expressed at high levels within the gap junction plaque (data not 
shown) with Cx45 homogenously present at low levels throughout the monolayer. 
Multiple labelling was performed to study the spatial relationship between the 
distributions of connexins relative to each other. From the double and triple imaging, a 
clear difference was observed in the distribution of each connexin at individual cell-to-
cell interfaces. The labelling pattern for Cx40 with Cx43 showed that a large proportion 
of cells displayed an individual colour per interface: either high Cx40, high Cx43 or a 
mixture of the two. This suggests that in those areas the amount of connexin present in 
the junctions and/or the make-up of connexons are near identical between the two cells. 
Similar observations were found in the RLE cell line transfected to co-express Cx40 
(Halliday et al. 2003; Thomas 2007) (Figure 4.11 (A)), N2a cells transfected with Cx40 
and Cx43 (Lin et al. 2010) and A7r5 which naturally co-express Cx40 and Cx43 
(Cottrell et al. 2002). This suggests that irrelevant of the cell type these labelling 
patterns observed are dependent on the connexins present at the membrane. Cx40 and 
Cx43 are frequently co-localised in cells of the cardiovascular system (Gros et al. 1994; 
Vozzi et al. 1999; Yeh et al. 2000) and are present within the same gap junction plaque 
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(Kanagaratnam et al. 2002; Severs et al. 2005). Inspection of the human Purkinje fibres, 
which co-express CX40 with CX43 at the intercalated disk commonly demonstrated a 
predominance of label for one connexin subtype at one interface and for the other 
connexin subtype at another interface confirming the labelling pattern observed in the 
HL-1 clones was a true representation of cardiac tissue in vivo (Figure 4.11 (B)). 
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Figure 4.11: Immunoconfocal analysis of Cx40/ Cx43 co-expression in two different cell 
models 
Double labelling with anti-Cx40 and anti-Cx43 in the RLE cell line that endogenously express Cx43 
transfected to co-express Cx40 (RLE Ind40) (A) and human Purkinje fibres (B) that co-express 
Cx40 with Cx43. Similar to the labelling pattern observed in clones 3 and 6, connexin localisation 
was heterogeneous. In both images an individual cell interface may demonstrate different labelling 
patterns indicating a predominance for one connexin subtype at one interface and for the other 
connexin subtype at another interface. Images were kindly gifted by Dr N. Thomas (A) and Dr R. 
Kaba (B). 
 
The single colour per interface was not observed for Cx40 with Cx45. We found 
isolated spots of Cx40 only, Cx45 only or an overlap of the two connexins throughout 
the monolayer. Studies on Cx40 and Cx45 mRNA levels showed that levels of both 
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Cx40 and Cx45 messenger followed a similar trend and variation between the four 
chambers indicating the two connexins may be spatially associated at the protein level 
(Vozzi et al. 1999) . In the rat conduction system the common bundle was shown to 
express Cx40 and Cx45 in a similar pattern to clone 6 (Severs et al. 2001). Labelling for 
Cx43 with Cx45 also revealed pattern of co-localisation comparable to that of Cx40 and 
Cx45. Studies using the RLE Ind45 cell line (Thomas 2007) and rabbit sinoatrial nodal 
cells (Honjo et al. 2002) reported a mixture of labelling with signals for Cx43 only, 
Cx45 only and a overlapping of the two connexins corroborating our observations in the 
HL-1 clones. When the three connexins were superimposed a clear difference was 
observed in the distribution of each connexin at the individual gap junction and cell-to-
cell interface indicated by the resulting colours. There were specific areas where all 
three connexins were present in the same gap junction producing a white signal similar 
to what has been observed at the intercalated disks in the human atrial myocardium and 
Purkinje fibres (Vozzi et al. 1999; van Veen et al. 2001). 
 
The varying degrees of co-localisation between the three connexins indicate a variety of 
structural arrangements of connexins may be present at the individual gap junction 
channel (e.g. heterotypic and heteromeric) although not all connexin combinations are 
compatible. Numerous investigations on Xenopus oocytes and HeLa transfectants have 
reported an absence of measurable gap junction currents between cells expressing Cx40 
and Cx43 in a heterotypic fashion (Bruzzone et al. 1993; White et al. 1995; Haubrich et 
al. 1996; Gu et al. 2000). This conclusion was supported by Lucifer yellow dye transfer 
studies showing there was no dye transfer between channels formed by Cx40 and Cx43 
(Elfgang et al. 1995) and in co-cultures in which no immunofluorescent signals were 
detected on apposed membranes (Haubrich et al. 1996; Rackauskas et al. 2007a). 
Haubrich et al (1996) further demonstrated an inherent structural basis to connexin 
incompatibility that implicated both extracellular loops, preventing the docking of 
mismatched connexons. Work in our laboratory also demonstrated that cells co-cultured 
with the RLE wild type (Cx43 homomeric connexons) and RLE Ind40 (Cx40 
homomeric, Cx43 homomeric and Cx40/Cx43 heteromeric connexons), no label for 
Cx40 was detected at any interface between the two cell types indicating an absence of 
heterotypic channels (Thomas 2007). However studies performed in HeLa and RIN cell 
transfectants reported the presence of heterotypic channels on cell pairs with a 
significantly reduced gap-junctional conductance which could be an indication of 
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reduced channel function and the inability of Cx40 and Cx43 to dock (Valiunas et al. 
2000; 2001; Cottrell and Burt 2001). It is also possible that the low levels of coupling 
could be accounted for by the presence of endogenous Cx45 interacting with Cx40 and 
Cx43 as found by Rackauskas et al. (2007a), which would also explain the differences 
of asymmetry in voltage dependence (Moreno 2004; Elenes et al. 2001). Since these 
studies by Valiunus et al. (2000) and Cottrell et al. (2001) were performed on cell pairs, 
and our experimental model was based on a cell monolayer, the assembly of Cx40 with 
Cx43 homomeric-heterotypic channels may be rarer in multicellular cultures because 
highly compatible connexons have an increased chance to form gap junctions and are 
less likely to form low compatibility channels such as Cx40 with Cx43. 
 
Connexons made from Cx45 are able to dock with connexons made up of either Cx43 
or Cx40 to form functional channels (Elfgang et al. 1995; Desplantez et al. 2004; 
Rackauskas et al. 2007a; Thomas 2007). Thus the presence of Cx45 makes it possible 
for a variety of different channel configurations to be formed. White et al. (1994) 
demonstrated that heterotypic channel formation is a selective property dependent on 
the expression of compatible connexins in the adjacent cells. In the lens Cx50 does not 
form heterotypic channels with Cx43, while Cx46 is compatible with both Cx43 and 
Cx50. In our cell line Cx45 could play a similar role in compatibility facilitating the 
functional linkage of gap junction channels in zones that express otherwise 
incompatible connexins. As a result if a large proportion of homomers are formed, then 
the known low compatibility between Cx40 and Cx43 (Elfgang et al. 1995; White and 
Bruzzone 1996) would also produce this specific connexin distribution. The connexon 
content of each interface would depend on the level of expression of individual 
connexins by adjacent cells modified by the docking of compatible connexons at other 
cell-to-cell interfaces. 
 
Alternatively results from the triple labelling could be due to a large proportion of 
heteromers produced containing channels composed of different ratios of Cx40, Cx43 
and Cx45. Co-immunoprecipitation experiments in clone 6 showed that the level of 
heteromers produced were considerably lower than theoretical models predicted 
assuming the connexon subtypes are free to associate in a random fashion (Brink et al. 
1997). Heteromerisation between Cx40 and Cx43 have been reported in several studies 
using affinity chromatography on a Nickel-nitrolacetate matrix (Ni
2+
-NTA) (He et al. 
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1999; Beyer et al. 2001; Valiunas et al. 2001). However one caveat of these studies is 
that analysis was only performed in the Triton X-100 fraction, which contains the non-
junctional connexins only. There is not only an assumption that the level of heteromers 
formed in the synthetic pathways is similar to that in the plasma membrane but this 
procedure is not  quantitative both of which we were able to overcome in our laboratory. 
We found that Cx40 and Cx43 heteromerise in both the junctional (19%) and non-
junctional (6%) fractions indicating that hetero-oligomerisation begins during the 
assembly of connexons in the trans-Golgi network before its incorporation into the gap 
junction plaque (Musil and Goodenough 1993; Laird 2006). The lower levels of Cx40 
and Cx43 interaction in the non-junctional fraction could be explained by presence of 
connexin monomers prior to oligomerisation in the ER-Golgi compartments. 
 
Due to the low levels of Cx45 expressed in the HL-1 clones we were unable to detect 
any interaction with Cx40 or Cx43. However using the RLE Ind45 cell line no 
heteromers were observed between Cx45 and Cx43 indicating that detection of an 
interaction in cells where only low amounts are expressed is unlikely to be feasible 
(Grikscheit 2010). This data is quite different from studies performed by Martinez et al. 
(2002a) who showed co-purification of Cx45 with V5-(His)6-tagged Cx43 on a Ni
2+
-
NTA matrix. Differences in these results and could be due to technical factors or to cell 
type specific heteromerisation  
 
Work on connexin hetero-oligomerisation report that this process may be an intrinsic 
process specific to each connexon type. For example the ‘selectivity’ signal that 
regulates connexin compatibility might be located in the amino terminal portion and 
differ between the connexin subtypes thereby enabling or preventing hetero-
oligomerisation (Lagree et al. 2003; Segretain and Falk 2004; Koval 2006). The 
segregation of connexins within a gap junction channel could also be dependent on the 
different affinities each connexin has for surrounding lipids or connexin-binding 
proteins (e.g. ZO-1) (Segretain and Falk 2004). Work by Das et al. (2001) demonstrated 
that the ability to form heteromeric channels is also dependent on the context of cell 
expression. Alveloar epithelial cells express Cx43 and Cx46 however only type I cells 
are able to form heteromers compared with type II in which Cx46 is retained in the 
trans-Golgi network preventing interactions with Cx43. Quantification of the level of 
heteromerisation in both the junctional and non-junctional fractions in clone 6 was also 
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consistent with what has been found in the human atria and the RLE Ind40 cell line 
(Grikscheit 2010). This suggests that heteromereisation is an intrinsic property of the 
connexins expressed and not the cell or tissue type.    
 
In recent years the major focus regarding connexin interacting proteins has been on ZO-
1 and its involvement in regulating the size and cellular distribution of gap junctions in 
the healthy and diseased myocardium (Hunter et al. 2005; Laing et al. 2007; Bruce et al. 
2008). In the HL-1 clones ZO-1 expression was confined to areas of inter-cellular 
contact only. A similar expression pattern was found in vivo where the distribution of 
ZO-1 was only present at the intercalated disk and preferentially associated at the edges 
of gap junctions (Barker et al. 2002; Bruce et al. 2008). Using double labelling we 
observed some degree of co-localisation between ZO-1 with either Cx40, Cx43 and 
Cx45 similar to what has been reported in the human ventricle (Bruce et al. 2008) and 
rat myocytes (Barker et al. 2002). In specific regions we found that ZO-1 did not 
directly overlap with the plaque interior but was associated at the perimeter in keeping 
with studies by Hunter et al. (2005) on HeLa and neonatal cardiac myocytes. These 
specialised microdomains within the plaque are likely to represent gap junction 
recruitment sites since work by Gaietta et al. (2002) and Lauf et al. (2002) demonstrated 
that Cx43 insertion into the plasma membrane occurred at the periphery of gap junction 
plaques. We also found areas of ZO-1 not co-localised with Cx40, Cx43 or Cx45. In 
these areas ZO-1 is most likely to be complexed with another type of cell junction such 
as adhesion junctions; e.g. N-cadherin (Barker et al. 2002). Molecular ‘cross-talk’ 
between different junction types has been proposed between mechanical and electrical 
junctions at the intercalated disk in the formation and stabilisation of gap junctions 
(Rohr 2007). For example the deletion of N-cadherin resulted in the destabilisation of 
adhesion junctions at the intercalated disk and a decrease in the levels of Cx43 (Hertig 
et al. 1996; Kostetskii et al. 2005). 
 
Co-immunoprecipitation studies confirmed the interaction of ZO-1 with Cx40 and Cx43 
in both the junctional and non-junctional fraction as found in the healthy and diseased 
heart (Bruce et al. 2008). These interactions are most likely through the C-terminus of 
the connexin motif and the PDZ domain of ZO-1 (Laing et al. 2005; Herve et al. 2007). 
ZO-1 interaction with Cx40, Cx43 and Cx45 through the PDZ binding domain has been 
demonstrated in a variety of cell models including porcine vascular endothelial cells 
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(Nagasawa et al. 2006), osteoblastic cells (Laing et al. 2001) and adult rat ventricular 
myocytes (Barker et al. 2002). Interactions in the non-junctional fraction include single 
connexons at the plasma membrane and may reflect a possible role of ZO-1 in gap 
junction turnover and compartmentalisation of connexins within the plasma membrane 
(Laing et al. 2007). For example the expression of ZO-1 at the edge of gap junction 
could promote the accretion of non-junctional connexons into the plaques (Hunter et al. 
2005; Laing et al. 2005) and the internalisation of connexons from the plaque via the 
formation of annular gap junctions (Bruce et al. 2008). Although we have not confirmed 
the exact role of ZO-1 in the HL-1 clones we can speculate that by controlling the rate 
of turnover, ZO-1 could potentially influence the level of cell-to-cell communication in 
these cells. 
 
In summary, the HL-1 clones expressed Cx40, Cx43 with very low levels of Cx45. All 
three connexins co-localised at varying levels resulting in the different colours produced 
by immunofluorescence. This heterogeneity is possibly due to (1) incompatibility of 
connexons composed Cx40 and Cx43 and (2) ability of Cx45 to freely dock with Cx40 
or Cx43 to form functional channels. Co-immunoprecipitation experiments showed that 
levels of heteromerisation were much lower than would be predicted from random 
association. ZO-1 interaction with Cx40 and Cx43 was detected by 
immunoprecipitation indicating a potential role for this protein in gap junction assembly 
and function in the HL-1 cells. Collectively these are all influential factors in impulse 
propagation, which will be studied, in the next chapter. 
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CHAPTER 5. 
The study of action potential propagation in the HL-1 clones 
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5.1. Introduction 
Cardiac excitation involves action potential generation by individual cells and its 
conduction from cell-to-cell through gap junctions (Kleber and Rudy 2004). For a single 
cell to reach the threshold of activation and serve as a source the liminal length 
requirements must be fulfilled resulting in a re-generative propagating action potential; 
otherwise only local electrotonic effects occur. The liminal length is defined as the 
length of tissue required to be raised above threshold so that the inward depolarising 
current from that region is greater than the repolarising influences of adjacent tissue 
(Fozzard and Arnsdorf 1991). 
 
Cellular parameters that govern action potential propagation are: (1) excitable 
membrane properties defined by distribution, density and type of voltage-gated ion 
channels participating in the action potential; (2) intracellular longitudinal resistance 
that affects the spread and charge of depolarising current in tissue is determined by the 
cytoplasmic and gap junction resistance; (3) cell membrane capacitance and (4) 
extracellular longitudinal resistance (Kleber and Rudy 2004; Spach et al. 2004; 
Desplantez et al. 2007). A modification of any of these elements is predicted to alter 
conduction velocity (CV) in the heart. For example reducing the availability of sodium 
(Na
+
) channels is accompanied by a decrease in the safety factor (SF) and drop in CV 
by a third followed by conduction block (Shaw and Rudy 1997; Wang and Rudy 2000; 
Kucera et al. 2001). In order to study action potential propagation, microelectrode 
arrays (MEA) in combination with optical mapping will be used to study the HL-1 
clones. 
 
A MEA consists of a matrix arrangement of 60 electrodes that allows the recordings of 
extracellular field potentials across a cell monolayer. The signal recorded by the MEA 
reflects changes of membrane potential caused by the flow of ions though the voltage-
gated ion channels crossing the cell membrane by local depolarisation (Yamamoto et al. 
1998; Stett et al. 2003; Hescheler et al. 2004). Thus any difference in transmembrane 
potential between cells would cause a current to flow through the cell interior across the 
membrane giving rise to a voltage gradient in the extracellular environment. The size of 
the voltage gradient is influenced by the amount of current produced by the 
neighbouring cells and the distance the signal is from the electrode. This technique 
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enables non-invasive recordings of field potential in any electrogenic tissue including 
neuronal (Baruchi et al. 2008; Brewer et al. 2009) and cardiac (Halbach et al. 2006; 
Fahrenbach et al. 2007) cell preparations. 
 
In contrast to MEA, optical mapping measures the differences in transmembrane 
potentials in excitable cells. The changes in membrane potential are detected using 
voltage-sensitive dyes (e.g. di-8- butyl-amino-naphthyl-ethenyl-pyridinium-propyl-
sulfonate (ANNEPS)) that insert into the external lipid bilayer of the cell. At the cell 
membrane the dye reacts to local changes in transmembrane potential with a shift in 
their optical properties. These changes are then recorded using appropriate detectors. 
The technique has a wide range of applications particularly in studying source-and-sink 
mismatches (Rohr et al. 1997) and the dependence of impulse propagation on tissue 
geometry (Fast and Kléber 1993; Rohr and Salzberg 1994; Fast et al. 1996). It not only 
provides a high temporal resolution necessary to detect the rapid change in membrane 
potential during the action potential upstroke but it is also able to provide better spatial 
resolution enabling the investigation of finer details of wave propagation (Morley and 
Vaidya 2001). This part of the study was done in collaboration with Dr M. Miragoli 
(Cardiovascular Science, NHLI). 
 
MEA and optical mapping provide efficient tools to study the propagation of the 
wavefront giving detailed descriptions of: (1) origin and spread of electrical activity; (2) 
CV; (3) curvature and homogeneity of the propagated wavefront and (4) electrical 
activity across the entire cell monolayer, an advantage over electrophysiological 
techniques such as patch-clamp which only work on a single cell at a time. In addition 
there are advantages unique to each technique; MEA enables the recordings of electrical 
activity on the same preparation over a length of time whereas optical mapping allows 
the action potential morphology and duration to be monitored from several sites at a 
high resolution across the monolayer. All these aspects on impulse are presented and 
discussed in detail in this chapter. 
 
 166 
5.2. Materials and methods 
HL-1 clones were routinely cultured as described in Chapter 2, section 2. Effects of cell 
density on connexin protein expression were detected by western blot technique 
(Chapter 2, section 5). 
 
5.2.1. Measurement of impulse propagation 
Cell preparation 
The seeding procedure used was the same for MEA and optical mapping. Once cells 
reached full confluency, they were trypsinised according to methods described in 
Chapter 2, section 2. After centrifugation the cell pellet was re-suspended in Claycomb 
medium using a volume equivalent to 10-20µl per 1cm
2
 of cells. The MEA and 35mm 
glass bottom dishes were coated with fibronectin (10mg/ml) in water. 10-20l of the 
cell suspension was seeded as a drop directly on the electrodes of the MEA. For optical 
mapping 10-20l of the cell suspension was seeded as a drop on 35mm glass bottom 
dishes (MatTek Corporation). Cells were left to attach for 20-30 minutes with 
incubation in an atmosphere of 5% CO2 at 37°C. After cell seeding the chambers were 
flooded with Claycomb medium (~800l). The next day the medium was changed and 
viewed under a microscope to ensure cells had attached over the electrodes and the 
35mm glass bottom dishes. Recordings were performed 24-48 hours after seeding. 
 
MEA apparatus 
The equipment used in this study was composed of glass MEA plates, the MEA 1060 
amplifier, the MC_Stimulus generator 2.1.5, the TC01/02 temperature controllers and 
the MC_Rack data acquisition and analysis software (Multichannel systems). 
 
MEA plates 
The standard MEA plate consist of 60 titanium nitride (TiN) electrodes in an 8x8 grid 
fabricated on a glass substrate (Figure 5.1 (A)). The electrodes have a diameter of 30M 
and the spatial resolution is 200m. The total distance across an MEA plate is 1400m 
and this value is used to calculate CV across a cell preparation. This will be explained in 
greater detail later in this section. Cell preparations can be cultivated directly on the 
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MEA plate and extracellular action potentials can be recorded over a length of time (up 
to several weeks). 
 
After each experiment the MEA plate was cleaned for re-use. The plate was thoroughly 
rinsed with tap water and filled with a 1% sodium dodecyl sulphate (SDS) solution in 
distilled water (dH2O) for a minimum of 3 hours to remove cellular debris from the 
surface of the electrodes. The plate was rinsed under a continuous stream of tap water 
between 2-24 hours followed by dH2O for a few minutes to ensure complete removal of 
the detergent. The MEA plate was sterilised with 75% ethanol and baked at 120ºC for a 
minimum of 2 hours before dry storage in a clean 100mm petri dish until ready for use. 
 
 
Figure 5.1: MEA plate 
The MEA plate consists of 60 titanium nitride (TiN) electrodes (A). Each electrode has a diameter of 
30M and the space between each electrode is 200M from centre to centre. Cells are seeded as a 
confluent drop directly on the TiN electrodes (B) and extracellular recordings performed 24-48 hours 
post-seeding. 
 
MEA recordings 
All the electrodes were in contact with the cell monolayer as shown in Figure 5.1 (B). 
This was essential to ensure a sufficient amount of electrical activity was produced by 
the cells for the signal to be detected by the electrodes. 
 
Prior to mounting the MEA onto the amplifier, the contact pads on the MEA were 
thoroughly cleaned with 75% ethanol. This was to remove any contaminants, for 
example grease, from touching the pads with bare fingers and to prevent poor contact 
between the pads and the amplifier pins. A bad contact results in increased noise levels 
on the affected channel. The medium was grounded either via: (1) an internal reference 
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electrode connected to the ground with the provided connector or (2) a silver wire 
connected to the amplifier's ground and placed into the chamber. 
 
Once connected to the amplifier the MC_Card pre-installed on the data acquisition 
computer acquired the analog input signals at a sampling rate of 25kHz and digitized 
the raw data (Figure 5.2 (A)). Extracellular recordings can be visualized using 
MC_Rack. All recordings were carried out at 37°C using the temperature controller 
(TC01/02) connected to the base of the amplifier. Usually signals were visually 
observed for 1-2 minutes to determine if the MEA was suitable for experimental use. 
The selection criteria were based on the size and the frequency of the cellular signals. 
 
For data acquisition, intrinsic beats were recorded prior to stimulation for 30-60 seconds 
using the MC_Rack software. Cells were then stimulated (MC_Stimulus 2.1.5) with a 
10ms bipolar pulse of 0.3-1V for 1 minute at either 1 or 2Hz (Figure 5.2 (B)). The 
frequency used was directly dependent on the intrinsic frequency generated by the cells. 
MC_Rack allowed the experimenter to select the location and number of electrodes 
required to stimulate the cells. Analysis of extracellular recordings and excitations maps 
were performed using MC_Rack, Microsoft Excel and GraphPad prism. 
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Figure 5.2: Set-up of the stimulus generator to the MEA amplifier 
Cells were stimulated using a stimulus generator directly transmitting the stimulation to any of the TiN 
electrodes present on the MEA plate. Action potentials recorded extracellularly were amplified and 
sent to the data acquisition system to be recorded and analysed on the computer (A). (B) is an example 
of a bipolar protocol used to stimulate the cellular preparation. Cells were normally stimulated at a 
frequency of 1-2Hz. 
 
Measurement of CV 
Spontaneous preparations 
Extracellular field potentials produced by the HL-1 clones are shown in Figure 5.3 (A). 
The field potential has several characteristic components that can be distinguished 
which include: (1) the first negative peak of the field potential (FPMin); (2) the last 
positive peak of the field potential (FPMax) and (3) the duration of the field potential 
(FPdur) defined as the time between (FPMin) and (FPMax) (Halbach et al. 2003) (Figure 
5.3 (A), enlarged electrode (E86)). Studies of simultaneous recordings of field 
potentials and intracellular action potentials have established a close correlation 
between: the time of upstroke and repolarising phases of the action potential to the 
FPMin and FPMax respectively (Halbach et al. 2003; Reppel et al. 2004).  
 
For extracting CV from the field potentials, a trigger detector was set-up in a single 
electrode (can be any electrode) using MC_Rack. The purpose of the trigger detector 
was to detect electrical activity above a threshold value of the field potential thereby 
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identifying the spontaneous activity (e.g. the dotted line on the enlarged electrode (E86) 
in Figure 5.3 (A)). This in turn generated a data stream (Figure 5.3 (B)) in the remaining 
electrodes relative to the trigger, which was always set at 0ms. Depending on the origin 
of activation the field potentials in the remaining electrodes occurred before or after the 
trigger electrode. This data stream was then used to set-up an analyser through 
MC_Rack defining the region of interest (ROI) representing the time range in which the 
field potentials on all 60 electrodes were analysed (Figure 5.3 (B), E85). Data within the 
ROI gave trace plots of the time taken for the action potential to reach each electrode 
from the origin of wavefront activation (Figure 5.3 (C)). CV was calculated using 
Equation 5.1 using Figure 5.3 (C) as an example. 
 
Equation 5.1: Measurement of CV from spontaneous preparations (mm/sec) 
D (A-B)  x 1000 
T (A-B)  
 
D = distance; T = time delay (ms); A = origin of activation in Figure 5.3 (C)); B = point 
furthest away from the origin of activation in Figure 5.3 (C)) 
 
The trace plot showed the consistency of each beat in each of the electrodes across the 
length of the recording (x-axis) highlighted by the enlarged image of the electrode (E75) 
in Figure 5.3 (C). 
 
To illustrate the spread of activation and electrical activity in different areas within a 
monolayer we were able to create two-dimensional false colour maps (Figure 5.3 (D)). 
Each colour map consisted of 64 colours representing time intervals determined by the 
ROI. For example in Figure 5.3 (D) the darkest colour denoted by the asterisk 
represented the fastest time delay and the lightest colour represented the slowest time 
delay in the ROI from the origin of activation. 
 
 Figure 5.3: Measuring CV in spontaneously contracting preparations 
(A) is a typical example of extracellular recordings produced by spontaneously contracting cell preparations. The key parameters of the field potential are indicated in the 
enlarged electrode 86: FMin is the size of the largest negative peak; FMax is the last positive peak and FPdur is the duration of the field potential. To calculate CV using recording 
(A) as an example, a trigger detector was set-up in one electrode (e.g. E86), which detects any electrical activity above a certain threshold (-100mV) of the field potential 
generating a data stream (B). This data stream was used to set-up an analyser enabling to define a region of interest (ROI) and measure CV from trace plots (C). Two-
dimensional false colour maps illustrate the origin of activation (D). Blank electrodes in the trace plots and false colour maps represent electrodes that were excluded because 
of electrical noise. 
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Stimulated preparations 
When cell preparations were electrically stimulated (e.g. top row of electrodes) the time 
delay between the artefact of stimulation and the field potential can be measured in any 
of the electrodes (e.g. Figure 5.4 (A), E28). An enlarged image of the time delay in 
action potential propagation along a row of electrodes from the point of stimulation (e.g. 
E71) to the remaining electrodes down the array (e.g. E72-78) is shown in Figure 5.4 
(B). CV was calculated using Equation 5.2. 
 
Equation 5.2: Measurement of CV from stimulated preparations (mm/sec) 
 
D (point of stimulation - electrode X)  x 1000 
T (field potential - artefact of stimulation)  
 
 
 
Figure 5.4: Measurement of CV in stimulated cellular preparations 
Cells were field stimulated with a 10ms bipolar pulse between 0.3-1V along a row of electrodes (e.g. top 
row). The time taken between the artefact of stimulation and the resulting field potential in any electrode 
(e.g. E28) was measured (A). The delay of excitation spread in a single row of electrodes is plotted 
against the respective distance of the electrodes from the origin of excitation (B). 
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Optical mapping 
The characteristics of impulse propagation were assessed optically with the voltage 
sensitive dye di-8-ANNEPS (Biotium). The dye was prepared in a stock solution of 1ml 
75% dimethyl sulphoxide (DMSO) and 25% pluronic acid. 10l of the stock solution 
was added to the cell preparation containing 1ml of normal Tyrode to give a final 
concentration of 135μM and incubated for 2 minutes at room temperature. The cell 
preparations were washed in normal Tyrode to remove any unbound dye. During the 
experiments, preparations were constantly superfused with normal Tyrode at 37°C. 
Tyrode was necessary for the optical mapping recording because the autofluorescence 
of the medium would interfere with the actual signal. The emitted fluorescence 
corresponding to transmembrane voltage changes were measured at an excitation 
wavelength of 470 ± 30nm and a recording wavelength of 550 ± 40nm using a CMOS 
fast-resolution camera (Ultima, SciMedia). Spontaneous activity in a given preparation 
was limited to recordings lasting 4 seconds each in order to avoid phototoxic effects of 
the dyes. Optical raw data was analyzed using software provided by camera 
manufacturer (BV_Analyze V9.09, SciMedia). After offset correction and digital 
filtering of the raw data, the frequency of spontaneous activations and the spatial 
activation patterns were determined separately for each preparation. 
 
5.3. Results 
5.3.1. Optimisation of seeding parameters  
From preliminary experiments we found that field potentials most suitable for 
measuring CV were obtained from cells covering the electrodes only compared to cells 
plated over the entire MEA plate. In both techniques cells were seeded as a monolayer 
with the only difference being in the surface area covered by the cells. In preparations 
covering the entire MEA plate, cells spontaneously contracted at a higher frequency of 
4-5Hz with poor signal to noise ratio (data not shown) when compared with cells 
covering only the electrodes (1-2Hz). Thus cells were always seeded as a drop covering 
only the electrodes. Despite this seeding optimisation, CV varied considerably between 
each experiment depending on the volume and size of the seeding drop. 
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To provide more consistency in CV, a range of cell densities (0.5-2cm
2
 of cells) and 
seeding volumes (5-40µl) were tested using clone 6. Figure 5.5 (A) displays a chart with 
the key volumes and cell densities tested with their corresponding CV (mm/sec). From 
these experiments we established that 0.5 and 1cm
2
 of cells in a volume of 10µl was 
optimum in providing the highest CV and most consistent data between experiments 
(1cm
2
/10µl: 44 ± 1mm/sec; 0.5cm
2
/10µl: 38 ± 1mm/sec) that peaked within 3-4 days 
post-seeding. Seeding cells below or above these values lead to lower CV (0.5cm
2
/5µl: 
27 ± 1mm/sec; 2cm
2
/30µl: 22 ± 1mm/sec) and on the occasions maximum velocities 
were reached on days 5-6 post-seeding. Seeding volumes of 10µl were optimum as 
smaller volumes (e.g. 5µl) were insufficient for the cells to be seeded in and larger 
volumes (e.g. 30-40µl) resulted in the spreading of the drop and cells not forming a 
confluent monolayer. 
 
To explain these differences in CV western blots measuring connexin40 (Cx40) and 
Cx43 expression were performed on cells cultured at different densities (50%-300%). 
Cells were harvested on day 3 which was typically the time point when CV peaked 
(Figure 5.5 (B)). We found that Cx40 and Cx43 expression reduced considerably when 
cells were seeded at 250% confluency (Cx40: ~75% drop; Cx43: ~50% drop) compared 
with when cells were at 100-200% confluency. This indicates that there is a range in 
which cells need to be seeded where connexin expression is optimum and the maximum 
CV is recorded. 
 
 
 
 
 
 
 
 
 
 
 175 
 
Figure 5.5: Optimisation of seeding parameters 
Cells were seeded at different densities (0.5-2cm
2
 of cells) and seeding volumes (5-30µl) on the MEA 
and the resulting CV measured (A). The exact cell density and seeding volume is listed below the 
chart. (B) are immunoblots of cells seeded at varying densities and detected for Cx40 and Cx43. The 
initial seeding density is indicated above the immunoblots. 
 
5.3.2. Action potential propagation in spontaneously contracting cultures using 
MEA and optical mapping 
Using the seeding protocol described in the section above, action potential propagation 
was measured using MEA and optical mapping in spontaneously contracting cultures in 
clone 6. Figure 5.6 (A) and (B) show typical examples of two-dimensional false colour 
maps generated from MEA and optical mapping respectively. In both examples the 
origin and the direction of the propagating wavefront is highlighted by the asterisk and 
arrows. In the majority of the preparations the electrical activity originated from the 
edge of the monolayer formed by the initial seeding drop and the spread of activation 
appeared relatively homogenous. CV were measured using MEA and optical mapping 
and no significant difference (p = 0.2684) was observed in the two techniques (MEA: 
41 ± 2mm/sec; optical mapping: 37 ± 2mm/sec; n = 8 and 18 respectively) (Figure 5.6 
(C)). 
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Figure 5.6: CV in spontaneously contracting cultures using MEA and optical mapping 
Typical examples of two-dimensional false colour maps from MEA (A) and optical mapping (OM) 
(B) in spontaneously contracting cultures of clone 6. In images (A) and (B) origin and spread of 
activation is denoted by the asterisk and arrows mark the direction of the propagating wavefront. CV 
was measured using both techniques and there was no significant difference (p = 0.2684) in the values 
(MEA: 41 ± 2mm/sec; optical mapping: 37 ± 2mm/sec; n = 8 and 18 respectively) (C). 
 
In many of the recordings analysed the natural pacemaker was always present at the 
edge of the preparation. We also observed that the origin of activation was not always at 
the same location in the preparation, indicating that there was more than one pacemaker. 
Optical mapping was used to illustrate the switch in the natural pacemaker within the 
same recording (Figure 5.7). At the beginning of the recording (Figure 5.7 (A), top left 
panel) electrical activity spread from the top right corner across the preparation. 
However ~300ms later during the same recording there were two pacemakers within the 
same preparation (Figure 5.7 (A), bottom panel) which collided in the centre. 
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Figure 5.7: Origin of natural pacemaker using optical mapping 
(A) shows a time course of wavefront propagation within the same cell preparation. The time difference in milliseconds (ms) is indicated below each of the images. In the top 
left panel of the recording, spread of activation is initiated from the top left corner. Approximately 300ms later during the same recording there appears to be two pacemakers 
at the top left and bottom right corner (bottom left panel). The red colour represents full-sized action potentials; green means there is an absence of depolarisation. (B) 
illustrates the corresponding activation maps for each of the panels. Asterisks mark the pacemaker location in each of the activation maps.  
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The overall spread of activation in the two panels are summarised by their 
corresponding activation maps and are marked by the asterisks indicating the pacemaker 
locations (Figure 5.7 (B)). 
 
To test the homogeneity of wavefront propagation, optical mapping was used to record 
action potential size, shape and duration from multiple sites within a monolayer. Figure 
5.8 (A) is an example of an activation map illustrating impulse propagation across the 
entire cell monolayer with examples of two optically recorded action potentials from the 
origin of activation (point 1) and at a location (point 2) further away from the origin. 
The action potential shape was homogenous across the monolayer and showed a good 
correlation to the action potentials recorded by patch-clamp (Figure 5.8 (B)). On 
average cells had an action potential duration at 50% repolarisation (APD50) of 46 ± 
2ms (n = 32) which was significantly longer (p > 0.05) compared to values calculated 
using patch-clamp (17 ± 6ms, n = 4). The differences in APD50 are possibly a result of 
motion artefacts due to cell or muscle contraction that distorts the optical action 
potential signal preventing accurate recordings of the repolarisation phase (Morley and 
Vaidya 2001; Efimov et al. 2004). To avoid motion artefacts and for accurate recordings 
of action potential durations, cell preparations will need to be supplemented with 
electromechanical uncoupling agents such as diacetyl monoxime and 2,3-butanedione 
monoxime (Morley et al. 1999; Sharifov and Fast 2003). Nevertheless optical mapping 
can still give an approximate representation of the action potentials generated by cells 
across a monolayer. 
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Figure 5.8: Action potential recordings by optical mapping 
A typical example of impulse propagation across the entire cell monolayer. In many of the 
preparations the natural pacemaker was always present at the edge of the monolayer as shown in this 
example (A). Analysis of action potential size and shape at multiple locations within a monolayer 
indicated a homogenous morphology (A). Points 1 and 2 on the activation map correspond to the grey 
and green traces of the optically recorded action potentials respectively. The black dotted line on the 
activation map denotes the spread of impulse propagation, initiated from the edge (point 1) and 
spreading across the preparation (point 2). This in turn corresponds to the difference in time delay 
observed in action potential activation between the two points. Comparing optically recorded action 
potentials to those recorded by patch-clamp (B) revealed a similar morphology. 
 
5.3.3. Frequency of intrinsic spontaneous rate in the HL-1 clones 
Extracellular field potentials were typically observed 1-2 days post-seeding. All the HL-
1 clones had an intrinsic spontaneous rate ranging from 1.3-1.5Hz with the exception of 
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clone 1 which had a higher intrinsic rate of 2.5Hz. The only significant difference in 
intrinsic frequency was between clones 1 and 6 (p < 0.05). It should be noted that after 
sub-cloning clone 1 had drifted and cells were unable to contract and generate action 
potentials spontaneously or after electrical stimulation. The data presented in Table 5.1 
and in Figure 5.12 were calculated when the cells were still contracting and able to 
generate action potentials. Table 5.1 is a summary of the spontaneous frequencies 
obtained in the HL-1 clones two days post-seeding.  
 
Table 5.1: Intrinsic rate of frequency in the HL-1 clones 
 
HL-1 clones Intrinsic frequency (Hz) 
1 2.5 ± 0.31 (n = 10) 
2 1.5 ± 0.22 (n = 6) 
3 1.4 ± 0.24 (n = 5) 
4 1.4 ± 0.24 (n = 5) 
6 1.3 ± 0.16 (n = 8) 
 
5.3.4. Action potential propagation under electrical stimulation in the HL-1 clones 
After days 2 and 3 post-seeding, some preparations did not always display spontaneous 
electrical activity but extracellular recordings could be elicited by electrical stimulation. 
Furthermore only certain preparations of spontaneously contracting cultures could be 
used to calculate CV accurately depending on location of the pacemaker. Thus for 
consistency, all the data from this stage of the study will be presented on electrically 
stimulated cultures. 
 
Cells could either be stimulated using point or line stimulation from the edge of the 
array (top, bottom, left and right rows). Line stimulations were preferred over point 
stimulations to produce a flat activation front. Electrical stimulation using a single 
electrode, produced a convex wavefront (i.e. excitation front is curving outwards) 
(Figure 5.9) comparable to studies by Knisley and Hill (1995) on the effects of 
stimulation on excitation wavefront. 
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Figure 5.9: Effects of point stimulation versus linear stimulations on activation spread 
Cells were stimulated using a point (A) or line (B) stimulation. Stimulation using a single electrode 
produced a convex wavefront whereas stimulation with a row of electrodes produced an almost flat 
excitation. The arrows mark the direction of wavefront propagation and the curvature of the wavefront is 
indicated by the black dotted lines. The stimulating electrodes are denoted by asterisks. White squares in 
the false colour maps are electrodes excluded due to electrical noise. 
 
When cells were stimulated in different directions no significant difference (p = 0.0682) 
in CV was observed (Table 5.2). No anisotropic propagation was detected, thus any of 
the rows at the edge of the MEA array could be used to electrically stimulate the cells. 
 
Table 5.2: CV when stimulated in different directions 
 
Stimulation CV (mm/sec) 
Top 36 ± 2 (n = 3) 
Bottom 35 ± 1 (n = 4) 
Left 40 ± 2 (n = 5) 
Right 38 ± 1 (n = 6) 
 
The electrical stimulation parameters used to dominate the natural pacemaker were 
dependent on the cells intrinsic rate of frequency. The HL-1 clones had an intrinsic rate 
between 1-1.5Hz with the exception of clone 1 (Table 5.1) and the rate of electrical 
stimulation sufficient to override this was 1-2Hz. However in certain occasions a higher 
rate of stimulation was required. For example in clone 1 which needed a higher 
frequency at 2.5Hz. To test if the frequency of stimulation was a determining factor in 
CV cells were paced at a range of frequencies from 1-5Hz. We observed that an 
increase in the rate of stimulation was accompanied by a decrease in CV, a pattern 
found in all the HL-1 clones. Figure 5.10 shows CV recorded from clones 4 (n = 3) and 
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6 (n = 4) at different rates of stimulation. CV was only significantly different in clone 4 
when stimulated at a frequency above 2Hz (3Hz: p < 0.01; 5Hz: p < 0.001).   
 
 
 
Figure 5.10: Effects of pacing frequency on CV 
Cells from clones 4 and 6 were electrically stimulated at different frequencies (1-5Hz) and the CV 
measured. No significant difference in CV was observed at 1-2Hz in both clones. At frequencies 
above 2Hz a drop in CV was observed but the values were not statistically different (p > 0.05) in cells 
from clone 6 (n = 4). However in clone 4 the reduction in CV upon stimulation above 2Hz was 
significantly different compared with 1Hz (n = 3; * p < 0.01; ** p < 0.001). This pattern in conduction 
drop upon an increase in frequency was observed in all the HL-1 clones.  
 
Recordings of action potential propagation monitored over time (days 1-5) indicated 
that CV gradually increased over days 1-2 and typically peaked on days 3-4 and 
dropped thereafter. This pattern was followed by all the HL-1 clones but data from 
clones 3 (n = 3) and 6 (n = 4) are shown as examples in Figure 5.11. As a general rule 
for all MEA experiments CV were recorded between days 2-5 when possible. 
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Figure 5.11: CV measured over days 
CV was recorded over days 1-5. Conduction gradually increased over days 1-2 and typically peaked at 
days 3-4. This was a pattern followed by all the HL-1 clones but a time course for only clones 3 (n = 
3) and 6 (n = 4) is shown. At some of the points the error bars are too small to be seen. 
 
Using the stimulation parameters described in Figure 5.10 action potential propagation 
was measured in the HL-1 clones when paced at 1-2Hz. The maximum CV recorded 
between days 3-4 is shown in Figure 5.12. We were unable to electrically stimulate 
clone 2 although they displayed spontaneous field potentials. Thus the maximum CV in 
clone 2 was calculated from spontaneous electrical activity. CV in clone 2 was 
significantly different (p < 0.001) compared to the rest of the HL-1 clones.  
 
 
 
Figure 5.12: CV in the HL-1 clones 
For each of the HL-1 clones, cells were paced at 1-2Hz and maximum CV (mm/sec) was recorded 
over days 3-4. Clone 6 was the fastest propagating clone (41 ± 2mm/sec; n = 13) followed by clone 4 
(35 ± 7; n = 7), clone 3 (29 ± 3; n = 10), clone 1 (24 ± 2; n= 4) and 2 (4 ± 1; n = 6). CV from clones 1, 
3, 4 and 6 were compared only with clone 2 and velocities were significantly different (** p < 0.001).   
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5.4. Discussion 
The key findings in this chapter were: (1) MEA can be used to measure impulse 
propagation from spontaneously contracting and electrically stimulated cultures of the 
HL-1 clones; (2) optical mapping not only confirmed the CV measured by MEA but 
gave valuable information on the homogeneity of the propagated wavefront using 
optically recorded action potentials from multiple sites across the cell monolayer; (3) 
the natural pacemaker normally originated from the edge of the cell monolayer with 
sometimes more than one pacemaker present; (4) the HL-1 clones had an intrinsic 
frequency rate of 1-2.5Hz; (5) CV was dependent on the time in culture and the 
frequency at which cells were electrically stimulated and (6) the HL-1 clones displayed 
differences in CV particularly in clone 2. 
 
We started by optimising the cell seeding protocol for MEA analysis to ensure cell 
preparations not only produced a sufficient amount of electrical activity to be detected 
by the electrodes but also with a high signal to noise ratio. It was important to seed the 
cells as a confluent monolayer ensuring cells were well interconnected with no gaps 
within the preparation. Recordings of field potentials most suitable for measuring CV 
were obtained from cells covering only the electrodes compared to cells seeded over the 
entire MEA plate. Although in both approaches cells were seeded as a monolayer, it 
appeared that the larger the surface area the more likely it was for the cells to 
intrinsically pace at a higher frequency. This made it difficult to accurately measure CV. 
Studies exploring the relationship between frequency and the size of cell aggregates 
demonstrated that the rhythm and strength of beating is not only influenced by the 
initial beat rate but also by the size of the network (i.e. an increase in rate is observed as 
the cell aggregates increase) (Kojima et al. 2006). Hachiro et al. (2007) also 
demonstrated that beating rhythm in an aggregate of cells is dependent on the strength 
of coupling through gap junctions. It is also possible the larger the cell aggregate the 
more likely it is for the monolayer to accommodate more pacemakers thereby increasing 
the strength of beat rate (Kojima et al. 2006). Thus the larger the cell aggregate, the 
greater the cell-to-cell interaction, which could explain the higher frequencies, observed 
in the larger monolayer. 
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Cells seeded on top of the electrodes, had an intrinsic rate of electrical activity of 1-2Hz. 
However CV varied depending on the number and the volume in which cells were 
seeded. For example the same number of cells was seeded in a volume of 5l and 10l 
but CV were slower in the smaller volume despite no difference in connexin expression. 
It is possible that the 5l was insufficient to maintain the cells in a healthy state 
particularly as they were left to adhere to the MEA for a minimum of 20 minutes. The 
smaller volume could have also prevented the cells from spreading so forcing a more 
compact aggregate to be formed and reducing the cell size. Mathematical studies 
comparing adult and neonatal cells with their respective gap junction distribution 
demonstrated that cell size is a greater determining factor in CV than differences in gap 
junction distribution. Thus the larger the cell the lower the internal resistance 
(determined by cell size, cytoplasmic resistivity, gap junctions and their conductance) 
and the faster the conduction (Spach et al. 2001; 2004).  
 
Increasing the number of cells seeded also resulted in lower CV. This was supported by 
western blot data showing that at high densities connexin expression is reduced. 
Changes in connexin expression due to cell density have also been reported in 
endothelial cells with a decrease in both Cx43 mRNA and protein levels at high 
confluency (Larson et al. 1997). Since gap junctions are key determinants in controlling 
the passage of current between adjacent cells, changes in intercellular coupling will alter 
the velocity of the propagating action potential (Shaw and Rudy 1997; Rudy 2005). 
Computer modelling demonstrated that reducing the gap-junctional coupling decreases 
CV but also increases the SF by almost three times before a conduction block (Shaw 
and Rudy 1997; Rudy 2005). From this data correlating different seeding densities and 
CV there is a ‘threshold’ of the number of cells seeded whereby: (1) the cell aggregate 
is large enough to contract; (2) cells within the aggregate are of the right size to 
electrically communicate and (3) connexin expression is optimal. For future the exact 
number of cells required for seeding an MEA plate and for protein measurements would 
need to be calculated rather than expressing the values as a percentage of the cell 
density. 
 
Using the optimised seeding parameters CV were measured in spontaneously 
contracting cultures of clone 6 using MEA and optical mapping. No difference in 
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velocities were observed since both techniques are similar in function with the key 
difference being MEA records extracellular field potentials from a cell monolayer 
(Halbach et al. 2006) whereas optical mapping detects local changes in membrane 
potential (Rohr and Salzberg 1994). In the majority of recordings the natural pacemaker 
was observed at the edge of the monolayer formed by the initial seeding. Using MEA 
we were only able to approximate the origin of activation since the natural pacemaker 
was not always observed within the array but just outside the recording area. Optical 
mapping overcame this problem, as we were able to always visualise the entire 
monolayer and pin point the exact location of the pacemaker confirming that the origin 
of propagation was mainly from the edge of the monolayer. This is likely since the sink 
at the edge of the preparation is smaller for the source to serve as a charge for the 
depolarising neighbouring cells. Therefore the source is better matched to the load 
permitting a successful propagation (Rohr et al. 1997). 
 
Further analysis of the natural pacemaker location indicated there was sometimes more 
than one pacemaker present within the monolayer with even two pacemakers colliding. 
Groups of cells intrinsically contracting at different rates are expected to synchronise 
their pacing, forming a focal pacemaker providing a better current source for activation 
of the surrounding quiescent tissue (Kucera et al. 2000; Joyner et al. 2007). This process 
of synchronisation in which cells with greater intrinsic automaticity dominate the 
overall rate of contraction is determined by intercellular coupling (gap junctions) 
(Hachiro et al. 2007; Joyner et al. 2007). In cell aggregates with multiple pacemakers a 
single group may not be dominant enough to drive the preparation, which could explain 
a switch in pacemaker midway through a recording or even pacemakers colliding. 
 
The HL-1 clones had similar rates of intrinsic frequency (1-1.5Hz) with the exception of 
clone 1 (2.5Hz). Comparisons in the amount of mRNA for Ca
2+
 handling proteins (e.g. 
sodium-calcium exchanger (NCX) and L- and T-type Ca
2+
 channel) showed that only 
clone 2 displayed major differences with considerably reduced levels of messenger 
expression compared with the other clones. There also appears to be no direct 
correlation between the generation and frequency of spontaneous activity and the 
absolute steady state levels of transcript coding for these proteins in the HL-1 clones. It 
is likely that the proportion of protein expression for each ion channel or Ca
2+
 handling 
protein (e.g. spontaneous contracting rate dependent on ryanodine receptor function and 
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NCX activation) is likely to determine the frequency of spontaneous action potentials. 
Further experiments will need to be performed to study the exact mechanisms that 
determine the intrinsic frequency. 
 
In spontaneously contracting cultures the propagating action potential had a convex 
wavefront indicating a source-and-sink mismatch whereby the local excitatory current 
supplied by the source is distributed over a larger area (sink) (Fast and Kleber 1997). In 
tissue, the geometry of the wavefront (i.e. flat, convex or concave) is a determinant of 
CV and a mismatch between the current source and the current required for the cells to 
be activated can cause delay in propagation (Fast and Kleber 1997; de Bakker and van 
Rijen 2006). Any potential problems caused by the wavefront curvature were 
circumvented by linearly stimulating the preparation ensuring a near flat activation. We 
found that CV did not differ significantly when stimulated in different directions. In the 
heart anisotropy arises from the spatial alignment of elongated cardiac myocytes and the 
preferential location of gap junctions at the end of the cells producing a higher 
resistivity in the transverse direction compared with the longitudinal direction. As a 
result propagation is faster in the longitudinal direction than in the transverse direction 
(Fast et al. 1996). Other factors governing anisotropy include cell size and shape and the 
spatial distribution of neighbouring cells (Bursac et al. 2002). In our model anisotropy 
was eliminated since the cells do not have a structured shape and gap junctions were 
distributed along the cell perimeter of the cells rather than at the cell ends similar to 
neonatal ventricular myocytes (Bursac et al. 2002). 
 
The frequency of stimulation was a key factor when measuring CV whereby an increase 
in pacing negatively correlated with a drop in CV. After action potential generation the 
voltage-gated ion channels that are activated enter a inactivated state and to regain their 
ability to open, the channels must undergo a recovery process at hyperpolarised 
potentials (Grant 2009). Keeping this in mind increasing the frequency shortens the time 
intervals between action potentials. Shortening the action potential duration could 
potentially interfere with the relative refractory period, an interval during which a 
second action potential can be elicited if the stimulus strength is greater than usual 
(Widmaier et al. 2006). In this period not all the sodium (Na
+
) channels would have 
returned to their resting state and some of the potassium channels that repolarised the 
membrane are still open. As a result if stimulation does takes place during the relative 
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refractory period the action potential upstroke may not be as fast as when all the sodium 
channels were to be open thereby decreasing membrane excitability. 
 
CV increased with time in culture with maximum velocities recorded on days 3-4 post-
seeding. The gradual increase in CV over time could be due to cells needing time to 
recover from the process of trypsinisation. Contraction of the HL-1 cells depends very 
much on their developmental stage. Over time cells become more mature and the 
localised activation sites recruit more neighbouring cells with more cell-to-cell contact, 
which could affect CV. Usually after day 4, a decrease in CV was observed. This could 
be attributed by cell growth and cultures becoming too dense. We know that connexin 
expression levels are reduced by at least 50% when cells are overgrown thereby 
reducing the intercellular coupling between cells. It is also possible that cells become 
damaged over time. Studies on the original HL-1 cell line also reported an increase in 
cell degeneration with myolysis and membrane blebbing that steadily increased with 
time in culture (Hong et al. 2008). Effects of cell density on ion channel expression are 
not known and will also need to be tested in high and low density cultures to further 
explain these differences in CV over time. 
 
When comparing the maximum CV in the HL-1 clones, clone 2 displayed the largest 
difference with significantly lower CV with the other clones. To confirm the role gap 
junctions play in conduction, uncoupling agents such as palmotelic acid and 
carbenoxolone should be used and the CV measured (Rohr et al. 1997; Spray et al. 
2002). In this study only heptanol was applied to the cell preparations which resulted in 
a complete but reversible block in conduction (data not shown). It would also be useful 
to use the antiarrhythmetic peptides AAP10 and ZPP123 (for further details see Chapter 
1, section 5.5) on clone 2 to enhance gap junctional communication and measure its 
effects on CV (Clarke et al. 2006; Easton et al. 2009).  
 
In Chapter 3 we reported no difference in current density of the voltage-gated ion 
channels (Na
+
, L- and T-type Ca
2+
) and intracellular Ca
2+
 release in both clones 2 and 6 
although we did find differences in resting membrane potential with clone 2 exhibiting a 
more depolarised potential. The lack of action potential recordings from clone 2 could 
be attributed to cell density problems since the cells clearly displayed spontaneous field 
potentials from a confluent monolayer. In Chapter 4 differences in connexin expression 
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were observed with clone 2 expressing significant lower amounts of Cx40 and Cx43 
compared with clone 6. Since gap junctions are key contributors to the spread of charge 
in action potential propagation, RNA interference (RNAi) was used to study the role of 
connexin expression in clone 6. The next chapter describes the optimisation of the 
RNAi technique using short interfering RNA to knock-down connexin expression. 
 190 
CHAPTER 6. 
Applying RNA interference to knockdown connexin 
expression 
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6.1. Introduction 
RNA interference (RNAi) was employed to knockdown specifically the expression of 
connexins and establish their respective importance in action potential propagation. 
RNAi is a naturally occurring post-transcriptional gene silencing mechanism employed 
by the cell to mediate gene regulation. The pathway is triggered by small RNA 
molecules that cause either a translational block or degradation of mRNA homologous 
in sequence to the RNA molecules. Post-transcriptional gene silencing was originally 
observed in plants where it was termed ‘co-suppression’ (Napoli et al. 1990) and later 
correctly described by Fire et al. in 1998 in C. Elegans as homology-dependent gene 
silencing. Since then similar findings have been described in several organisms 
including fruit flies (Kennerdell and Carthew 1998), mice (Lewis et al. 2002) and 
human cells (Elbashir et al. 2001a). 
 
In animals and plants the two major classes of RNA molecules that regulate gene 
expression are: (1) short interfering RNA (siRNA) exogenously excised from long 
double-stranded (ds) RNA derived from foreign nucleic acids such as viruses and 
transposons functioning as part of the innate cellular defence mechanism (Carthew and 
Sontheimer 2009) and (2) microRNA (miRNA) which is non-coding RNA processed 
from stem-loop precursors transcribed in the nucleus to regulate endogenous gene 
expression (Filipowicz et al. 2008; Bartel 2009). Despite these differences in origin both 
processes require the cleavage of dsRNA by the ribonuclease III protein Dicer 
(Bernstein et al. 2001) producing RNA duplexes 21-23 nucleotides in length with 
dinucleotide overhangs at their 3’ end and monophosphate groups at their 5’ end 
(Zamore et al. 2000; Elbashir et al. 2001b). The 3’ overhangs in the RNA duplex 
provides a recognition site for the nuclease-containing multi-protein structure called the 
RNA induced silencing complex (RISC) (Hammond et al. 2000; Martinez and Tuschl 
2004). The RNA duplex enters the RISC assembly pathway through the unwinding of 
its ds by RNA helicase in an ATP-dependent step culminating in the stable association 
of one of the two strands with the Argonaute effector protein (Zamore et al. 2000; 
Nykanen et al. 2001). Strand selection is dictated by the relative thermodynamic 
stabilities of the two duplex ends (Carthew and Sontheimer 2009). This guide strand 
directs mRNA target recognition by Watson-Crick base pairing, whereas the other 
strand of the original small RNA duplex is discarded. In the final step siRNA guide 
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strands direct the RISC to (1) perfectly complementary RNA targets, which are then 
degraded by the RISC-associated endoribonulcease (Martinez et al. 2002b; Schwarz et 
al. 2004) or (2) mismatches between the siRNA/target duplex leading to the suppression 
of mRNA translation or exonucleolytic degradation. 
 
In mammalian cells, RNAi can be induced artificially by the introduction of synthetic ds 
siRNA molecules (21-23 nucleotides) the preferred approach for inducing RNAi in this 
study, long dsRNA (>30 nucleotides), or by transduction of plasmid or viral vector 
systems that express short hairpin RNA (shRNA) which are subsequently processed to 
siRNA by the cellular machinery. A schematic representation of the RNAi mechanism 
is illustrated in Figure 6.1. 
 
The rapid development of the RNAi technique has been enhanced by a more complete 
knowledge of gene sequences. However its application in mammalian cells has been 
hindered by an anti-viral interferon response triggered in the presence of long dsRNA 
molecules resulting in the cessation of all protein synthesis (Clemens and Elia 1997; 
Player and Torrence 1998). However Elbashir et al. demonstrated that the interferon 
response and the subsequent non-specific degradation of mRNA, was only triggered by 
dsRNA longer than 30 nucleotides and dsRNA of 19-21 nucleotides in length were 
sufficient for RNAi activity (Bass 2001; Elbashir et al. 2001a; Caplen 2002). 
Collectively these findings have enabled the application of RNAi in mammalian cells 
and its potential use in therapeutic treatments including malignant, infectious and 
autoimmune diseases (McManus and Sharp 2002; Lieberman et al. 2003; Sioud 2004). 
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Figure 6.1 Schematic representation of the RNAi pathway 
RNAi is a naturally occurring pathway that can be activated by: (1) siRNA produced in response to a 
virus; (2) miRNA to regulate gene expression and (3) artificially either by synthetic double-stranded 
(ds) siRNA molecules (19-21 nucleotides in length), long dsRNA molecules or through short hairpin 
RNA (shRNA) expressed in plasmid or viral vector systems. miRNA and shRNA are produced in the 
nucleus as hairpin structures which are then exported and processed into long dsRNA molecules. 
dsRNA are cleaved into 21-23 nucleotide long RNA molecules by the enzyme Dicer in an ATP-
dependent step. The processed siRNA is then incorporated into the RISC multi-protein complex which 
contains a helicase that unwinds the duplex. The single strands of the RNA the duplex are then able to 
guide the RISC complex to the target mRNA. In the final step selective gene silencing is achieved by 
one of two ways (1) the target mRNA is either degraded by the RISC-associated endoribonulcease or 
(2) repression of mRNA translation. 
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One of the main challenges in using RNAi as a tool to study gene function is the 
successful delivery of siRNA into cells. A variety of strategies have been developed for 
in vitro delivery of dsRNA either by transfection (e.g. electroporation and lipid-
mediated reagents) or through plasmid and viral vectors expressing shRNA (e.g. 
adenovirus and lentivirus). Each of the techniques has its benefits and drawbacks. 
Electroporation was the transfection method used in this study because it is a convenient 
and non-toxic delivery strategy of siRNA molecules into cells. It is also the method of 
choice for in vitro delivery of a large variety of molecules from ions to drugs, 
antibodies, cytokines and plasmid DNA and in vivo drug delivery to malignant tumours 
(Gehl 2003; Mir 2009). siRNA are small (21 nucleotides) and the molecules only need 
to be delivered into the cytoplasm to be active. Thus electroporation conditions can be 
less extreme, requiring lower voltages and shorter pulse durations. An alternative 
strategy is using lentiviral particles expressing shRNA that can now be purchased as 
transduction-ready viruses for a target gene in any mammalian cell type including 
primary and non-dividing cells. The benefits of using shRNA lentiviral particles include 
high transduction efficiency and the possibility of developing a stable expression of the 
shRNA while retaining high cell survival. Stable gene silencing for longer periods of 
time may also be advantageous if the target protein has a slow rate of turnover. A 
problem of this method is that integration of the transgene is random, so the silencing 
efficiency can vary considerably depending on the integration site. However this can be 
overcome by selection of the clones using an antibiotic resistance. 
 
Another important aspect for induction of successful RNAi is the effectiveness of the 
siRNA sequence against the mRNA target. With siRNA molecules being commercially 
available, some empirical rules for the basic structure of effective siRNA sequences 
have emerged (Reynolds et al. 2004; Luo and Chang 2004; Elbashir et al. 2002). Such 
guidelines have been taken into account in the development of siRNA design tools (i.e., 
algorithms) that are able to predict possible siRNA candidates for a target gene. Some 
of the rules include: (1) avoiding target regions where the mRNA can form a hairpin 
structure affecting siRNA accessibility; (2) selecting a target site in a gene that is only 
specific to its sequence; (3) low guanine-cytosine content (less than 50%) to reduce 
thermal stability and facilitate the unwinding and incorporation of the strands into RISC 
(Khvorova et al. 2003; Schwarz et al. 2004) and (4) keeping the length of dsRNA to 21-
23 nucleotides preventing an interferon response. 
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In this chapter we only discuss the optimisation for the connexin40 (Cx40) and Cx43 
siRNA sequences. As mentioned in Chapter 4 we were unable to detect Cx45 by 
western blot, therefore the effectiveness of Cx45 siRNA sequences were characterised 
functionally using microelectrode arrays (MEA). This will be discussed in greater detail 
in Chapter 7. Several preliminary steps were required before RNAi could be used 
reliably to specifically knockdown connexin expression. The first stage of my 
investigation was to optimise: (1) the siRNA transfection efficiency of the different 
siRNA sequences available; (2) electroporation parameters to ensure high transfection 
efficiency with minimal cell death; (3) the concentration of siRNA required to maintain 
gene silencing without causing cell toxicity and off-target effects and (4) the duration of 
the silencing effect. 
 
6.2. Materials and methods 
The HL-1 clones were cultured using the methods described in Chapter 2, section 2. 
Effects of RNAi on connexin protein expression were detected by western blot, as 
described in Chapter 2, section 5. Immunofluorescent labelling and confocal 
microscopy was used to assess the specificity of connexin down-regulation according to 
the methods described in Chapter 2, section 5. 
 
6.2.1. siRNA sequences 
Pre-designed siRNA sequences (Silencer® Select Pre-designed & Validated siRNA) 
were purchased from Ambion. siRNA sequences were designed by applying an 
algorithm optimized to produce highly specific and efficient siRNA molecules that 
cause minimal off-target effects. The sequences used were chemically synthesised, 
high-performance liquid chromatography-purified (>95% purity) in the form of 
annealed ds molecules ready for transfection. For Cx40 and Cx43 three different 
molecules targeting different locations of the respective mRNA sequence were tested 
for the best knockdown efficiency by western blot analysis. A range of siRNA 
concentrations (0.25-2µM) was also tested for the best down-regulation and for any 
non-specific effects on gene expression. A summary of the siRNA sequences tested in 
this study are listed in Table 6.1. 
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Table 6.1: List of Cx40 and Cx43 siRNA sequences tested 
 
The siRNA used in this study were pre-designed to be 21 nucleotides in length with the 
dinucleotide 3’ overhangs that can be incorporated directly into the RISC complex by-
passing the initial processing step involving the Dicer. Either of the two strands from 
the ds siRNA were able to guide the RISC to the target mRNA in a complementary 
driven fashion. Homology searches were performed with the basic local alignment 
search tool, BLAST (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi). The location where 
each of the above siRNA sequences binds Cx40 mRNA and Cx43 mRNA is shown by 
the highlighted numbers. 
Name Abbreviation Sequence 
Homology 
(%) 
 
Mouse 
Cx40-
siRNA 
 
A  
Cx40mRNA 1034             1052 
          |                 |     
       5'-GGCUUCAUCCACAUGCACUtt-3' 
     3'-ctCCGAAGUAGGUGUACGUGA-5' 
 
100 
 
B 
Cx40mRNA 3059              3077   
          |                 | 
       5'-GGAAAUACUAUGUUUGACUtt-3' 
     3'-ctCCUUUAUGAUACAAACUGA-5' 
 
100 
 
C 
Cx40mRNA 1108              1126 
          |                 | 
       5'-GGGCUACCAUAGUGACAAAtt-3' 
     3'-tcCCCGAUGGUAUCACUGUUU-5' 
 
100 
 
 
Mouse 
Cx43-
siRNA 
 
A  
Cx43mRNA 1126              1144 
          |                 |   
       5'-GCGCAGAGCAAAAUCGAAUtt-3' 
     3'-gtCGCGUCUCGUUUUAGCUUA-5' 
 
100 
 
B  
Cx43mRNA 1579              1597 
          |                 | 
       5'-GCUUAAAUUCUAGUAAGAGtt-3' 
     3'-ctCGAAUUUAAGAUCAUUCUC-5' 
 
100 
 
C  
Cx43mRNA 1106              1124 
          |                 | 
       5'-GCAAAACUGGGCGAAUUACtt-3' 
     3'-tgCGUUUUGACCCGCUUAAUG-5' 
 
100 
 
Rat 
Cx43-
siRNA 
 
Cx43mRNA 1046              1064 
          |                 | 
    5’–GCUGGUUACUGGUGACAGAtt-3’ 
     3’-ttCGACCAAUGACCACUGUCU-5’ 
94 
 197 
6.2.2. siRNA delivery 
Electroporation requires the application of a pulsed electrical field to induce the 
reversible breakdown of the lipid bilayer creating temporary pores (40-120nm in 
diameter) in the plasma membrane that re-seal within seconds (Neumann et al. 1982). 
This process permeabilises the host cells to a wide variety of molecules such as siRNA. 
For small molecules, diffusion alone may be sufficient for intracellular uptake 
(Neumann et al. 1998). In our study we used a capacitance to increase the pulse duration 
and provide an electrophoretic drive for the negatively charged siRNA to enter the cells. 
Although electroporation is a convenient and efficient method of delivery, cell viability 
is a crucial aspect and is dependent on the experimental conditions used (e.g. voltage 
parameter) and the parameters are specific for each cell type. Thus a range of 
electroporation conditions including the field strength (voltage) and pulse lengths 
(capacitance) were tested to ensure maximum transfection efficiency and cell recovery. 
 
Cells were cultured to sub-confluency in a 75cm
2
 flask (~8.5 x 10
6
 cells at confluency) 
and were no more than 4-5 days old. The cells were treated with trypsin, collected by 
centrifugation (130gmax, 5 minutes) and re-suspended in a volume of 1.2ml in serum 
free Claycomb medium (SFM) to give an approximate density of 2x10
6
 cells per 400µl 
SFM. siRNA molecules were purchased as a powder form of the dried oligonucelotides 
which were then re-suspended in nuclease-free water (in accordance to manufacturer’s 
instructions) to give a final concentration of 100µM. siRNA was gently mixed with the 
~2 x 10
6
 cells in a volume of 400µl (to give a final concentration of 0.25-2M 
depending on the experiment) in a sterile electroporation cuvette, where the two 
metallic plates are separated by 0.4cm and pulsed using an Electro Cell Manipulator 
630 (PrecisionPulse, Harvard Apparatus). During a single experiment all siRNA 
treatments were pulsed using the same electroporation cuvette to minimise any 
variability of the electrical field. Between siRNA treatments the cuvette was thoroughly 
rinsed with sterile distilled water to remove any remnant of siRNA and transfected cells 
from the previous electroporation. Although parameters for electroporation had been 
developed previously in our laboratory for smooth muscle cells, re-optimisation was 
necessary to maximise siRNA delivery and minimise cell death. Thus cells were 
subjected to a range of voltages and capacitance and the time constant () recorded after 
electroporation. The time constant is the length of time required for the voltage in the 
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circuit to fall exponentially (1/e) by approximately 63% of its initial value. The time 
constant is dependent on the volume in the electroporation cuvette and the conductivity 
of the medium. 
 
Following transfection, cells were removed from the cuvette by gentle pipetting and 
seeded in a 6-well plate. Cells were seeded at confluency since these cells are mildly 
‘contact-inhibited’ making them less likely to divide and prevent any dilution of the 
siRNA The medium was changed 3-4 hours post-seeding to remove any dead cells and 
cellular debris caused by the electroporation and incubated in an atmosphere of 5% CO2 
at 37ºC for a minimum of 48 hours to recover from electroporation injury. The effects 
of electroporation on cell morphology and survival rate were examined visually using a 
phase contrast microscope 24-48 hours post-seeding. siRNA knockdown was assessed 
by western blot procedure in cells harvested 48-72 hours post-transfection. 
 
6.3. Results 
6.3.1. Identification of siRNA sequences that effectively knockdown connexin 
expression  
Clone 6 was transfected with three different siRNA molecules (2M) for Cx40 and 
Cx43 and the best down-regulatory effects on connexin expression examined. The 
electroporation parameters (250V and a 25ms time constant) and the siRNA 
concentration used had been previously established in our laboratory (2M). A typical 
example of a western blot obtained from the same batch of cells exposed to different 
siRNA sequences is shown in Figure 6.2 (A). 
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Figure 6.2: Western blot analysis of the ability of different siRNA sequences to knockdown Cx40 
and Cx43 expression 
Cells were treated with three different siRNA sequences, A (Seq A), B and C (2M) for both Cx40 
and Cx43 (A). Knockdown efficiency was compared to the expression levels in the control sample 
(cells electroporated without siRNA) which was regarded as 100%. For Cx40, all three sequences used 
produced significant down-regulatory effects (n = 3; ** p < 0.001) in comparison to the control.  
Similar to Cx40, the three sequences used for Cx43 also resulted in significant protein knock down (n 
= 3; * p < 0.05; ** p < 0.001).  
 
All down-regulatory effects through siRNA were compared to connexin expression 
levels in the control sample, which were cells electroporated without siRNA. The 
immunoblots were quantified by densitometric scanning and a summary of the results 
obtained from the different siRNA sequences for Cx40 (n =3) and Cx43 (n = 3) is 
shown in Figure 6.2 (B). Although all the siRNA sequences used produced significant 
down-regulatory effects (p < 0.05), for the remainder of the investigation only 
sequences A were used for both Cx40 and Cx43 siRNA. 
 
6.3.2. Optimisation of siRNA down-regulation for Cx40 and Cx43 
The electroporation parameters used lead to approximately 50% cell death. To account 
for this, twice the number of cells normally required to seed a 6-well plate, were seeded 
to produce comparable densities to the seeding control. To optimise parameters for 
siRNA transfection and reduce cell death, a range of different voltages 200V-280V and 
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capacitances 100-1000μF were tested. Table 6.2 lists a summary of the key voltages and 
capacitances tested with their corresponding effects on cell death. 
 
Table 6.2: Range of pulse durations obtained with the varying capacitances 
 
Volume of cells 
used (µl) 
Voltage 
(V) 
Capacitance 
(µF) 
Time constant 
(ms) 
Cell death  
(%) 
400 250 1000 ~25 75 
400 200 1000 ~25 50 
400 280 400 ~10 50 
 
The images recorded 24-48 hours post-seeding demonstrated that voltage appeared to be 
a greater determinant on cell survival than the time constant, which is controlled by the 
size of the capacitance. We also found that cell death was exclusively caused by the 
electroporation procedure and not from the siRNA. As a result the voltage was reduced 
to 200V with the same time constant of 25ms. This not only reduced cell death (Figure 
6.3 (A)) but also the transfection efficiency of the siRNA (Figure 6.3 (B)). Thus voltage 
was a greater determinant of siRNA delivery than the capacitance but the disadvantage 
being more cell death (30-40% cell survival). Previous experiments have shown that 
reducing the time constant can also decrease cell death (data not shown). Therefore we 
chose to increase the voltage to 280V, to improve siRNA efficiency and decrease the 
time constant to ~10ms. When these values were used, maximum siRNA efficiency and 
minimum cell death were achieved (Figure 6.3 (B)). 
 
 201 
 
Figure 6.3: Optimisation of electroporation parameters 
Cells were electroporated at three different voltages (200V/250V/280V) and two different capacitances (1000 or 400µF per 400µl of cells). The phase contrast micrographs 
show the effects of the different electroporation parameters on cell death in comparison to the seeding control 24 hours post-transfection (A). The transfection efficiency of 
the different parameters for both Cx40 and Cx43 siRNA delivery was assessed by western blot technique 48 hours post-transfection (B). The electroporation parameters used 
and the time constant () obtained are indicated above the images for (A) and (B). The different siRNA treatments are also indicated above the immunoblots for (B). Results 
indicate that siRNA delivery was greatest and cell death was minimal at 280V and 400µF per 400µl of cells. 
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These results were not only reproducible within the same clone but the electroporation 
parameters could also be applied to a different clone such as clone 3 and achieve similar 
results in knockdown efficiency as shown in Figure 6.4. 
 
 
Figure 6.4: Cx40 and Cx43 knockdown in HL-1 clones 
Two different HL-1 clones were treated with Cx40 and Cx43 siRNA (2M) using the same optimised 
electroporation parameters. Clone numbers and the different treatments are indicated above the 
immunoblots. Controls were cells electroporated without siRNA. Efficiency of connexin knockdown 
was similar in both clones. 
 
To minimise any off-target effects and/or an interferon response from the siRNA it was 
important to use the lowest and most effective siRNA concentration. A range of 
concentrations from 0.25-2M were tested for Cx40 and Cx43 down-regulation in clone 
6 (Figure 6.5). Levels of Cx40 expression were reduced significantly at 2M (~60%). 
This knockdown effect gradually declined as the siRNA concentration decreased. A 
similar pattern was also observed for Cx43 siRNA with maximal effect shown at 1-2M 
(60-70%). Knockdown of either connexin did not appear to affect the expression of the 
co-expressed connexin. 
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Figure 6.5: Western blot of siRNA dose response for Cx40 and Cx43 siRNA 
Cells were treated with a range of siRNA concentrations for both Cx40 and Cx43 (0.25-2M). siRNA 
treatments were compared to the control of cells electroporated without siRNA. The specific siRNA 
treatment and the concentrations used are indicated above the immunoblots. Maximal effects of 
siRNA knockdown for both Cx40 and Cx43 were obtained at 2µM. Knockdown of either connexin 
had no effect on the co-expressing connexin. 
 
To visualise the effects of Cx40 and Cx43 siRNA and verify that knockdown of either 
connexin did not affect Cx45 expression, clone 6 was transfected simultaneously with 
Cx40 and Cx43 siRNA and analysed by immunofluorescence. Double labelling of Cx40 
and Cx43 showed that after siRNA treatment many of the cells lack Cx40 and Cx43 
compared to electroporated control (Figure 6.6 (A) and (B)). However a small 
proportion of the cells expressed low levels of Cx40 and Cx43 within the cytoplasm and 
junction indicating that the connexins had not yet been degraded or that some cells were 
not efficiently transfected. This also further demonstrates that the siRNA technique is a 
form of protein knockdown rather than a knockout. Figure 6.6 (C) demonstrated that in 
the presence of Cx40 and Cx43 siRNA, Cx45 was still detected at the protein level 
indicating the specificity of the siRNA technique. To show species specificity, cells 
(mouse cell line) were transfected with a rat Cx43 siRNA (one base mismatch with 
Cx40 mouse mRNA) that was effective in the rat epithelial cell line (RLE) (personal 
communication with Dr K. Grikscheit). The rat Cx43 siRNA had no effect on Cx43 
expression levels (data not shown). 
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Figure 6.6: Immunoconfocal analysis of Cx40 and Cx43 knockdown in clone 6 
Double labelling of Cx40 (red) and Cx43 (green) after electroporation (EP) (A) and treatment with 
Cx40 and Cx43 siRNA (2µm) (B). After siRNA treatment many of the cells lack Cx40 and Cx43 at 
the junction. Knockdown of either connexin did not affect Cx45 expression (C). 
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To assess the duration of connexin knockdown cells were treated with Cx40 and Cx43 
siRNA (2M) and evaluated at days 2 and 3. Western blot analysis for the time course 
of connexin suppression is presented in Figure 6.7 (A). Quantification of Cx40 and 
Cx43 siRNA over the two days (Figure 6.7 (B)) indicated that the siRNA mediated 
effects was most prominent on day 2 in contrast to day 3 but connexin suppression was 
still maintained at over 50%. 
 
 
Figure 6.7: Western blot analysis of Cx40 and Cx43 suppression over time 
Cells were electroporated with Cx40 and Cx43 siRNA (2M) and detected for both connexins at days 
2 and 3 post-transfection (n = 3) (A). siRNA was able to down-regulate both Cx40 and Cx43 by over 
60% in comparison to the seeding and electroporated controls at day 2 (B). Although connexin 
expression levels increased at day 3, knockdown of either connexin was still maintained at over 50% 
(B). 
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6.4. Discussion 
There are currently a range of techniques available to study connexin gene function 
including the transfection of cell lines (Halliday et al. 2003), the use of mutant 
constructs through molecular cloning (Joshi-Mukherjee et al. 2008) and cells from 
animal knockout studies (Beauchamp et al. 2004). In this investigation we have used 
RNAi to knockdown and study connexin(s) expression because of its specificity against 
a target gene. Before connexin function could be assessed, siRNA delivery and 
transfection efficiency needed to be optimised to give maximum protein suppression 
and minimum cell death. 
 
An important aspect for the activation of RNAi is the effectiveness of the siRNA 
sequence used against the target mRNA. Although Ambion guarantee that at least one 
of the three siRNA sequences purchased should knockdown either Cx40 or Cx43, their 
effectiveness in reducing protein expression still needed to be tested. We found that 
sequence B was most effective in reducing Cx40 expression and sequence A for Cx43 
and the electroporation procedure itself did not affect connexin expression. 
 
Previous studies in our laboratory have shown that siRNA delivery by chemical 
transfection caused a wide range of side effects depending on the cell type (Charolidi 
2008). This led us to explore the physical delivery method of electroporation. A key 
advantage of electroporation over other methods is that electropermeabilization is 
independent of the cell-cycle stage making it possible to deliver siRNA to non-dividing 
cells or slowly dividing cells (Ovcharenko et al. 2005). It also requires fewer pipetting 
steps thereby reducing variability of procedures and is more cost effective when 
compared with chemical transfection. 
 
The optimum electroporation parameters are generally specific for each cell type. The 
key parameters that influence electroporation efficiency are the voltage and the pulse-
length. From the range of voltages and capacitances tested, the optimum electroporation 
parameters for siRNA delivery in the HL-1 clones were a high voltage and low 
capacitance. We found that the voltage, which presumably determines the pore size and 
number of pores formed in the plasma membrane, was the more important parameter in 
determining the effectiveness of transfection. However an increase in voltage caused a 
significant decrease in cell survival. This negative effect on cell viability was minimised 
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by decreasing the pulse lengths (capacitance) of the electrical field. Both the size of the 
electrical field and the pulse length are also critical in ensuring cell recovery and 
membrane pore re-sealing. When the pores are open for a prolonged amount of time 
cellular toxicity may be increased by the influx of external medium (Bonnafous et al. 
1999). In extreme conditions, intracellular content may leak out due to osmotic 
swelling, leading to cell death (Gehl 2003). It is also important to ensure the parameters 
are not too extreme on the cellular structure since intact function of the cytoskeleton is 
important for pore closure (Teissie and Rols 1994). 
 
Reducing cell death was crucial to enable the transfected cells to be studied on MEA as 
part of the functionality study and allow a direct comparison with the siRNA treated 
cells prepared for western blot analysis. This aspect of the study will be discussed in 
greater detail in Chapter 7. To verify the voltage and time constant were optimal in 
siRNA delivery, two of the HL-1 clones were transfected with Cx40 and Cx43 siRNA 
and comparable results were obtained. These parameters were also used on the RLE cell 
line by a colleague in the laboratory (Grikscheit 2010) to reduce Cx43 expression. 
 
siRNA is highly specific, but its use at high concentrations may cause non-specific 
target effects (e.g. interferon response) or off-target effects that include any alterations 
of non-target genes (Shrey et al. 2009). It was also important to check for siRNA 
mediated toxicity since a potential disadvantage of electroporation is that it requires 
higher amounts of siRNA for successful gene silencing in comparison to chemical 
transfection (Ovcharenko et al. 2005). At all the siRNA concentrations tested (0.25-
2µM) knockdown of either Cx40 or Cx43 did not affect cell survival and the protein 
expression of the co-expressed connexin. Species specificity was demonstrated using a 
rat Cx43 siRNA that contained a single mismatch with the mouse Cx43 mRNA 
sequence demonstrating that 100% homology of the siRNA-target mRNA duplex is 
required to activate RNAi (Tuschl et al. 1999; Elbashir et al. 2001c). 
 
The effectiveness of siRNA is transient and is also dependent on the half-life of the 
target protein (Kurreck 2009). A pronounced inhibition of protein expression was 
observed within 48 hours post-transfection. The level of inhibition decreased at day 3 
but a significant level of down-regulation was still maintained. This may be expected 
since the half-life of connexins is short ranging from 1-5 hours (Laird 2006). A 
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reduction in the effectiveness of siRNA may also be caused by cell division. It was also 
important the duration of gene silencing was sustained over days 2 and 3 for MEA 
recordings, which was the primary technique used to study connexin function. 
 
In conclusion siRNA parameters were optimised in terms of: (1) siRNA sequences used 
for their best down-regulatory effects; (2) electroporation parameters to maximise 
siRNA transfection efficiency and minimise cell death and (3) siRNA concentration for 
best knockdown without causing any off-target effects. The next step was to apply 
siRNA in the clone 6 to study the role(s) of the individual connexins in relation to 
action potential propagation, which will be discussed in the following chapter. 
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CHAPTER 7. 
Functional effects of connexin suppression on action potential 
propagation 
 210 
7.1. Introduction 
In Chapter 5, it was shown using microelectrode arrays (MEA) that the HL-1 clones 
displayed different conduction velocities (CV) particularly clones 2 and 6, which also 
displayed significant differences in connexin expression. To examine the role played by 
each connexin and their various combinations in action potential propagation, we used 
RNA interference (RNAi) optimised and detailed in Chapter 6 to knockdown 
connexin(s) expression. Changes in CV caused by altered connexin expression levels 
were assessed by MEA. 
 
Gap junctions play a key role in mediating electrical coupling in the heart by permitting 
low resistance pathways for action potential propagation (Rohr 2004). Connexin43 
(Cx43) is the principal cardiac connexin expressed throughout the atrial and ventricular 
myocardium; Cx40 is typically expressed in atrial tissue and in the His bundle and 
Purkinje fibres; Cx45 is present in the sinoatrial and atrioventricular nodes and at very 
low levels in the ventricular myocardium where it co-localises with Cx43 (van Veen et 
al. 2001; Severs et al. 2008). The biochemical and electrical characteristics of gap 
junction channels depend on their constituent connexin subtypes. Cx40 forms channels 
with the highest conductance of 150-200pS followed by Cx43 with a conductance of 
60-120pS and Cx45 that forms low conductance channels of 22-39pS depending on the 
species and experimental conditions (van Veen et al. 2001). These properties confer 
distinctive passive electrical properties to specific regions of the heart (Vozzi et al. 
1999). 
 
Changes in cell-to-cell coupling through alterations in gap junction organisation and 
connexin expression contribute to abnormal impulse propagation as shown by 
theoretical modelling (Shaw and Rudy 1997; Spach et al. 2001) and in both human 
(Dupont et al. 2001b; Kanagaratnam et al. 2002) and animal knockout models (Gutstein 
et al. 2001a; Leaf et al. 2008; Bagwe et al. 2005). For example, patients with congestive 
heart failure have reduced levels of CX43 and increased heterogeneity of CX43 
expression. These changes in connexin expression would result in slow macroscopic 
conduction and inhomogeneous wavefront propagation increasing the susceptibility to 
arrhythmias (Dupont et al. 2001b; Yamada et al. 2003). Thus the precise relationship 
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between Cx40, Cx43 and Cx45 in action potential propagation is critical for 
understanding the role of connexin expression in arrhythmogenesis. 
 
Our goals in this study were to: (1) identify the most effective siRNA sequence in Cx45 
knockdown; (2) assess the role of Cx45, Cx40 and Cx43 in impulse propagation; (3) 
assess the effects of knocking down more than one connexin subtype (Cx40+Cx43; 
Cx40+45; Cx40+43+45; Cx40+Cx43+Cx45) and (4) quantify the relative amounts of 
Cx40 and Cx43 co-expressed at the junctional and non-junctional fractions after siRNA 
treatment. 
 
7.2. Methods 
The HL-1 clones were cultured using the methods described in Chapter 2, section 2. 
Small interfering RNA (siRNA) was delivered into cells by electroporation as described 
in Chapter 6, section 2. The functional consequences after siRNA treatment with Cx45, 
Cx40 and Cx43 were determined by MEA (Chapter 5, section 2). The siRNA data in 
this chapter were from electrically stimulated preparations of clone 6 at a frequency of 
1-2Hz. MEA recordings were performed 2-5 days post-transfection and only the 
maximum down-regulatory effects on CV were presented. A list of the Cx45 siRNA 
sequences used in this study is listed in Table 7.1. Effects of siRNA on the total, 
junctional and non-junctional connexin expression were detected by western blot 
(Chapter 2, section 5). 
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Table 7.1: List of Cx45 siRNA sequences used in this study 
 
Homology searches were performed with the basic local alignment search tool, BLAST 
(http://www.ncbi.nlm.nih.gov/blast/Blast.cgi). The location where each of the above 
siRNA sequences binds to Cx45 mRNA is shown by the highlighted numbers. siRNA 
sequences C and D overlap part of the mouse mRNA sequence by 6 base-pairs. 
 
7.3. Results 
7.3.1. Effects of Cx45 knockdown on Cx40 and Cx43 protein expression 
As described in Chapter 4, Cx45 was expressed at levels at least twenty times lower 
levels compared to Cx40 and Cx43 rendering it difficult to detect the protein by western 
blot. Because of this, five siRNA sequences targeting different regions of the Cx45 
mouse mRNA were used as there was no alternative way of checking and confirming 
that what we observed by MEA was only caused by Cx45 knockdown. Selection criteria 
for Cx45 siRNA were based on sequences that caused minimal interference with Cx40 
and Cx43 expression levels. Cells were electroporated with Cx45 siRNA using the 
Abbreviation Cx45 sequences 
Homology 
(%) 
A 
157777 
Cx45mRNA 1341             1359 
          |                 |     
       5'-CCAGAUCAGAUCCAGUACAtt-3' 
     3'-ctGGUCUAGUCUAGGUCAUGU-5' 
 
100 
 
B 
157775 
Cx45mRNA 922               941   
          |                 | 
       5'-GCCAACCAAAACCUAAGCAtt-3' 
     3'-ctCGGUUGGUUUUGGAUUCGU-5' 
 
100 
 
C 
61750 
Cx45mRNA 851               869 
          |                 | 
       5'-GGACCAUGAAGAGGAUCCUtt-3' 
     3'-tcCCUGGUACUUCUCCUAGGA-5' 
 
100 
 
D 
61834 
Cx45mRNA 863               881 
          |                 |   
       5'-GGAUCCUAUGAUGUAUCCAtt-3' 
     3'-gtCCUAGGAUACUACAUAGGA-5' 
 
100 
 
E 
61662 
Cx45mRNA 573               591 
          |                 | 
       5'-GGAGAGUCCAUCUACUAUGtt-3' 
     3'-ctCCUCUCAGGUAGAUGAUAC-5' 
 
100 
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optimised transfection parameters of 280V with a time constant of 10ms and scraped on 
day 2 post-transfection. The total expression levels for Cx40 and Cx43 were detected 
after Cx45 siRNA by western blot (Figure 7.1 (A)) and quantified using densitometric 
scanning (Figure 7.2 (B) and (C)). Expression levels of Cx40 and Cx43 in the control, 
which were cells electroporated without siRNA, were taken as 100%. Thus any effect 
observed after siRNA treatment was normalised to that level. After Cx45 siRNA, Cx40 
expression levels were either comparable to the control or greater, with a maximum 
increase of 30% observed with sequence A. Similarly following Cx43 siRNA treatment, 
protein levels were either similar to the control or slightly increased again with the 
maximum increase of 30% observed with sequence A. Although the total Cx40 and 
Cx43 expression was not greatly affected after Cx45 siRNA treatment we also tested for 
any alterations in the junctional and non-junctional fractions for Cx40 and Cx43 using 
two of the sequences (B and C) and no change was observed (data not shown). 
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Figure 7.1: Effects of Cx45 knockdown on Cx40 and Cx43 total protein expression 
Cx40 and Cx43 total protein levels were measured after treatment with Cx45 siRNA using five 
different sequences. Cx40 and Cx43 expression after siRNA treatment was normalised to the control 
sample (cells electroporated without siRNA) and was expressed as a percentage. Overall levels of 
Cx40 and Cx43 were either comparable to the control or increased by approximately 10-30% 
depending on the siRNA sequence used. Cx45 siRNA with sequences D and E were done separately to 
sequences A, B and C with their own controls to which levels of expression were compared to. For the 
purposes of illustration the immunoblots were cropped with sequences D and E added at the end. 
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7.3.2. Functional assessment of Cx45 knockdown using MEA 
Effects of Cx45 knockdown on action potential propagation were examined by MEA as 
shown in Figure 7.2. No significant difference (p = 0.31) was observed between the 
seeding (no electroporation) and electroporated (cells electroporated without siRNA) 
controls indicating that the electroporation procedure itself did not affect action 
potential propagation (seeding control: 41 ± 3mm/sec; electroporated only control: 37 ± 
2mm/sec; n = 8 and 6 respectively). All five sequences of Cx45 siRNA reduced CV 
significantly (p < 0.001) when compared to the electroporated control. On average 
propagation velocities decreased from 37 ± 2mm/sec; n = 6 in the electroporated control 
to 14 ± 6mm/sec; n = 3 in sequence A; 19 ± 2mm/sec; n = 3 in sequence B; 16 ± 
5mm/sec; n = 3 in sequence C; 12 ± 2mm/sec; n = 3 in sequence D and 14 ± 1mm/sec; n 
= 3 in sequence E. This significant reduction in CV (p < 0.001) by at least 50% was 
unexpected considering the low levels of Cx45 expression in clone 6. Although a strong 
reduction in CV was recorded with all five Cx45 siRNA sequences, only sequences B 
and C were used for the remainder of this chapter. 
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Figure 7.2: Effects of Cx45 knockdown on action potential propagation 
Cells from clone 6 were electroporated with five different siRNA molecules of Cx45 and effects on CV 
were recorded using MEA. CV were comparable between the seeding control (SC) and electroporated 
(EP) control that were cells electroporated without siRNA (SC: 41 ± 3mm/sec; EP: 37 ± 2mm/sec; p = 
0.31). After siRNA treatment all five Cx45 siRNA sequences (Seq) significantly reduced CV (** p < 
0.001) by at least 50% compared to both the electroporated control (sequence A: 14 ± 6mm/sec; n = 3; 
sequence B: 19 ± 2mm/sec; n = 3; sequence C: 16 ± 5mm/sec; n = 3; sequence D: 12 ± 2mm/sec; n = 
3; sequence E: 14 ± 1mm/sec; n = 3.  
 
7.3.3. Effects of Cx40, Cx43 and Cx45 knockdown on action potential propagation 
The most effective siRNA sequences used for Cx40 and Cx43 knockdown were 
established in Chapter 6. Using these sequences and those for Cx45 described in the 
section above CV were recorded over days 2-5 post-transfection. Results show an 
overall decrease in CV regardless of which connexin or combination of connexins was 
being used (Figure 7.3). When expression of either Cx40 or Cx43 was down-regulated, 
an approximately 30% reduction (p < 0.01) in CV was observed from the electroporated 
control (control: 37 ± 2mm/sec n = 6; Cx40 siRNA 24 ± 2mm/sec; n = 10; Cx43 
siRNA: 28 ± 2mm/sec; n = 8) (Figure 7.3 (A)). For Cx45 knockdown the average CV 
recorded from the five siRNA sequences tested showed a 50% reduction in CV (Cx45 
siRNA: 16 ± 2mm/sec; n = 3; p < 0.001). 
 
After assessing the respective importance of each connexin in impulse propagation, the 
next step was to use a combination of two or more connexin siRNA (Cx40+43; 
Cx40+45; Cx43+45 and Cx40+43+45) and measure CV following treatment (Figure 7.3 
(B)). Simultaneous knockdown of two connexins irrespective of the connexin subtype 
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resulted in CV being halved (control: 37 ± 2mm/sec; n = 6; Cx40+43 siRNA 21 ± 
2mm/sec; n = 3; Cx40+45 siRNA: 22 ± 1mm/sec; n = 3; Cx43+45 siRNA: 23 ± 
1mm/sec; n = 3; p < 0.001 using a one-way analysis of variance with Tukey’s multiple 
comparison test). Furthermore a reduction of Cx40, Cx43 and Cx45 at the same time 
also resulted in CV being halved with no add-on effect of all three connexins being 
suppressed (Cx40+43+45 siRNA: 23 ± 2mm/sec; n = 3; p < 0.001). When using Cx45 
siRNA, two different molecules (sequences B and C) were used to study the effects 
observed by MEA and an average of both these values are presented.  
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Figure 7.3: Effects of Cx40, Cx43 and Cx45 knockdown on action potential propagation 
Cells were transfected with siRNA for Cx40, Cx43, Cx45, Cx40+43, Cx40+45, Cx43+45 and 
simultaneous knockdown of the three connexins. Effects of siRNA treatment on CV were compared to 
the electroporated control. Knockdown of Cx40 or Cx43 resulted in a 30% drop in CV (control: 37 ± 
2mm/sec; n = 6; Cx40 siRNA 24 ± 2mm/sec; n = 10; Cx43 siRNA: 28 ± 2mm/sec; n = 8) and 
suppression of Cx45 reduced CV by approximately half (Cx45 siRNA: 16 ± 2mm/sec; n = 8) (A). 
Comparable results were obtained by simultaneous knockdown of Cx40+43, Cx40+45, Cx43+45 and 
Cx40+43+45 (Cx40+43 siRNA 21 ± 2mm/sec; n = 3; Cx40+45 siRNA: 22 ± 1mm/sec; n = 3; 
Cx43+45 siRNA: 23 ± 1mm/sec; n = 3; Cx40+43+45 siRNA: 23 ± 2mm/sec; n = 3) (B). The levels of 
significance are denoted above each sample (* p < 0.01; ** p < 0.001).  
 
7.3.4. Quantification of Cx40/Cx43 co-expression ratio after siRNA treatment 
To correlate the functional effects of CV with the levels of respective connexin 
expressed after siRNA treatment it was important to determine the levels of connexin 
expressed and to quantify the exact ratios of each co-expressed connexin. Effects of 
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altered Cx40/Cx43 co-expression ratios were examined only because Cx45 could not be 
detected by western blot. 
 
Figure 7.4 (A) shows western blot analysis of clone 6 after Cx40 and Cx43 siRNA 
treatment. Clone 6 was electroporated with siRNA and cells were extracted into their 
junctional and non-junctional fractions on day 2 post-transfection. Using the Cx40- and 
Cx43-V5tag described in Chapter 2 we were able to quantify the relative amount of 
Cx40 and Cx43 co-expressed by the cells. Effects of siRNA on protein levels were 
compared to both the seeding and electroporated controls. Blots show that in the control 
samples, Cx40 and Cx43 were expressed at comparable levels in the total, junctional 
and non-junctional fractions. After treatment with the respective siRNA, the total 
cellular expression (junctional + non-junctional) for Cx40 and Cx43 was significantly 
reduced by at least 50% (p < 0.05). No significant effect was observed in protein 
expression of the co-expressed connexin (p > 0.05). 
 
The relative amounts of Cx40 and Cx43 in the control and siRNA treated samples are 
shown in Figure 7.4 (B) and (C). Although the bands for total connexins were 
quantified, only data for the junctional and non-junctional connexins are shown since 
the signal intensities were equal to the sum of both the fractions. In the electroporated 
only sample, levels of Cx40 were 25% higher at the junction in comparison to the 
seeding control but was not considered to be significant (p = 0.07). All siRNA effects 
were compared with the electroporated control. After Cx40 siRNA treatment, the 
junctional and non-junctional levels of Cx40 were reduced significantly with a more 
pronounced knockdown in the junctional sample (p = 0.0011) demonstrating that 
knockdown of Cx40 is in fact greater than the values calculated for the cells as a whole. 
A similar pattern was also observed after Cx43 siRNA with a greater down-regulatory 
effect at the junction (p = 0.0019). Knockdown of either connexin had minimal effects 
on both the junctional and non-junctional expression levels of the co-expressed 
connexin (p > 0.05). A summary of the quantification data in Figure 7.3 (B) and (C) is 
presented in Table 7.2. 
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Figure 7.4: Quantification of Cx40/Cx43 co-expression after siRNA treatment 
Cells from clone 6 were treated with Cx40 and Cx43 siRNA (2M) and extracted into their junctional 
(J) and non-junctional fractions (NJ) on day 2 post-transfection and analysed by western blot (A). Total 
(T) samples were prepared by mixing equal volumes of the junctional and non-junctional fractions. 
Control samples included the seeding control (SC) and cells electroporated (EP) without siRNA. 
Treatment with Cx40 and Cx43 siRNA resulted in reduced levels of expression of their respective 
protein. Effects of siRNA were a significantly greater at the junctional fraction compared to the non-
junctional fraction (Cx40 siRNA: p = 0.0011; Cx43 siRNA: p = 0.0019). Knockdown on either 
connexin did not affect the expression of the co-expressed connexin (p > 0.05 using an unpaired t test).  
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Table 7.2: Cx40 and Cx43 expression levels in the junctional and non-junctional fractions after 
siRNA treatment 
  
Samples 
Cx40 arbitrary units; n = 4 Cx43 arbitrary units; n = 4 
Junctional Non-junctional Junctional Non-junctional 
Seeding control 88 ± 11 86 ± 27 91± 4 80± 17 
Electroporated control 120 ± 13 80 ± 21 84 ± 11 73 ± 17 
Cx40 siRNA 39 ± 5 40 ± 16 75 ± 2 60 ± 17 
Cx43 siRNA 100 ± 15 96 ± 25 30 ± 3 39 ± 7 
Cx40 + 43 siRNA 34 ± 1 57 ± 19 27 ± 3 44 ± 10 
 
Similar analysis by western blot was performed on cells treated with the simultaneous 
knockdown of Cx40 and Cx43 as shown in Figure 7.5 (A). Effects of Cx40 and Cx43 
knockdown in the total, junctional and non-junctional fractions were compared with 
similar fractions from the electroporated cells. Reduction of both connexins was 
significantly greater (p < 0.005) at the junctional membrane similar to that observed 
after Cx40 and Cx43 siRNA treatment. These data for simultaneous knockdown are 
presented in Table 7.2. 
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Figure 7.5: Western blot analysis data of simultaneous knockdown of Cx40 and Cx43 
Clone 6 was electroporated with Cx40 and Cx43 simultaneously and scraped on day 2 post-
transfection. The total (T), junctional (J) and non-junctional (NJ) fractions were analysed and siRNA 
effects were compared to electroporated (EP) control (A). Knockdown of both connexins resulted in 
approximately 60-70% reduction in Cx40 and Cx43 expression. It should be noted that reduction in 
connexin expression was significantly greater in the junctional fraction (B) than the non-junctional 
fraction (p < 0.005) (B). 
 
After establishing the relative amounts of connexin expressed in the control samples 
(seeding and electroporated only) and after siRNA treatment the Cx40/Cx43 co-
expression ratios was calculated based on the quantification values presented in Table 
7.2. In the control samples the Cx40/Cx43 co-expression ratio was approximately 1:1 at 
the junctional and non-junctional fractions (Figure 7.5). After Cx40 siRNA the ratio 
decreased due to the lower levels of Cx40 expressed although the ratio was slightly 
higher in the non-junctional fraction reflecting the greater proportion of Cx40 
knockdown in the junctional fraction. The opposite effect was seen after Cx43 siRNA 
where Cx43 levels were considerably reduced. No change was observed in the ratio of 
Cx40/Cx43 when Cx40 and Cx43 were simultaneously reduced (Figure 7.6). A 
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summary of the co-expression ratios in the control and siRNA treated samples are 
presented in Table 7.3. 
 
 
Figure 7.6: Co-expression ratios of Cx40/Cx43 after Cx40 and Cx43 siRNA treatment  
Cx40/Cx43 co-expression ratios were calculated in the control samples and after siRNA treatment in 
the junctional (A) and non-junctional (B) fractions. The electroporated (EP) sample had a slightly 
higher ratio of Cx40 and Cx43 compared with the seeding control. Co-expression ratios decreased 
when Cx40 was reduced and vice versa when Cx43 was decreased. Simultaneous knockdown of both 
connexins did not alter the co-expression ratio. All data were expressed as arbitrary units (au). 
 
Table 7.3: Cx40/Cx43 co-expression ratio in the junctional and non-junctional fractions 
  
Samples 
Cx40/Cx43 co-expression ration arbitrary units; n = 4 
Junctional Non-junctional 
Seeding control 1.08 ± 0.03 1.13 ± 0.12 
Electroporation only 1.52 ± 0.03 1.07 ± 0.03 
Cx40 siRNA 0.52 ± 0.06 0.68 ± 0.13 
Cx43 siRNA 2.4 ± 0.34 2.4 ± 0.33 
Cx40 + 43 siRNA 1.28 ± 0.14 1.35 ± 0.12 
 
7.4. Discussion 
Changes in gap junction organisation and connexin expression can result in disturbances 
of the normal cardiac rhythm. In this study we have assessed the effects of changing 
Cx40, Cx43 and Cx45 expression levels on the CV in cardiac myocytes using RNAi to 
knockdown connexin(s) expression. The major findings were: (1) knockdown of Cx45 
produced a decrease in CV by approximately 50% with little or no effect on Cx40 and 
Cx43 protein expression; (2) knockdown of Cx40 or Cx43 resulted in an approximately 
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30% reduction in CV; (3) knockdown of two or all three connexins reduced CV by 40-
50% and (4) depending on the siRNA treatment the reduced CV approximately 
corresponded to alterations in Cx40 and Cx43 protein levels at the membrane. 
 
We began our investigation by identifying the most effective siRNA sequence for Cx45 
since this had already been established for Cx40 and Cx43 in Chapter 6. As described in 
Chapter 4, Cx45 expression levels were too low to be detected by western blot. Thus to 
select the most appropriate siRNA for Cx45 knockdown we chose sequences that 
showed no interference with Cx40 and Cx43 total expression levels indicating 
specificity. Only one of the five siRNA used resulted in an increase of Cx40 and Cx43 
expression with minimal effects caused by other sequences. This led us to functionally 
assess the effects of Cx45 suppression by MEA. All five sequences tested resulted in a 
50% reduction of CV. From the BLAST homology searches (Table 7.2) we knew that 
these effects were not caused by siRNA sequences targeting the same region of the 
mouse Cx45 mRNA and are a result of true Cx45 knockdown. The findings of 
decreased CV caused by Cx45 siRNA were unexpected considering its mRNA was 
detected in low abundance comparable to studies in the human (Vozzi et al. 1999), 
neonatal mouse hearts (Lin et al. 2010) and the northern blot data presented in Chapter 
4. Cx45 also has the lowest current-carrying capacity compared with Cx40 or Cx43 
with a single channel conductance of approximately 33pS (Moreno et al. 1995; Elenes 
et al. 2001; Beauchamp et al. 2004). However when Cx45 was detected by 
immunofluorescence expression levels was homogenous across the cell monolayer 
albeit at low levels. 
 
The majority of experimental data investigating the role Cx45 in cardiac development 
and conduction comes from transgenic animal models. Cx45 knockout studies resulted 
in death at embryonic day 10 from endocardial cushion defects and contractile failure 
(Alcolea et al. 1999; Kruger et al. 2000; Kumai et al. 2000) indicating the critical role of 
Cx45 in cardiac development and differentiation. Cx45 deletion could potentially have a 
variety of down-stream targets, which in turn could affect impulse propagation. For 
example immunofluorescence of cryosections through the atrioventricular canal 
revealed that the sub-cellular translocalisation from the cytoplasm to the nucleus of Ca
2+
 
dependent transcription factor NF-ATc1 was significantly reduced in Cx45 deleted mice 
at embryonic day 10. This translocation process of NF-ATc1 requires a rise in 
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intracellular Ca
2+
 for phosphatase activity of calcineurin. The dephosphorylation of NF-
ATc1 by calcineurin in the cytoplasm enables it to enter the nucleus and bind to DNA 
and other factors (Kumai et al. 2000). Accordingly it can be assumed that Cx45 plays a 
crucial role in the activation of Ca
2+
 dependent transcription factors in early 
cardiogenesis (Kumai et al. 2000). Although the precise mechanism of Cx45 function is 
unclear, these studies have highlighted the importance of Cx45 in cardiac 
morphogenesis and function. 
 
Due to the embryonic lethality of Cx45 deletion, studies on mice that were deficient in 
Cx40 and lacked one allele of Cx45 were used to further deduce the functions of Cx45 
beyond embryonic day 10 although only 15% of the mice survived to adulthood (Kruger 
et al. 2006). Subsequent electrocardiograms (ECG) of these mice revealed a significant 
prolongation of the PQ interval and QRS duration compared to mice with the Cx40 
deletion only in the presence of normal Cx45 levels (Kruger et al. 2006). This supports 
the present findings that even the loss of one allele for Cx45 can slow conduction 
considerably and aggravate the cardiovascular abnormalities of Cx40 deficient mice. 
Despite its low levels of expression, Cx45 appears critical in impulse propagation. 
 
Suppression of Cx45 had very little effect on Cx40 and Cx43 expression levels 
particularly at the junction so effects on CV could not be readily explained by this 
mechanism. However immunofluorescence data from the triple labelling of Cx40, Cx43 
and Cx45 (Chapter 4, section 3) illustrated that all three connexins co-localise at the 
same cell-to-cell interface. There is also substantial evidence from biochemical and 
electrophysiological data that Cx45 can freely dock with Cx40 or Cx43 to form 
heterotypic channels with unique biophysical properties (Koval et al. 1995; Desplantez 
et al. 2004; Rackauskas et al. 2007a). In our laboratory co-culture studies of the rat liver 
epithelial cell model induced to express Cx45 revealed strong immunolabelling between 
cells expressing Cx43 only and those expressing Cx43 and Cx45 indicating 
compatibility (Thomas 2007). From this information we could speculate that the loss of 
Cx45 could have a modulatory effect on the formation of gap junction channels 
composed of Cx40 and Cx43 as these connexins do not appear to be functionally 
compatible with each other (White et al. 1995; Haubrich et al. 1996; Rackauskas et al. 
2007a). Cx45 could play a similar role to Cx46 in the lens which is required if 
heterotypic channels are to be formed between Cx50 and Cx43 (White et al. 1994). 
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Through this mechanism the loss of Cx45 could alter the type of connexins constituting 
the gap junction channels and thereby intercellular coupling between cells. As a result, 
effects of Cx45 may be considerably greater than its low level of expression would 
suggest. Further experiments by dual voltage patch-clamp measuring the macroscopic 
and single channel conductance will be required to determine the exact properties of gap 
junction channels that remain after Cx45 siRNA. 
 
Suppression of Cx40 resulted in a 30% reduction in CV. Quantification after Cx40 
siRNA revealed that Cx40 was reduced by approximately 70% and this knockdown was 
more pronounced at the junction with a lesser effect in the non-junctional fraction. After 
Cx40 siRNA there were minimal effects on Cx43 expression in both the junctional and 
non-junctional fractions. The Cx40/Cx43 co-expression ratio also decreased by 
approximately 50%. We were unable to quantity Cx45 levels but protein expression was 
still detected by immunofluorescence after Cx40 siRNA (Chapter 6, section 3). 
 
The decrease in CV after Cx40 suppression is consistent with findings from Cx40 
homozygous knockout mice (Kirchhoff et al. 1998). ECG studies on these mice 
revealed prolonged P wave duration, PQ interval and QRS duration (Kirchhoff et al. 
1998; Simon et al. 1998; Hagendorff et al. 1999; Schrickel et al. 2009). Impulse 
propagation studied by transesophageal atrial stimulation in Cx40 knockout
 
studies also 
revealed a number of conduction abnormalities in sinoatrial, intra-atrial, atrioventricular 
and His-Purkinje conduction including an increased susceptibility for re-entrant 
arrhythmias (Hagendorff et al. 1999; Tamaddon et al. 2000). Verheule et al. (1999) 
showed that in Cx40 knockout
 
mice a 30% decrease in CV in the right atrium produced 
no signifiant effect on ventricular conduction highlighting the importance of Cx40 in 
atrial conduction. Supportive results were also obtained by Bagwe et al. (2005). The 
ablation of Cx40 can also lead to developmental malformations which need to be taken 
into account as inclusion of these animals could influence analysis of conduction (Gu et 
al. 2003; Leaf et al. 2008). 
 
Beauchamp et al. (2006) reported an increase in CV in Cx40 ablated atrial cell strands 
from neonatal cardiac myocytes. The group also observed a 2.4 fold increase in the 
Cx43 signal at the junctional membrane although there was no change in the total Cx43 
expression. This property of increase in Cx43 at the junctional membrane may decline 
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during growth and development as it was absent in adult Cx40 knockout
 
atria in the 
same study (Beauchamp et al. 2006). Results from patients undergoing coronary artery 
surgery also showed a strong correlation between high levels of CX40 immunosignal 
and decreased CV during sinus rhythm (Kanagaratnam et al. 2002). Differences in 
results could be due to the experimental methods used. Connexin quantification by 
Kanagaratnam et al. (2002) was based on the antibody specificity which can be affected 
by the topological arrangement and steric hindrance of co-expressed connexins. 
Problems with steric hindrance were also reported by Grikscheit et al. (2008) where 
measurements of gap junction size differed with the antibody used. In this study it is 
clearly demonstrated that knockdown of Cx40 has little or no effect on Cx43 
expression, particularly at the junctional membrane. This indicated that the decrease in 
CV is a true effect of reduced Cx40 levels. 
 
Cx43 siRNA resulted in an approximate 70% knockdown of Cx43 protein expression 
with a 30% reduction in CV. Similar to Cx40, Cx43 suppression was more pronounced 
at the gap junction plaque and no effect on Cx40 expression was observed in both the 
junctional and non-junctional fractions. These findings of higher Cx40 and Cx43 levels 
in the non-junctional fraction may suggest that connexin trafficking and degradation are 
regulated by the amount of the non-junctional connexins. Studies by VanSlyke et al. 
(2009) hypothesised that connexin trafficking is a concentration-driven process in 
which a certain non-junctional level is necessary to obtain successful oligomerisation 
and transport to the plasma membrane. 
 
The significance of reduced levels of Cx43 has been well illustrated in transgenic 
models. Knockout mice of Cx43 resulted in mice surviving to term but dying shortly 
after birth due to obstruction of the right ventricular outflow tract (Reaume et al. 1995). 
The development of cardiac-restricted conditional knockout Cx43 circumvented these 
problems enabling the role of Cx43 in cardiac conduction to be assessed (Gutstein et al. 
2001a). Despite a normally formed heart, conditional knockout mice demonstrated 
marked reduction of ventricular CV with the development of spontaneous ventricular 
arrhythmias and sudden cardiac death by two months of age (Gutstein et al. 2001a). 
These studies demonstrated that there is no essential requirement for Cx43 during 
cardiac development but it is required for maintaining cardiac electrical stability in the 
more mature ventricle (Gutstein et al. 2001a). In mice where cardiac specific Cx43 is 
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ablated progressively during postnatal development, Cx43 expression levels were 
reduced finally to 20% whereupon there was a significant slowing of CV to half of that 
observed in control hearts (Danik et al. 2004). There are conflicting data on conduction 
properties in heterozygous Cx43 mice. Some studies report conduction slowing 
(Guerrero et al. 1997; Thomas et al. 1998) whereas others find no electrophysiological 
differences compared with wild type hearts (Morley et al. 1999). Discrepancies in 
results could be due to different methodologies or other factors such as phosphorylation 
which plays a key role in regulating intercellular communication (Kwak and Jongsma 
1996; Ai et al. 2010). 
 
In cultured myocytes isolated from rabbit left ventricles, Cx43 levels were reduced to 
those observed in heart failure (up to 70% knockdown) using siRNA (Ai et al. 2010). 
This reduction produced a significant decrease in intercellular dye coupling. 
Correspondingly, in parallel studies overexpression of these connexins improved dye 
coupling. This work by Ai et al. (2010) most importantly illustrated that even moderate 
changes in Cx43 protein (~40%) can contribute to impaired intercellular coupling in the 
failing heart contradictory to previous studies suggesting that at least 80-90% of 
uncoupling had to occur to affect CV (Danik et al. 2004; Peters 2006). Studies on Cx43 
deleted atrial strands reported a 40% drop in CV comparable to our results obtained by 
siRNA (Beauchamp et al. 2006).  
 
The expression levels of a large number of genes have been shown to be modified in 
Cx43 heterozygous and null mice (Iacobas et al. 2005). The loss of Cx43 in both 
homozygous and heterozygous knockout mice lead to a variety of electrophysiological 
alterations including a higher potassium (K
+
) current density, shorter action potential 
(Danik et al. 2008; Kontogeorgis et al. 2008) and faster upstroke velocity (dV/dtmax) 
(Beauchamp et al. 2004). This electrical remodelling may be a compensatory response 
of the myocytes, which could subsequently contribute to the conduction delays 
observed. In this work we could exclude effects of compensation of other connexins 
particularly at the junctional membrane. No difference in the shape and size of the 
extracellular field potentials were observed with or without siRNA indicating that the 
changes in CV are a gap-junction-mediated effect. However measurements of the 
dV/dtmax with and without siRNA will need to be performed to confirm this. 
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The mechanism underlying the decreased CV following Cx40 and Cx43 siRNA 
treatment is most likely due to reduced intercellular coupling and gap-junctional 
conductance rather than through the formation of heterotypic-heteromeric channels. 
Evidence for decreased gap-junctional conductance in hearts lacking Cx43 has come 
from numerous studies (Beauchamp et al. 2004; Vink et al. 2004; Yao et al. 2003). For 
example Beauchamp et al. (2004) reported a 96% reduction in conductance in 
ventricular strands from Cx43 knockout mice which corresponded to a 97% drop in CV. 
Further experiments on clone 6 will need to be performed by dual cell patch-clamp to 
assess the total gap-junctional conductance after siRNA and if coupling is influenced by 
the formation of Cx40-Cx43 heterotypic channels. 
 
After Cx40 and Cx43 siRNA treatment CV decreased by approximately 30% but this 
effect was slightly greater following the reduction of Cx40 compared with Cx43. 
Channels composed of Cx40 have a higher unitary conductance ranging from 150-
200pS in comparison to those composed of Cx43 which ranges from 60-120pS (Gros 
and Jongsma 1996). These differences in unitary conductance could explain why Cx40 
channels may conduct action potentials more rapidly than cells connected by Cx43 
channels (Kirchhoff et al. 1998). 
 
Simultaneous knockdown of two and all three connexins resulted in CV being halved. 
We were only able to quantify protein expression after the simultaneous knockdown of 
Cx40 and Cx43. Reduction of Cx40 and Cx43 was achieved to similar levels with no 
difference in the Cx40/Cx43 co-expression ratio. No additive effect on CV was 
observed after Cx45 and Cx40, Cx45 and Cx40 and all three connexins. Results also 
indicate that the loss of Cx45 was equal to that of both Cx40 and Cx43 knockdown. 
When levels of all three connexins were reduced, action potential propagation was still 
maintained albeit at considerably reduced levels compared to the controls. 
 
The lack of additive effects on propagation following the loss of two or more connexins 
could be explained by the siRNA not completely suppressing the expression of the 
connexin gene. The residual 20-30% remaining after knockdown is still functional. 
Theoretical models have demonstrated that reduced coupling can cause large reductions 
in velocity before conduction block is observed. Shaw and Rudy (1997) have shown 
that markedly slowed CV can still be maintained with reduced gap junction coupling 
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through an increase in the safety factor greater than during normal conduction. This 
suggests that after siRNA treatment cells must remain coupled though low-level 
expression of gap junction channels composed of Cx40, Cx43 and Cx45 thereby 
maintaining propagation. siRNA could also be utilised to assess the individual roles of 
each connexin in the various diseased states. For instance reduced levels of CX43 
expression have been consistently reported in patients with heart failure which are 
thought to increase the susceptibility to arrhythmias as shown in the transgenic animal 
models ((Chapter 1, section 5.4).  In addition it would be useful to study the effects of 
siRNA with optical mapping which provides a higher spatial resolution compared with 
the MEA to analyse differences in the pattern of excitation and propagation.  
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CHAPTER 8. 
General discussion 
 232 
8.1. Introduction 
In the concluding chapter of my thesis I would like to summarise the principal findings 
of my project, discuss ideas emerging from them and suggest future developments. 
 
8.2. Overview of key findings 
The aim of my study was to investigate the influence of connexin expression/co-
expression levels on action potential propagation using the HL-1 cell line. Because the 
cells were tumour-derived, they were heterogeneous in population containing cells 
blocked at various developmental stages (Trosko et al. 1993). To obtain more 
homogenous cell lines, clones were selected from low density HL-1 cultures on their 
ability to contract and therefore, possess some functional excitation-contraction 
coupling. Homogeneity was essential in correlating a change in function with molecular 
intervention and exclude differences due to a heterogeneous cell line. To study action 
potential propagation the clones had to fulfil two main criteria: (1) the expression of ion 
channels necessary to generate action potentials and (2) the expression of gap junctions 
that form cell-to-cell pathways for the propagation of current flow in the heart. 
 
We demonstrated that the HL-1 clones expressed the major Ca
2+
 handling proteins and 
displayed spontaneous intracellular Ca
2+
 transients [Ca
2+
]i. Functional expression of the 
major cardiac ion channels involved in excitation (sodium (Na
+
), L and T-type Ca
2+
) 
were studied in clones 2 and 6. No difference in current densities were observed despite 
major differences in mRNA channel expression indicating differences in post-
transcriptional regulation between the two clones. Cells in clone 2 displayed a more 
depolarised membrane potential than clone 6. Action potentials were always recorded 
from clone 6 but were rare in clone 2. This was most likely due to differences in cell 
culture density since patch-clamp experiments required the cells to be isolated and the 
development of spontaneous contraction in the HL-1 cells is dependent on the 
development stage of the culture (Claycomb et al. 1998). Spontaneous electrical activity 
and contraction suggested the existence of some form of pacemaking in the cells. 
Hyperpolarisation-activated ‘funny’ current (If) was present in clone 6 but not in clone 2 
suggesting that in this clone other currents could contribute to action potential 
generation such as [Ca
2+
]i (Lakatta et al. 2003). 
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All the HL-1 clones expressed connexin40 (Cx40), Cx43 and Cx45 at varying levels 
with significantly lower amounts present in clone 2. There was a good correlation 
between the level of mRNA and the corresponding connexin expression indicating that 
regulation was predominantly at the transcriptional level. Using the Cx40- and Cx43-
V5tag and -tag developed in our laboratory, Cx40/Cx43 co-expression was quantified 
with a ratio of approximately 1:1. Despite Cx45 being expressed at a level that was least 
twenty times lower than Cx40 and Cx43, immunoconfocal analysis revealed that 
expression was relatively homogenous. After triple labelling, a clear difference was 
observed in the distribution of each connexin at each cell-to-cell interface. Differences 
in connexin co-localisation were attributed to incompatibilities between connexons 
particularly between Cx40 and Cx43 to form heterotypic channels (Bruzzone et al. 
1993; Haubrich et al. 1996). Evidence for a substantial amount of interaction between 
Cx40 and Cx43 was found in similar amounts in both clone 6 and human atrial tissue 
but the levels of heteromerisation were a lot lower than theoretically calculated (Brink 
et al. 1997). In the healthy and diseased heart connexins also interact with various 
partner proteins that influence the size and organisation of gap junctions (Hunter et al. 
2005; Bruce et al. 2008). Zonula occludens-1 (ZO-1) was shown to co-localise with all 
three connexins by immunofluorescence and co-immunoprecipitation experiments 
provided further evidence of interactions with Cx40 and Cx43 as expected for a cell of 
myocyte origin. 
 
Action potential propagation was recorded in the HL-1 clones including clone 2 using 
microelectrode arrays (MEA). The clones displayed differences in conduction velocities 
(CV) with clone 6 producing the fastest propagation across a monolayer. The natural 
pacemaker came from the edge of the preparation most likely due to source-and-sink 
factors (Rohr et al. 1997). Further analysis indicated there was sometimes more than 
one pacemaker present within the monolayer. Optical mapping confirmed the 
observations made with MEA and gave further details on action potential amplitude and 
duration at multiple sites on a monolayer revealing homogenous impulse propagation. 
 
To deduce the role of gap junction expression on impulse propagation, RNA 
interference (RNAi) with small interfering RNA (siRNA) was used in clone 6 to 
knockdown connexin expression. Cells were electroporated with siRNA for Cx40, Cx43 
and Cx45 and expression was down-regulated by approximately 60-70%. Cx45 could 
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not be detected by western blot so siRNA effects were assessed using MEA. 
Knockdown of Cx40 and Cx43 resulted in an approximately 30% reduction in CV. All 
the siRNA sequences used to reduce Cx45 levels resulted in a 50% reduction in CV. 
Double (Cx40 + Cx43, Cx40 + Cx45, Cx43 + Cx45) and triple (Cx40 + Cx43 + Cx45) 
siRNA also resulted in CV being halved. These results indicate that although gap 
junctions play a key role in conduction, synergism between membrane excitability (e.g. 
Na
+
 channels) and intercellular coupling are likely to govern CV (Shaw and Rudy 1997; 
van Veen et al. 2005). 
 
8.3. Relevance of connexin co-expression in the heart 
As discussed in the introduction Cx40, Cx43 and Cx45 are co-expressed in the heart in 
characteristic combinations in a chamber related, myocyte type-specific and 
developmentally-regulated manner (Vozzi et al. 1999; Severs et al. 2004a). This opens 
the possibility for a wide range of different molecular stoichiometries (Cottrell and Burt 
2005). However it is still unclear how the different stoichiometries translate into 
different electrophysiological properties in vivo.  
 
So far the functional properties of connexin co-expression in the intact heart have been 
extrapolated from in vitro cell models and transgenic animals. For example pairing of a 
Cx40 connexon with a Cx45 connexon showed asymmetrical voltage dependence, a 
property associated with rectifying channels. However whether such unidirectional 
channels play a role in current spread in vivo in the heart is unknown but may be 
functionally relevant in the central nervous system where signal propagation in one 
direction is preferred (Rackauskas et al. 2007a). Co-expression of incompatible 
connexons (e.g. Cx40 and Cx43) could lead to communication barriers. In the rat heart 
Cx40 is preferentially located in the His bundle and the proximal region of the bundle 
branches compared with myocytes of the surrounding tissue expressing mainly Cx43 
(Gros et al. 1994). If these two connexons are incompatible, then the conduction system 
could be electrically isolated from the surrounding tissue and the amount of current 
flowing through Cx40 channels will be greater than that flowing through Cx43 channels 
providing a more efficient conduction (Bastide et al. 1993). 
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Knockdown of each of the three connexins affected impulse propagation with the 
largest effect produced by Cx45 indicating that, despite low levels of expression, it is 
crucial in regulating intercellular communication in the HL-1 clones. Collectively these 
approaches have enabled CV to be assigned to each combination of co-expressed 
connexins that occurs in vivo and to predict the electrophysiological consequences of 
disease-related alteration in connexin levels. 
 
8.4. Strengths and limitations 
The use of the HL1- cell line was highly advantageous due to its ability to be serially 
passaged without the loss of contraction and differentiation. As demonstrated 
throughout my thesis the HL-1 clones exhibited a gene expression profile similar to that 
of primary cardiac myocytes. The connexin expression profiles in the HL-1 clones, 
which resemble those of atrial myocytes, present an advantage over existing in vitro cell 
models designed to investigate cell-to-cell communication.  
 
Majority of the studies investigating the biophysical properties of the different gap 
junction channel types formed are based on communication-deficient cell lines 
engineered to express or co-express exogenous connexins such as Xenopus oocytes 
(Bruzzone et al. 1993; 1994) and HeLa cells  (Haubrich et al. 1996; Gemel et al. 2006; 
Rackauskas et al. 2007a). Although these cellular models have provided valuable 
information, they are unlikely to represent the actual ratios of connexins co-expressed in 
cardiac tissue and the expression levels of the transfected connexins are generally static. 
Selected data comparing the HL-1 clones and human tissue indicated similarities in 
connexin co-localisation patterns (Cx40 and Cx43), co-expression ratios of Cx40/Cx43 
and levels of heteromerisation (Cx40 and Cx43), a unique advantage over transfected 
cell models. In addition results from the HL-1 clones were reproducible, time and cost 
effective and amenable to transfection using RNAi or plasmid DNA constructs followed 
by selection with antibiotics to modulate a specific protein.  
 
One of the limitations in our study was the inability to study the biological significance 
of Cx45. The low levels of Cx45 expressed in the HL-1 clones made detecting this 
protein by western blot difficult and we were unable to correlate the amount of Cx45 
reduced and the decrease in CV after siRNA. In our cell model we were also not able to 
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study anisotropy by the lack of a structured cell shape and the distribution of gap 
junctions along the cell perimeter compared with cardiac myocytes in which the gap 
junctions are located at cell-to-cell ends at the intercalated disk. When relating CV to 
connexin expression and its potential role in arrhythmias in vivo additional factors are 
likely to be involved. Arrhythmias are multifactorial in origin involving an interplay 
between gap-junctional coupling, membrane excitability and cell and tissue architecture 
(Severs et al. 2008). For example atrial fibrillation leads to electrical and structural 
remodelling including fibroblast proliferation, fibrosis and cell death (de Bakker and 
van Rijen 2006). Fibrosis involves a large accumulation of collagen sheets, which act as 
electrical insulators so impairing electrical coupling between myocytes. Moreover 
fibroblasts could modulate impulse propagation by forming gap junctions with cardiac 
myocytes (Rohr 2004; Miragoli et al. 2007). 
 
In summary findings in vitro particularly between connexin co-expression could be 
extrapolated to in vivo and patient samples to further our knowledge on the 
physiological consequences of altered connexin expression in modulating impulse 
propagation in both the healthy and diseased heart. 
 
8.5. Future directions 
mRNA quantification 
In this study mRNA transcribed by the HL-1 clones was quantified by Northern blot. 
Although this technique provides a direct relative comparison of mRNA abundance 
between samples and additional information on the transcript size and alternative 
splicing there are limitations associated with northern analysis (Bustin 2000). For 
example quantification relies on the integrity of the RNA samples and how efficiently it 
has transferred onto the membrane. As a result, if the samples are degraded or RNA 
transfer is incomplete, the ability to quantify is severely compromised. For future 
experiments a more sensitive approach such as real-time polymerase chain reaction 
(PCR) could be employed to study gene expression. real-time PCR relies on the specific 
amplification of target RNA and its detection through a fluorescence tag at the end of 
every cycle rather than after a fixed number of cycles. Thus the higher the initial starting 
copy number of the mRNA target, the quicker the fluorescence is observed. In addition 
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compared with northern blot, real-time PCR can be used to quantify mRNA levels from 
small samples, is less time consuming and above all accurate (Wang and Brown 1999).       
 
Action potential recordings in clone 2 
Action potentials were recorded from clones 2 and 6 using patch electrodes. However 
we were only able to record a single action potential from clone 2 despite the clone 
producing spontaneous [Ca
2+
]i and extracellular field potentials. Both these experiments 
indicate that cells in clone 2 are able to produce action potentials once confluence is 
achieved. This is an important factor in HL-1 cells as their differentiation is very much 
dependent on cell density and time spent in culture (Claycomb et al. 1998). To test the 
hypothesis that action potential production in clone 2 is truly density dependent, the cell 
monolayer needs to be accessible to micro electrodes, already used in a variety of 
studies (Jongsma and van Rijn 1972; Bursac et al. 2003). A future protocol would 
involve the seeding of a confluent cell monolayer and sharp micropipettes fabricated 
with a tip resistance of 50 M used to impale the cell monolayer. Recordings would be 
made in cells superfused with normal Tyrode. Using this protocol should give us further 
information on action potential shape and duration particularly in clone 2 and if any 
differences are observed in action potential morphology between single cells and a cell 
monolayer. 
 
Pacemaker generation 
The HL-1 clones provide an ideal cell model in which pacemaker automaticity could be 
generated. Although this was not extensively studied we were able to record If but only 
in clone 6. This suggests there are other mechanisms likely to be involved: (1) cyclic 
release of [Ca
2+
]i from the sarcoplasmic reticulum (SR) though the ryanodine receptor 
(RyR) and (2) sodium-calcium exchanger (NCX) that provides a transient inward 
current associated with SR Ca
2+
 release and an increase in [Ca
2+
]i (Lakatta et al. 2003). 
RNAi could be used to knockdown these key proteins (e.g. RyR2 and NCX 1.1) seeing 
as there are a range of siRNA commercially available. Alternatively pharmacological 
agents could be used to block ion channels. RNAi is preferable because of the 
specificity of the technique. This protocol could also be employed to study the role of 
membrane excitability (e.g. Na
+
 and Ca
2+
) in action potential propagation since 
suppression of all three connexins only resulted in a slowing of CV rather than 
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conduction block. The functional consequences could be analysed not only by patch-
clamp but also through MEA which will potentially provide a bridge between single 
cells and the whole tissue. Figure 8.1 is a schematic view of the ion channels that could 
affect automaticity and membrane excitability. 
 
 
Figure 8.1: Schematic diagram of the ion channels responsible for pacemaker generation and 
membrane excitability 
RNAi or pharmacological agents could be used to test the role of each ion channel responsible for 
action potential generation and membrane excitability (i.e. the amount of charge produced by the 
inward currents). Ion channels are listed with the corresponding gene name and pharmacological 
agent. Functionality could be assessed on: (1) action potentials recorded from single cells or (2) 
extracellular field potentials from a cell monolayer using MEA. Image was modified from Dobrzynski 
et al. (2007). 
 
Connexin compatibility 
To test the hypothesis that cells composed of Cx40 and Cx43 are not capable of forming 
heterotypic channels, co-culture studies using siRNA could be performed. We know 
that cells in clone 6 expressed Cx40 and Cx43 at a ratio of 1:1 and siRNA suppressed 
connexin expression by approximately 60-70%. To investigate this hypothesis cells 
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treated with Cx40 siRNA can be co-cultured with cells treated with Cx43 siRNA. One 
group of cells will be stained with membrane permeant fluorescent probes such as 
CMFDA (5-chloromethylfluorescein diacetate) or CMHC (4-chloromethyl-7-
hydroxycoumarin) to help discriminate between Cx40 and Cx43 expressing cells. 
Compatibility could be verified by immunoconfocal analysis. Electrophysiological 
studies on cell pairs from the co-culture would help gain further information regarding 
the precise molecular make-up of the type of channels formed when Cx40 and Cx43 are 
co-expressed. We were unable to study cell-to-cell communication using scrape-loading 
in the HL-1 clones as no dye transfer was observed with Lucifer yellow (data not 
shown). However there are a variety of different molecules that could be tested (e.g. 
neurobiotin, ethidium bromide) to characterise the permeability-selectivity of the 
channels formed (Elfgang et al. 1995). 
 
Assessing the role of connexin interacting proteins 
In this study we did not examine the functional role of ZO-1 in the HL-1 clones. 
Previous studies have demonstrated that ZO-1 plays an important role in modulating 
gap junction size and the recruitment of connexons to the gap junction periphery. To 
assess of role of ZO-1 in regulating cell-to-cell communication, siRNA could be applied 
and the effects assessed by MEA. It is also likely that ZO-1 functions in parallel with 
other connexin interacting partners such as N-cadherin and β-catenin that are known to 
interact with Cx43 (Hertig et al. 1996; Kostin et al. 1999). Thus the HL-1 clones could 
be used to study connexin protein interactions and further our understanding in their 
role in formation and stability of gap junctions particularly as mutations or suppression 
of these proteins can: (1) lead to slow conduction and arrhythmias and (2) reductions in 
Cx43 expression (Li et al. 2006). 
 
8.6. Concluding comment 
In summary we have demonstrated the HL-1 clones provide a useful model in studying 
varying aspects of cardiac biology and electrophysiology including cellular signalling, 
signal transduction and Ca
2+
 handling. The work on gap junction expression using 
RNAi has clearly identified that each of the connexins plays a specific role in 
conduction. This data should aid our understanding of gap junction function in the 
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healthy and diseased heart by showing how alterations of connexin co-expression can 
affect the communication behaviour of cells. 
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